|4-氨基-1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-1,3,5-三嗪-2(1H)-酮|CsnPharm

CAS No.: 320-67-2

5-氮胞苷 Catalog No. CSN19354

Synonyms: Azacitidine;5-AzaC;Ladakamycin

5-Azacytidine is a nucleoside analogue of cytidine that specifically inhibits DNA methylation by trapping DNA methyltransferases.

规格	价格	促销价格	库存	数量

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

加入购物车大规格询价

加入收藏

产品咨询

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

纯度 & 质量文件批次:

靶点选择性

生物活性

实验方案

技术信息

生物活性

描述DNA methyltransferase enzymes (DNMTs) are responsible for the DNA methylation process which could catalyze the transfer of a methyl group from S-adenosyl methionine to the cytosine target nucleotide producing methylcytosine^[5]. Azacytidine (5-AZ) is a DNMT inhibitor with IC50 value of 0.8 - 3 μmol/L on MM cells^[6]. The K12-72.1 cells were treated with 5-AZ at both 5 and 10 μM, and the methylation status of the CpG sites in the promotor region of the gene PGP9.5 were measured by bisulfite sequencing. It was found that both concentrations could cause demethylation of the CpG sites and increased the expression of the gene PGP9.5. Moreover, after the treatment of 50 μM of 5-AZ on MCF10CA1a and MCF7 cells, the cell viability as measured by MTT assay decreased significantly compared with control^[7]. The nude mice with SKOV3 xenografts were treated with 2 mg/kg 5-AZ thrice weekly for 10 weeks. The volume and weight per nodule were decreased after the treatment of 5-AZ, which indicated that the 5-AZ could inhibit growth of tumors^[8].
作用机制The 5-AZ could inhibit the DNA methylation through covalently binding to DNA methyltransferases, forming nucleoprotein adducts. Therefore, the number of active DNA methyltransferase enzymes in the cells are depletes^[9].
细胞研究

Cell Data

Cell Lines	Concentration	Assay Type	Time	Activity Description	Data Sources
92.1	0.5/1/2 μM	Growth Inhibition Assay	7 d	inhibits cell growth in a dose dependent manner	25146981
92.1	0.5/1 μM	Function Assay	48 h	decreases clonogenicity dose-dependently	25146981
92.1	0.5/1 μM	Cell Viability Assay	5 d	decreases radiation-induced cell viability inhibition	25146981

更多
动物研究
剂量
Mice: 5 mg/kg^[5], 25 mg/kg^[6] (i.p.), 38 mg/kg^[6] (p.o.)

给药途径
i.p., p.o.

毒性数据 (半致死量)
MTD = 90 mg/kg i.v.^[3]
临床研究

动物研究
剂量	Mice: 5 mg/kg^[5], 25 mg/kg^[6] (i.p.), 38 mg/kg^[6] (p.o.)
给药途径	i.p., p.o.
毒性数据 (半致死量)	MTD = 90 mg/kg i.v.^[3]

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT02275663	Acute Myeloid Leukemia	Phase 2	Unknown	October 2018	Saudi Arabia ... more >> King Fahad Medical City Recruiting Riyadh, Saudi Arabia, 11525 Contact: Ibraheem Motabi, MD +966112889999 ext 11998 imotabi@kfmc.med.sa Collapse <<
NCT01193517	Colorectal Cancer	Phase 1 Phase 2	Completed	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01241786	Chronic Lymphocytic Leukemia (... more >>CLL) and Small Lymphocytic Lymphoma (SLL) Collapse <<	Phase 2	Terminated(anticipated results... more >> not seen and population not seen) Collapse <<	-	United States, New Jersey ... more >> Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Collapse <<

更多
参考文献

实验方案

计算器摩尔计算器总药量计算器工作液计算器
储存液制备
- 1 mg
- 5 mg
- 10 mg
- 1 mM
- 4.0948 mL
- 20.4742 mL
- 40.9484 mL
- 5 mM
- 0.8190 mL
- 4.0948 mL
- 8.1897 mL
- 10 mM
- 0.4095 mL
- 2.0474 mL
- 4.0948 mL

技术信息

CAS号

320-67-2

储存条件

粉末: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C

液体: -20°C:3-6 月 -80°C:12月

分子式

C8H12N4O5

运输

蓝冰

分子量

244.20

别名

Azacitidine;5-AzaC;Ladakamycin;NSC 102816;5-Azacitidine;Antibiotic U 18496;Mylosar;NSC 103-627;WR 183027;U-18496;Abbreviations: 5AC;5AZC. 5-azacytidine;azacytidine;ladakamycin. US brand names: Mylosar;Vidaza;5-氮杂胞苷;5-氮胞苷

溶解度

DMSO	32.0 mg/mL (131.0 mM)
Water	insoluble

动物实验配方

5% DMSO+30% PEG 300+water

10 mg/mL

大规格询价

号为必填项

姓名: 邮箱: 手机号:

留言:

提交

Cell Lines	Concentration	Assay Type	Time	Activity Description	Data Sources

92.1	0.5/1/2 μM	Growth Inhibition Assay	7 d	inhibits cell growth in a dose dependent manner	25146981
92.1	0.5/1 μM	Function Assay	48 h	decreases clonogenicity dose-dependently	25146981
92.1	0.5/1 μM	Cell Viability Assay	5 d	decreases radiation-induced cell viability inhibition	25146981
92.1	0.5/1 μM	Function Assay	48 h	causes global DNA hypomethylation at L-1 repeat loci	25146981
A253	10 µM	Function Assay	0-4 d	increases the mRNA expression level of the M3R after 24 h	25485536
A253	10 µM	Function Assay	72 h	increases the expression level of the M3R in both membrane and cytosolic preparations	25485536
A253	10 µM	Function Assay	0-4 d	reduces the 5-methylcytosine content	25485536
A2780	5 µM	Function Assay	7 d	increases DNA methylation level	25299694
A2780	5 µM	Function Assay	7 d	weakens the level of methylation	25299694
A498	10 µM	Function Assay	72 h	induces the ADAMTS18 gene expression	25569086
Be(2)-C	3 μM	Function Assay	72 h	induces p19-INK4d expression significantly	25104850
BGC-823	5 μM	Function Assay	72 h	decreases the PRL-3 protein level signifcantly	25475733
BGC-823	5 μM	Function Assay	72 h	decreases the mRNA expression of PRL-3 significantly	25475733
Bxpc-3	5/10 μM	Growth Inhibition Assay	24/48/72 h	inhibits the proliferation of Bxpc-3 cells in time- and concentration-dependent manners	25061731
Bxpc-3	5/10 μM	Apoptosis Assay	24/48/72 h	induces apoptosis in time- and concerntration manners	25061731
Bxpc-3	5/10 μM	Function Assay	24/48/72 h	decreases β-catenin expression after 24 h	25061731
Bxpc-3	5/10 μM	Function Assay	24/48/72 h	decreases cyclinD1 expression at the concerntration of 10 μM	25061731
Bxpc-3	5/10 μM	Function Assay	24/48/72 h	down-regulateS c-myc mRNA expression in time- and concentration-dependent manners	25061731
CA46	20 µM	Function Assay	48 h	increases PTPL1 mRNA expression	26133246
Caco2	10 μM	Function Assay	48 h	increases NPC1L1 expression	24904062
CaKI-2	10 µM	Function Assay	72 h	induces the ADAMTS18 gene expression	25569086
CD3+ T-cells	5/20 μM	Function Assay	48 h	upregulates p15 expression	24757283
CD3+ T-cells	5/20 μM	Function Assay	48 h	upregulates the expression of FOXP3	24757283
CD3+ T-cells	5 μM	Function Assay	48 h	reduces long-term memory cell phenotype	24757283
CD4+ T-cells	5/20 μM	Function Assay	48 h	upregulates p15 expression	24757283
CD4+ T-cells	5/20 μM	Function Assay	48 h	upregulates the expression of FOXP3	24757283
CD4+ T-cells	5/20 μM	Function Assay	48 h	reduces TBET1 mRNA expression	24757283
CD4+ T-cells	5/20 μM	Function Assay	48 h	upregulates the expression of RORγt	24757283
CD4+ T-cells	5/20 μM	Function Assay	48 h	inhibits memory T-cells	24757283
CD8+ T-cells	5/20 μM	Function Assay	48 h	upregulates p15 expression	24757283
CD8+ T-cells	5/20 μM	Function Assay	48 h	inhibits memory T-cells	24757283
CNDT2	5µM	Function Assay	4 d	reduces the methylation levels of WIF1, P16, CXCL14, NKX2–3, CDH1, LAMA1, and CTNNB1	24762809
CNDT2	5µM	Function Assay	4 d	increases gene expression of WIF1, P16, CDH1, LAMA1, and CTNNB1	24762809
CP70	5 µM	Function Assay	7 d	increases DNA methylation level	25299694
CP70	5 µM	Function Assay	7 d	weakens the level of methylation	25299694
HC45	5µM	Function Assay	4 d	reduces the methylation levels of WIF1, P16, CXCL14, NKX2–3, CDH1, LAMA1, and CTNNB1	24762809
HepG2	0-25 μM	Function Assay	24 h	decreases subtilisin/kexin type 9 (PCSK9) protein levels dose dependently	24855646
HepG2	0-25 μM	Function Assay	24 h	increases low density lipoprotein receptor (LDLR) gene expression	24855646
HepG2	10 μm	Function Assay	0-24 h	decreases PCSK9 and HMGCR expression and increases LDLR expression after 6 h	24855646
HepG2	10 μm	Function Assay	24 h	promotes cytosolic neutral lipid accumulation independently of exogenous lipoproteins	24855646
HepG2	10 μm	Function Assay	24 h	prevents SREBP processing	24855646
HL-60	5 μM	Function Assay	72 h	significantly upregulates ZNF382 expression	25319049
HL-60	1.0 μM	Growth Inhibition Assay	48 h	significantly inhibits HL-60 cell growth	25051119
HL-60	1.0 μM	Function Assay	48 h	increases p21WAF1/CIP1 and caspase-3 expression	25051119
HL-60	1.0 μM	Function Assay	48 h	decreases Bcl-xL expression significantly	25051119
HL-60	10 μM	Apoptosis Assay	72 h	induces apoptosis significantly	24680865
HREC	5/10 μM	Function Assay	48 h	induces PEDF in a dose-dependent manner	25352747
HREC	5/10 μM	Function Assay	48 h	down-regulates of VEGF, ICAM-1 (not protein level in HRPE cells), IL-1β dose-dependently	25352747
HRPE	5/10 μM	Function Assay	48 h	induces PEDF in a dose-dependent manner	25352747
HRPE	5/10 μM	Function Assay	48 h	down-regulates of VEGF, IL-1β, and MMP2 dose-dependently	25352747
HuTu-80	1/5/10 μM	Function Assay	48/72 h	increases the expression of human NPC1L1 mRNA in a dose-dependent manner	24904062
IMR32	3 μM	Function Assay	72 h	induces p19-INK4d expression significantly	25104850
IMR5-75	3 μM	Function Assay	72 h	induces p19-INK4d expression significantly	25104850
Jurkat	0.1-50 μM	Growth Inhibition Assay	12-72 h	inhibits cell growth in a dose dependent manner	26133246
Jurkat	3.5 µM	Function Assay	48 h	increases PTPL1 mRNA expression	26133246
Ketr-3	10 µM	Function Assay	72 h	induces the ADAMTS18 gene expression	25569086
MCF7	0.3 μM	Function Assay	4 d	increases the gene expression of IGFBP7, SFRP1 and SLC6A15 combined with GSK126	25477340
MCF7	0.3 μM	Growth Inhibition Assay	4 d	decreases the cell growth 24.8% combined with GSK126	25477340
MCF7	5 μM	Function Assay	48 h	displays selective toxicity toward suspended MCF-7 cells	24633350
MCF7	10 μM	Function Assay	24 h	induces the cleavage of caspase 7 and PARP	24633350
MCF7	0–0.5 μM	Function Assay	7 d	inhibits the growth MCF-7 tumorspheres in suspension cultures	24633350
MCF7	0.5 μM	Function Assay	14 d	reduces the size of MCF-7 colonies embedded in soft agar	24633350
MCF7	0.05–20 μM	Function Assay	1 d	reduces the clonal survival of MCF-7 cells in monolayer cultures	24633350
MCF7	0.5–10 μM	Function Assay	48 h	inhibits the gap closure in the wound healing assay	24633350
MCF7	0/10 μM	Function Assay	24 h	inhibits the activity of MMP9	24633350
MCF-7	1/2.5/5 μM	Function Assay	24/48 h	increases PARP cleavage	25817229
MDA-MB-231	1/2.5/5 μM	Function Assay	48 h	decreases the PTPN12 expression at the concerntration of 5 μM 48 h	25817229
MDA-MB-231	1/2.5/5 μM	Function Assay	48 h	increases the levels of E-cadherin mRNA at the concerntration of 2.5 μMfor 48 h	25817229
MDA-MB-231	1/2.5/5 μM	Function Assay	24/48 h	induces significant PARP cleavage after 48 h	25817229
MDA-MB-231	1/2.5/5 μM	Function Assay	24/48 h	increases the expression of miRNA-124 at the concerntration of 5 μM	25817229
MDA-MB-231	0.5–10 μM	Function Assay	36 h	inhibits the migration	24633350
Mel 285	0.5/1/2 μM	Growth Inhibition Assay	7 d	inhibits cell growth in a dose dependent manner	25146981
Mel 285	0.5/1 μM	Function Assay	48 h	decreases clonogenicity dose-dependently	25146981
Mel 290	0.5/1/2 μM	Growth Inhibition Assay	7 d	inhibits cell growth in a dose dependent manner	25146981
Mel 290	0.5/1 μM	Function Assay	48 h	decreases clonogenicity dose-dependently	25146981
Mel 290	0.5/1 μM	Function Assay	48 h	decreases invasion dose dependently	25146981
MKN28	5 μM	Function Assay	72 h	decreases the PRL-3 protein level signifcantly	25475733
MKN28	5 μM	Function Assay	72 h	decreases the mRNA expression of PRL-3 significantly	25475733
MKN45	5 μM	Function Assay	72 h	decreases the PRL-3 protein level signifcantly	25475733
MKN45	5 μM	Function Assay	72 h	decreases the mRNA expression of PRL-3 significantly	25475733
MSCs	10 μM	Function Assay	24 h	promotes the commitment of MSCs to myocardial differentiation	25351395
MV4-11	5 μM	Function Assay	72 h	significantly upregulates ZNF382 expression	25319049
OCM1	0.5/1/2 μM	Growth Inhibition Assay	7 d	inhibits cell growth in a dose dependent manner	25146981
OCM1	0.5/1 μM	Function Assay	48 h	decreases clonogenicity dose-dependently	25146981
OCM1	0.5/1 μM	Cell Viability Assay	5 d	decreases radiation-induced cell viability inhibition	25146981
OCM1	0.5/1 μM	Function Assay	48 h	causes global DNA hypomethylation at L-1 repeat loci	25146981
OCM3	0.5/1/2 μM	Growth Inhibition Assay	7 d	inhibits cell growth in a dose dependent manner	25146981
OCM3	0.5/1 μM	Function Assay	48 h	decreases clonogenicity dose-dependently	25146981
OCM3	0.5/1 μM	Function Assay	48 h	decreases invasion dose dependently	25146981
OCM3	0.5/1 μM	Function Assay	48 h	causes global DNA hypomethylation at L-1 repeat loci	25146981
OMM1	0.5/1/2 μM	Growth Inhibition Assay	7 d	inhibits cell growth in a dose dependent manner	25146981
OMM1	0.5/1 μM	Function Assay	48 h	decreases clonogenicity dose-dependently	25146981
OMM1	0.5/1 μM	Function Assay	48 h	decreases invasion dose dependently	25146981
PC3	0.2 μM	Function Assay	4 d	increases the gene expression of IGFBP7, SFRP1 and SLC6A15 combined with GSK126	25477340
PC3	0.2 μM	Growth Inhibition Assay	4 d	decreases the cell growth to 20.3% combined with GSK126	25477340
Raji	0.1-50 μM	Growth Inhibition Assay	12-72 h	inhibits cell growth in a dose dependent manner	26133246
Raji	15 µM	Function Assay	48 h	increases PTPL1 mRNA expression	26133246
SGC-7901	5 μM	Function Assay	72 h	decreases the PRL-3 protein level signifcantly	25475733
SGC-7901	5 μM	Function Assay	72 h	decreases the mRNA expression of PRL-3 significantly	25475733
T47D	0.5 μM	Function Assay	4 d	inhibits tumorsphere formation	24633350
T-cells	5/20 μM	Growth Inhibition Assay	0-48 h	inhibits cell growth in a dose dependent manner	24757283
U937	10 μM	Apoptosis Assay	72 h	induces apoptosis significantly	24680865

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT02275663	Acute Myeloid Leukemia	Phase 2	Unknown	October 2018	Saudi Arabia ... more >> King Fahad Medical City Recruiting Riyadh, Saudi Arabia, 11525 Contact: Ibraheem Motabi, MD +966112889999 ext 11998 imotabi@kfmc.med.sa Collapse <<
NCT01193517	Colorectal Cancer	Phase 1 Phase 2	Completed	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01241786	Chronic Lymphocytic Leukemia (... more >>CLL) and Small Lymphocytic Lymphoma (SLL) Collapse <<	Phase 2	Terminated(anticipated results... more >> not seen and population not seen) Collapse <<	-	United States, New Jersey ... more >> Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Collapse <<
NCT00652626	MDS AML ... more >> Solid Tumors Multiple Myeloma Non-Hodgkin's Lymphoma Hodgkin's Disease Collapse <<	Phase 1	Completed	-	United States, California ... more >> Sutter East Bay Hospitals Berkley, California, United States, 94704 United States, Florida Palm Springs Research Institute Hialeah, Florida, United States, 33012 United States, Georgia MCG Cancer Center Augusta, Georgia, United States, 30912 United States, Illinois Joliet Oncology-Hematology Associates, Ltd. Joliet, Illinois, United States, 60435 United States, Kentucky University of Kentucky-Markey Cancer Center Clinical Research Organization Lexington, Kentucky, United States, 40536 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, New York Montefiore Medical Center Bronx, New York, United States, 10461 United States, North Dakota Mid Dakota Clinical P.C. - Cancer Treatment and Research Center Bismarck, North Dakota, United States, 58501 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, Rhode Island Pharma Resource East Providence, Rhode Island, United States, 02915 United States, Texas Cancer Therapy and Research Center San Antonio, Texas, United States, 78229 Collapse <<
NCT02750995	Myelodysplastic Syndrome ... more >> Acute Myeloid Leukemia Collapse <<	Phase 1	Recruiting	September 2020	Denmark ... more >> Dept of Hematology, Herlev Hospital Recruiting Herlev, Denmark, 2730 Contact: Jytte Kock, Nurse +45 38682129 jytte.kock@regionh.dk Contact: Staffan Holmberg, MD +45 60744083 staffan.holmberg@regionh.dk Principal Investigator: Inge Høgh Dufva, Lector Sub-Investigator: Staffan Holmberg, MD Sub-Investigator: Anne Ortved Gang, MD Collapse <<
NCT01152346	Myelodysplastic Syndrome	Phase 1	Completed	-	United States, California ... more >> Pacific Cancer Medical Center Inc. Anaheim, California, United States, 92801 Wilshire Oncology Medical Group Corona, California, United States, 92879 California Cancer Associates Fresno, California, United States, 93720 United States, Florida Holy Cross Hospital Fort Lauderdale, Florida, United States, 33308 France Service d'hématologie clinique Hôpital Avicenne Bobigny cedex, France, 93009 CHU de Brest- Hôpital Morvan Brest, France, 29609 Centre Hospitalier Lyon Sud Lyon, France, 69495 Hôpital Archet 1 Nice, France, 06200 Hôpital Haut-Lévêque Pessac, France, 33604 CH Annecy Pringy, France, 74374 CHU Purpan Toulouse, France, 31059 Centre régional de cancérologie Henry-Kaplan Service d'Hématologie et thérapie cellulaire Tours, France, 37000 Service d'hématologie et de médecine interne CHU de Nancy Hôpital de Brabois Vandoeuvre, France, 54511 Collapse <<
NCT00387465	Recurrent Non-Small Cell Lung ... more >>Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Collapse <<	Phase 1 Phase 2	Completed	-	United States, California ... more >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Sidney Kimmel Cancer Center San Diego, California, United States, 92121 United States, Maryland Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States, 21231 Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 Collapse <<
NCT01305499	Acute Myeloid Leukemia	Phase 2	Recruiting	February 2019	United States, Connecticut ... more >> Yale School of Medicine Not yet recruiting New Haven, Connecticut, United States, 06520 Contact: Steven Gore, MD steven.gore@yale.edu United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Active, not recruiting Baltimore, Maryland, United States, 21231 United States, Ohio Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Not yet recruiting Cleveland, Ohio, United States, 44106 Contact: Benjamin Tomlinson, MD Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Hetty Carraway, MD, MBA 216-445-5899 carrawh@ccf.org Collapse <<
NCT01542684	-	-	Terminated(Slow Accrual)	-	-
NCT00569660	Myelofibrosis	Phase 2	Completed	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01088373	Myelodysplastic Syndromes	Phase 2	Completed	-	France ... more >> Hôpital kremlin Bicêtre Le Kremlin-Bicêtre, IDF, France, 94275 Chu Brabois Nancy, Vandoeuvre, France, 54511 CHU d'Amiens Amiens, France, 80054 CHU Angers Angers, France, 43033 Hôpital de la cote basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93009 CHU Haut-Lévèque Bordeaux, France, 33604 CH René Dubos Cergy-pontoise, France, 95303 CHU de Clermont Ferrand, France, 63058 Centre Hospitalier Sud-Francilien Corbeil-Essonnes, France, 91106 CHU Henri Mondor Creteil, France, 94010 CHU de Grenoble Grenoble, France, 38043 CH Le mans Le mans, France, 72037 Centre Hospitalier de Lens Lens, France, 32307 CHRU de Limoges Limoges, France, 87046 Hôpital Edouard Heriot, dpt Hématologie Clinique Lyon, France, 69437 Institut Paoli-Calmette, Département d'hématologie Marseille, France, 13009 Centre Hospitalier de Meaux Meaux, France, 77100 Hopital de l'Hotel Dieu, Hematology Dpt Nantes, France, 44093 CHU Archet Nice, France, 06202 CHR La Source orléans Orléans, France, 45067 Hôpital Saint Louis Paris, France, 75010 Saint-Louis Hospital Paris, France, 75010 Hôpital Saint-Antoine Paris, France, 75012 Hôpital la pitié-Salpétrière Paris, France, 75013 Hopital Cochin Service d'Hématologie Paris, France, 75679 Hôpital Maréchal Joffre Perpignan, France, 66046 Hôpital Jean-Bernard Poitiers, France, 86021 centre hospitalier Jacques Puel Rodez, France, 12027 Hôpital Henri Becquerel Rouen, France, 76038 Hôpital Purpan, médecine Interne Toulouse, France, 31059 Hôpital PURPAN, Service d'Hématologie Clinique Toulouse, France, 31059 CHU Bretonneau Tours, France, 37044 Institut gustave Roussy Villejuif, France, 94805 Collapse <<
NCT01167816	Pancreatic Cancer	Phase 1	Terminated(The study was termi... more >>nated as the Prinicipal Investigator left the site- all previous subjects enrolled are deceased) Collapse <<	-	United States, Oklahoma ... more >> Stephenson Cancer Center Oklahoma City, Oklahoma, United States, 73104 Collapse <<
NCT00569660	-	-	Completed	-	-
NCT02530463	Leukemia Myel... more >>odysplastic Syndrome Collapse <<	Phase 2	Recruiting	September 2022	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Collapse <<
NCT00652626	-	-	Completed	-	-
NCT03161223	Lymphoma, T-Cell	Phase 1 Phase 2	Recruiting	June 30, 2020	United States, New York ... more >> Center for Lymphoid Malignancies at CUMC Recruiting New York, New York, United States, 10019 Contact: Michelle Malanga, MPA Principal Investigator: Owen A O'Connor, M.D., PhD Sub-Investigator: Jennifer E Amengual, M.D. Sub-Investigator: Ahmed Sawas, M.D. Sub-Investigator: Changchun Deng, M.D. Sub-Investigator: Lorenzo Falchi, M.D. Italy University of Bologna Not yet recruiting Bologna, Italy Principal Investigator: Pier Luigi Zinzani, M.D., PhD. Korea, Republic of Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of Principal Investigator: Won Seog Kim, M.D., Ph.D. Collapse <<
NCT00384839	Prostate Cancer	Phase 2	Completed	-	United States, Colorado ... more >> Rocky Mountain Cancer Center-Midtown Denver, Colorado, United States, 80218 United States, Florida Cancer Centers of Florida, P.A. Ocoee, Florida, United States, 34761 United States, Minnesota Minnesota Oncology Hematology, P.A. Minneapolis, Minnesota, United States, 55404 United States, Nevada Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89109 United States, New York New York Oncology Hematology, P.C. Albany, New York, United States, 12208 United States, North Carolina Raleigh Hematology Oncology Associates Cary, North Carolina, United States, 27511 Northwestern Carolina Oncology Hematology Hickory, North Carolina, United States, 28602 United States, Texas Texas Oncology, P.A. Dallas, Texas, United States, 75246 Texas Oncology, P.A. Fort Worth, Texas, United States, 76104 Tyler Cancer Center Tyler, Texas, United States, 75702 Deke Slayton Cancer Center Webster, Texas, United States, 77598 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 United States, Washington Cancer Care Nrothwest-South Spokane, Washington, United States, 99202 Collapse <<
NCT01542684	Leukemia	Phase 2	Terminated(Slow Accrual)	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT03113643	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 1	Recruiting	May 31, 2023	United States, California ... more >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Anthony Stein, MD 626-359-8111 AStein@coh.org Principal Investigator: Anthony Stein, MD United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Andrew Lane, MD, PhD 617-632-4589 andrew_lane@dfci.harvard.edu Principal Investigator: Andrew Lane, MD, PhD United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Naveen Pemmaraju, MD 713-792-4956 npemmaraju@mdanderson.org Principal Investigator: Naveen Pemmaraju, MD Collapse <<
NCT00384839	-	-	Completed	-	-
NCT02009436	Recurrent Non-Small Cell Lung ... more >>Carcinoma Stage IV Non-Small Cell Lung Cancer Collapse <<	Phase 1	Unknown	-	United States, New York ... more >> Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Roman Perez-Soler 718-405-8404 rperezso@montefiore.org Principal Investigator: Roman Perez-Soler Collapse <<
NCT03298321	-	-	Not yet recruiting	October 2020	France ... more >> Service de rythmologie - GH Est-Hôpital Louis Pradel - CHU de Lyon HCL Not yet recruiting Bron, France, 69229 Contact: Philippe CHEVALIER, MD 04 72 35 76 89 ext +33 philippe.chavalier@chu-lyon.fr Contact: Camille VALLA 04 27 85 62 69 ext +33 camille.valla@chu-lyon.fr Principal Investigator: Philippe CHEVALIER, MD Collapse <<
NCT02399917	Acute Biphenotypic Leukemia ... more >> Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Collapse <<	Phase 2	Completed	-	United States, Texas ... more >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00387647	Leukemia	Phase 2	Completed	-	United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT00387647	-	-	Completed	-	-
NCT00350818	Myelodysplastic Syndrome ... more >> Leukemia Collapse <<	Phase 1	Completed	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00339196	Acute Myelogenous Leukaemia (A... more >>ML) Myelodysplastic Syndrome (MDS) Collapse <<	Phase 2	Completed	-	France ... more >> Chu Saint Louis Paris, France, 75010 Collapse <<
NCT00728520	Acute Myeloid Leukemia ... more >> Elderly Collapse <<	Phase 2	Unknown	June 2012	United States, Missouri ... more >> Kansas City Veterans Affairs Medical Center Recruiting Kansas City, Missouri, United States, 64218 Contact: Sarah E Spencer, RN, BSN 816-861-4700 ext 57665 sarah.spencer@va.gov Contact: Suman Kambhampati, MD 816-861-4700 ext 57075 suman.kambhampati@va.gov Principal Investigator: Suman Kambhampati, MD Sub-Investigator: Peter J. Van Veldhuizen, MD Sub-Investigator: Chao H. Huang, MD Sub-Investigator: Chester Stone, MD Collapse <<
NCT03019003	Head and Neck Cancer	Phase 1 Phase 2	Recruiting	July 2024	United States, Massachusetts ... more >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Sara Pai, MD, PhD 617-726-5251 sara.pai@mgh.harvard.edu Principal Investigator: Sara Pai, MD, PhD Principal Investigator: Lori Wirth, MD Collapse <<
NCT00326170	-	-	Completed	-	-
NCT00326170	Myelodysplastic Syndrome ... more >> Acute Myelogenous Leukemia Collapse <<	Phase 2	Completed	-	United States, Texas ... more >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT03248479	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndromes Collapse <<	Phase 1	Recruiting	August 2022	United States, California ... more >> City of Hope Recruiting Duarte, California, United States, 91010 Principal Investigator: Guido Marcucci United States, Colorado University of Colorado Cancer Center Recruiting Aurora, Colorado, United States, 80045 Principal Investigator: Daniel Pollyea United States, Florida H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Principal Investigator: David Sallman United States, Missouri Research Medical Center (HCA Midwest Health) Recruiting Kansas City, Missouri, United States, 64131 Principal Investigator: Suman Kambhampati United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Principal Investigator: Mark Frattini United States, Tennessee Tennessee Oncology Centennial Clinic (Sarah Cannon Research Institute) Recruiting Nashville, Tennessee, United States, 37203 Principal Investigator: William Donnellan United Kingdom Churchill Hospital, Oxford University Not yet recruiting Oxford, United Kingdom, OX3 7LE Principal Investigator: Paresh Vyas Collapse <<
NCT01180322	Acute Myeloid Leukemia (AML)	Phase 2	Unknown	October 2016	Austria ... more >> Universitätsklinikum Innsbruck Innsbruck, Austria, 6020 Krankenhaus der Barmherzigen Schwestern Linz, Austria, 4010 Elisabethinen Krankenhaus Linz Linz, Austria, 4020 Landeskliniken Salzburg Salzburg, Austria, 5020 Hanuschkrankenhaus Wien, Austria, 1140 Germany Universitätsklinikum Charité Berlin Berlin, Germany, 13353 Knappschaftskrankenhaus Bochum-Langendreer Bochum, Germany, 44892 Universitätsklinikum Bonn Bonn, Germany, 53111 Städtisches Klinikum Braunschweig Braunschweig, Germany, 38114 Klinikum Bremen-Mitte Bremen, Germany, 28177 Klinikum Darmstadt Darmstadt, Germany, 64283 Universitätsklinikum Düsseldorf Düsseldorf, Germany, 40225 Kliniken Essen Süd, Evangelischs Krankenhaus Essen, Germany, 45239 Klinikum Esslingen Esslingen, Germany, 73730 Klinikum Frankfurt-Höchst Frankfurt, Germany, 65929 Medizinisches Versorgungszentrum Fulda Fulda, Germany, 36043 Universitätsklinikum Gießen Gießen, Germany, 35392 Wilhelm-Anton-Hospital Goch Goch, Germany, 47574 Universitätsklinikum Göttingen Göttingen, Germany, 37075 Sklepios Klinik Hamburg-Altona Hamburg, Germany, 22763 Evangelisches Krankenhaus Hamm Hamm, Germany, 59063 Klinikum Hanau Hanau, Germany, 63450 KRH Klinikum Hannover-Siloah Hannover, Germany, 30449 Medizinische Hochschule Hannover Hannover, Germany, 30625 SLK-Kliniken Heilbronn Heilbronn, Germany, 74078 Städtisches Klinikum Karlsruhe Karlsruhe, Germany, 76133 Universitätsklinikum Schleswig-Holstein Kiel, Germany, 24116 Caritas-Krankenhaus Lebach Lebach, Germany, 66822 Klinikum Lippe Lemgo, Germany, 32657 Klinikum Lüdenscheid Lüdenscheid, Germany, 58515 Klinikum der Johannes-Guttenberg-Universität Mainz, Germany, 55131 Johannes Wesling Klinikum Minden Minden, Germany, 32429 Stauferklinikum Schwäbisch-Gmünd Mutlangen, Germany, 73557 Klinikum rechts der Isar München, Germany, 81675 Klinikum Passau Passau, Germany, 94032 Krankenhaus der Barmherzigen Brüder Regensburg, Germany, 93049 Caritas-Klinik St. Theresia Saarbrücken, Germany, 66113 Klinikum Stuttgart Stuttgart, Germany, 70174 Diakonie-Klinikum Stuttgart Stuttgart, Germany, 70176 Krankenhaus der Barmherzigen Brüder Trier, Germany, 54292 Universitätsklinikum Tübingen Tübingen, Germany, 72076 Universitätsklinikum Ulm Ulm, Germany, 89081 Schwarzwald-Baar-Klinikum Villingen-Schwenningen, Germany, 78050 Helios Klinikum Wuppertal, Germany, 42283 Collapse <<
NCT02018926	Myelodysplastic Syndrome	Phase 1 Phase 2	Completed	-	United States, District of Col... more >>umbia Georegetown University Washington, D.C., District of Columbia, United States, 20057 United States, Florida Lakes Research Miami Lakes, Florida, United States, 33014 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Hampshire Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New York New York Medical College Valhalla, New York, United States, 10595 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, South Carolina St. Francis Hospital Greenville, South Carolina, United States, 29601 United States, Texas Cancer Care Centers of South Texas New Braunfels, Texas, United States, 78130 Cancer Care Centers of South Texas San Antonio, Texas, United States, 78229 United States, Vermont Fletcher Allen Health Care and Vermont Cancer Center Burlington, Vermont, United States, 05405 Collapse <<
NCT02829840	Leukemia FLT3... more >>-Mutated Acute Myeloid Leukemia FLT3-Mutated High-Risk Myelodysplastic Syndrome Collapse <<	Phase 1 Phase 2	Withdrawn	-	-
NCT01541280	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 2	Completed	-	France ... more >> University Hospital of Nantes Nantes, France, 44000 Collapse <<
NCT03397173	Myelodysplastic Syndromes ... more >> Myeloproliferative Neoplasm Acute Myeloid Leukemia Collapse <<	Phase 2	Recruiting	January 2020	United States, Ohio ... more >> Cleveland Clinic, Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Aziz Nazha, MD 216-445-0320 nazhaa@ccf.org Principal Investigator: Aziz Nazha, MD Collapse <<
NCT02497404	Leukemia, Erythroblastic, Acut... more >>e Myelodysplastic Syndromes Collapse <<	Phase 2	Recruiting	July 2021	United States, New York ... more >> Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact: Jennifer Bourke, RN 212-746-2844 jeb9097@med.cornell.edu Principal Investigator: Sebastian Mayer, MD Sub-Investigator: Koen van Besien, MD Sub-Investigator: Tsiporah Shore, MD Sub-Investigator: Usama Gergis, MD Sub-Investigator: Adrienne Phillips, MD Sub-Investigator: Jingmei Hsu, MD Sub-Investigator: Joseph Scandura, MD Collapse <<
NCT00915785	Myelodysplastic Syndromes ... more >> Leukemia, Myeloid, Acute Collapse <<	Phase 2	Completed	-	United Kingdom ... more >> King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS Collapse <<
NCT01617226	Leukemia, Myeloid, Acute	Phase 2	Active, not recruiting	September 2019	United Kingdom ... more >> Barts and the London NHS Trust London, Greater London, United Kingdom, E1 1BB King's College Hospital London, Greater London, United Kingdom, SE5 9RS Hammersmith Hospital London, Greater London, United Kingdom, W12 0HS The Christie Hospital Manchester, Greater Manchester, United Kingdom, M20 4BX Royal Liverpool University Hospital Liverpool, Merseyside, United Kingdom, L7 8XP Belfast City Hospital Belfast, Northern Ireland, United Kingdom, BT9 7AD Nottingham University Hospitals NHS Trust Nottingham, Nottinghamshire, United Kingdom, NG27 2UH Oxford University Hospitals NHS Trust Oxford, Oxfordshire, United Kingdom, OX3 9DU University Hospital of Wales Cardiff, South Wales, United Kingdom, CF14 4XW Queen Elizabeth Hospital Birmingham, West Midlands, United Kingdom, B152TH St James's University Hospital Leeds, West Yorkshire, United Kingdom, LS9 7TF Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN Southampton General Hospital Southampton, United Kingdom, SO16 6YD Collapse <<
NCT00997243	Leukemia Myel... more >>odysplastic Syndromes Collapse <<	Phase 2	Terminated(Drug no longer bein... more >>g supplied by sponsor) Collapse <<	-	United States, Ohio ... more >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Collapse <<
NCT02124174	Acute Myelogenous Leukemia AML... more >> Myelodysplastic Syndrome MDS Collapse <<	Phase 2	Recruiting	January 2021	United States, Illinois ... more >> Loyola University Cardinal Bernardin Cancer Center Recruiting Maywood, Illinois, United States, 60153 Contact: Mary Lee, BSN Contact: Ceil Petrowsky, MSN Principal Investigator: Patrick Stiff, MD Collapse <<
NCT01442714	Leukemia Acut... more >>e Myeloid Leukemia (AML) Myelodysplastic Syndromes (MDS) Collapse <<	Phase 2	Terminated(Lack of efficacy - ... more >>Inability to meet the primary response endpoint) Collapse <<	-	United States, California ... more >> Stanford University School of Medicine Stanford, California, United States, 94305 Collapse <<
NCT01442714	-	-	Terminated(Lack of efficacy - ... more >>Inability to meet the primary response endpoint) Collapse <<	-	-
NCT01926587	Myelodysplastic Syndrome ... more >> Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Collapse <<	Phase 1 Phase 2	Active, not recruiting	January 2019	United States, Arizona ... more >> Banner MD Anderson Cancer Center Gilbert, Arizona, United States, 85234 United States, California City of Hope Duarte, California, United States, 91010 Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States, 92270 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Kansas Cancer Center of Kansas Wichita, Kansas, United States, 67214 United States, Missouri Saint Louis University Saint Louis, Missouri, United States, 63110 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Mount Sinai Medical Center New York, New York, United States, 10029 White Plains Hospital Center for Cancer Care White Plains, New York, United States, 10601 United States, South Carolina Carolina Blood and Cancer Care Associates Rock Hill, South Carolina, United States, 29732 United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 France Hôpital St. Louis Paris, France, 75475 Collapse <<
NCT01839240	Adult Acute Megakaryoblastic L... more >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Active, not recruiting	September 2018	United States, Illinois ... more >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Collapse <<
NCT01324960	Myelodysplastic Syndromes	Phase 1 Phase 2	Withdrawn	December 2014	France ... more >> CHU de Bicêtre Le Kremlin-Bicêtre, Ile de France, France, 94275 CHU Cochin Paris, Ile de France, France, 75679 CHU d'Amiens Amiens, France, 80054 CHU Angers Angers, France, 43033 CH d'Avignon Avignon, France, 84000 Hôpital de la Côte Basque Bayonne, France, 64100 Hopital Avicenne Bobigny, France, 93009 CHU de Caen Caen, France, 14033 CHU de Clermont Ferrand, France, 63058 Centre Hospitalier Sud-Francilien Corbeil-Essonnes, France, 91106 CHU Grenoble Grenoble, France, 38043 Hôpital Versailles Le Chesnay, France, 78157 Hôpital Saint Vincent Lille, France, 59020 CHRU Hurriez Lille, France, 59057 CHRU Limoges Limoges, France, 87046 Hôpital Edouard Heriot, dpt Hématologie Clinique Lyon, France, 69437 Hôpital Paoli-Calmettes Marseille, France, 13273 Hematology Dpt, Hopital de l'Hotel Dieu Nantes, France, 44093 CHU Archet Nice, France, 06202 Hopital Saint Louis Paris, France, 75475 Hôpital Saint Antoine Paris, France, 75571 Centre Hospitalier Joffre Perpignan, France, 66046 Hôpital Jean-Bernard Poitiers, France, 86021 CHRU de Reims Reims, France, 51092 Centre Henri Bequerel Rouen, France, 76038 Centre Hospitalier Universitaire de STRASBOURG Strasbourg, France, 67098 Hopital Purpan Service d'Hématologie Clinique Toulouse, France Hopital Bretonneau Tours, France, 37044 Collapse <<
NCT00997243	-	-	Terminated(Drug no longer bein... more >>g supplied by sponsor) Collapse <<	-	-
NCT00443261	-	-	Terminated(Accrual problems)	-	-
NCT03572387	Prostatic Neoplasms ... more >> Prostate Neoplasms Prostate Cancer Collapse <<	Phase 2	Recruiting	August 1, 2021	United States, New York ... more >> Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Principal Investigator: William Oh, MD Collapse <<
NCT03298516	Leukemia, Myeloid, Acute	Phase 1	Recruiting	September 30, 2023	United States, California ... more >> City of Hope Recruiting Duarte, California, United States, 91010 United States, Colorado University of Colorado Hospital - Anschutz Cancer Pavilion Recruiting Aurora, Colorado, United States, 80045 United States, Connecticut Yale School of Medicine Recruiting New Haven, Connecticut, United States, 06510 United States, New York Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749 Recruiting New York, New York, United States, 10032 United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Canada, Alberta University of Alberta Hospital Recruiting Edmonton, Alberta, Canada, T6G 1C9 Canada, Ontario Sunnybrook Health Sciences Centre Not yet recruiting Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Hospital; Department of Med Oncology Recruiting Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Jewish General Hospital / McGill University Not yet recruiting Montreal, Quebec, Canada, H3T 1E2 Korea, Republic of Seoul National University Hospital Not yet recruiting Seoul, Korea, Republic of, 03080 Collapse <<
NCT01913951	Myelodysplastic Syndromes	Phase 1	Active, not recruiting	December 31, 2021	United States, Missouri ... more >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Collapse <<
NCT00443261	Squamous Cell Carcinoma	Phase 1	Terminated(Accrual problems)	-	United States, Missouri ... more >> Kansas City VA Medical Center Kansas City, Missouri, United States, 64128 Collapse <<
NCT01462578	Acute Myelocytic Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 2	Active, not recruiting	August 2020	Germany ... more >> Charité Campus Benjamin Franklin Berlin, Germany Universitätsklinikum Bonn Bonn, Germany Klinikum Chemnitz (Küchwald) Chemnitz, Germany Universitätsklinikum Carl Gustav Carus, Medizinische Klinik und Poliklinik I Dresden, Germany Universitätsklinikum Essen, Klinik für Hämatologie (Westdeutsches Tumorzentrum) Essen, Germany Klinikum der J. W. Goethe-Universität, Medizinische Klinik II Hämatologie / Onkologie Frankfurt am Main, Germany Universitätsklinikum Freiburg Freiburg, Germany Universitätsklinikum Heidelberg, Medizinische Klinik, Abt. Innere Medizin V Heidelberg, Germany Klinikum rechts der Isar der TU München, III. Med. Klinik und Poliklinik München, Germany LMU München, Klinikum Großhadern, Med. Klinik III München, Germany Universitätsklinikum Münster, Innere Medizin A - KMT-Zentrum Münster, Germany Collapse <<
NCT03573024	Acute Myeloid Leukemia	Phase 2	Recruiting	June 2023	United States, Colorado ... more >> Universtiy of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Lauren Dabdoub 720-848-1156 lauren.dabdoub@ucdenver.edu Principal Investigator: Daniel Pollyea, MD Collapse <<
NCT00739388	Leukemia	Phase 2	Completed	-	Switzerland ... more >> Kantonspital Aarau Aarau, Switzerland, CH-5001 Kantonsspital Baden Baden, Switzerland, CH-5404 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Inselspital Bern Bern, Switzerland, CH-3010 Spitalzentrum Biel Biel, Switzerland, CH-2500 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital, Luzerne Luzerne, Switzerland, CH-6000 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Hopitaux Universitaires de Geneve Thonex-Geneve, Switzerland, CH-1226 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Collapse <<
NCT00934440	Renal Cell Carcinoma	Phase 1 Phase 2	Terminated	-	United States, Kansas ... more >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Stormont-Vail Cotton O'Neil Cancer Center Topeka, Kansas, United States, 66606 Collapse <<
NCT00934440	-	-	Terminated	-	-
NCT01700673	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 2	Active, not recruiting	November 2019	United States, Maryland ... more >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 Collapse <<
NCT01379274	MDS	Phase 2	Terminated(Loss of funding.)	-	United States, Illinois ... more >> Rush University Medical Center Chicago, Illinois, United States, 60612 Collapse <<
NCT03182894	Metastatic Colorectal Cancer	Phase 1 Phase 2	Withdrawn(Study will not be co... more >>nducted due to changes related to the investigational agent.) Collapse <<	July 30, 2020	United States, Pennsylvania ... more >> UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Collapse <<
NCT03745716	MDS	Phase 3	Not yet recruiting	December 2020	-
NCT02447666	Myelodysplastic Syndrome ... more >> Leukemia, Myelomonocytic, Juvenile Collapse <<	Phase 2	Active, not recruiting	February 28, 2019	-
NCT01305135	High Grade Myelodysplastic Syn... more >>drome Lesions Collapse <<	Phase 1 Phase 2	Completed	-	France ... more >> CHU de Haut-Lévèque Pessac, Bordeaux - Pessac, France, 33604 CHU d'Amiens Amiens, France, 80054 CHU d'Angers Angers, France, 49033 Hôpital de la cote basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93009 CHRU de Caen - Hôpital Côte de Nacre Caen, France, 14033 CHU Estaing Clermont-Ferrand, France, 63000 CHU Dijon Hôpital d'enfants Dijon, France, 21000 CHU Albert Michallon Grenoble, France, 38043 CH Le Mans Le Mans, France, 72000 CHU de Limoges Limoges, France, 87042 Centre Hospitalier Lyon Sud Lyon, France, 69495 Institut Paoli-Calmette Marseille, France, 13009 CHU Brabois Nancy, France, 54511 CHU Hotel dieu Nantes, France, 44093 CHU NICE, Hôpital l'Archet Nice, France, 06202 Hôpital saint louis - Hématologie Clinique Paris, France, 75010 Hôpital Saint Louis - Hématologie Séniors Paris, France, 75010 Hôpital Saint Antoine Paris, France, 75012 Hôpital cochin Paris, France, 75014 Centre hospitalier Joffre Perpignan, France, 66046 CHU de Poitiers Poitiers, France, 86021 CH de Périgueux Périgueux, France, 24019 Hôpital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Hôpital Hautepierre Strasbourg, France, 67098 Hôpital PURPAN - Hématologie Clinique Toulouse, France, 31059 Hôpital Purpan - Médecine Interne Toulouse, France, 31059 Hôpital Bretonneau Tours, France, 37000 CH de Valence Valence, France, 26953 Institut Gustave Roussy Villejuif, France, 94805 Tunisia Hôpital Aziza Othmana Tunis, Tunisia Collapse <<
NCT01652781	Myelodysplastic Syndrome	Phase 2	Unknown	December 2016	Korea, Republic of ... more >> Seoul St. Mary's Hospital Recruiting Seoul, Korea, Republic of, 137-701 Contact: Yoo-Jin Kim, MD, PhD 82-2-2258-6057 yoojink@catholic.ac.kr Contact: Kyungmin Kim 82-2-2258-7926 ddok9765@hotmail.com Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Je Hwan Lee, MD, PhD Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Sung Soo Yoon, MD, PhD Collapse <<
NCT00624936	Leukemia Myel... more >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Collapse <<	Phase 1	Completed	-	United States, Ohio ... more >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Collapse <<
NCT03047993	Myelodysplastic Syndrome ... more >> Other Diseases of Blood and Blood-forming Organs Collapse <<	Phase 1 Phase 2	Recruiting	November 2023	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact cdinardo@mdanderson.org Collapse <<
NCT00915252	Acute Myeloid Leukemia	Phase 2	Completed	-	Germany ... more >> RWTH Aachen, Medizinische Klinik IV Aachen, Germany, 52074 Sozialstiftung Bamberg, Klinikum am Bruderwald, Med. Klinik V Bamberg, Germany, 96049 Klinikum Bayreuth, Medizinische Klinik IV Bayreuth, Germany, 95445 Charite Campus Benjamin Franklin, Universitätsmedizin Berlin, Medizinische Klinik III Berlin, Germany Städt. Kliniken Bielefeld gem. GmbH, Klinikum Mitte, Klinik für Hämatologie, Onkologie, Palliativmedizin Bielefeld, Germany, 33604 Klinikum Chemnitz, Krankenhaus Küchenwald, Klinik für Innere Medizin III Chemnitz, Germany Universitätsklinikum Carl Gustav Carus, Medizinische Klinik und Poliklinik I Dresden, Germany Katholische Krankenhaus Duisburg Duisburg, Germany, 47166 Universitätsklinikum Erlangen, Medizinische Klinik 5 Erlangen, Germany Universitätsklinikum Essen, Klinik für Hämatologie Essen, Germany Klinikum Frankfurt (Oder) GmbH Frankfurt (Oder), Germany, 15236 Klinikum der Johann Wolfgang Goethe-Universität Frakfurt am Main Frankfurt am Main, Germany Asklepios Klinik St. Georg, Hämatologische Abteilung Hamburg, Germany St. Bernward Krankenhaus Hildesheim, Medizinische Klinik II Hildesheim, Germany Westpfalz-Klinikum GmbH, Med. Klinik I Kaiserslautern, Germany, 67655 Stiftungsklinikum Mittelrhein, Hämatologie/ Onkologie Koblenz, Germany, 56068 Johannes Gutenberg-Universität Mainz Klinikum, III. Medizinische Klinik und Poliklinik Mainz, Germany Phillips Universität Marburg, Fachbereich 20, ZIM Marburg, Germany Klinikum rechts der Isar, III. Medizinische Klinik Muenchen, Germany Universitätsklinikum Münster, Medizinische Klinik und Poliklinik A Münster, Germany, 48149 Klinikum Nürnberg, Medizinische Klinik 5 Nurnberg, Germany Klinikum Osnabrück, Klinik für Onkologie, Hämatologie, Immunologie Osnabruck, Germany Klinikum der Universität Regensburg, Klinik und Poliklinik für Innere Medizin I Regensburg, Germany Robert-Bosch-Krankenhaus, Zentrum für Innere Medizin Stuttgart, Germany Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I Trier, Germany, 2920 Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany, 65199 Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II Wurzburg, Germany Collapse <<
NCT00766116	Acute Myeloid Leukemia	Phase 1 Phase 2	Active, not recruiting	December 2017	United States, California ... more >> UCSD Moores Cancer Center La Jolla, California, United States, 92093 Stanford University Stanford, California, United States, 94305 United States, Georgia Northside Hospital/BMTGA Atlanta, Georgia, United States, 30342 Collapse <<
NCT01556477	Myelodysplastic Syndrome ... more >> Acute Myelogenous Leukemia Collapse <<	Phase 2	Unknown	November 2014	Sweden ... more >> Lars Möllgård Recruiting Stockholm, Sweden, 141 86 Collapse <<
NCT01998035	Lymphoid Malignancies ... more >> Lymphoma Hodgkin Lymphoma Non-hodgkin Lymphoma Collapse <<	Phase 1 Phase 2	Recruiting	February 2019	United States, New York ... more >> Columbia University Medical Center Recruiting New York, New York, United States, 10019 Contact: Celeste Rojas 212-326-5720 cr2393@cumc.columbia.edu Principal Investigator: Owen A O'Connor, MD, Ph.D. Collapse <<
NCT02458235	Acute Myelogenous Leukemia ... more >> Acute Lymphoid Leukemia Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Collapse <<	Phase 2	Active, not recruiting	December 2019	United States, California ... more >> University of California San Francisco Medical Center San Francisco, California, United States, 94143 Collapse <<
NCT01599325	Myelodysplastic Syndrome (MDS)	Phase 2	Completed	-	China ... more >> Peking University People's Hospital Beijing, China, 100044 The 301 Hospital- Chinese PLA General Hospital Beijing, China, 300200 The Third Hospital of Peking University Beijing, China West China Hospital of Sichuan University Chengdu, China, 610041 Guangdong General Hospital Guangzhou, China, 510080 1st Hospital Zhejiang University (The First Affiliated Hospital of Zhejiang University ) Hangzhou, China, 310003 Ruijin Hospital Shanghai Jiaotong University Shanghai, China, 200025 Shanghai 6th Hospital Shanghai, China, 200233 The 1st Hospital of Soochow University Suzhou, China, 215006 Blood Disease Hospital, Chinese Academy of Medical Science and Peking Union Medical College Tianjin, China, 300041 Wuhan Union Hospital Wuhan, China, 430000 Collapse <<
NCT01599325	-	-	Completed	-	-
NCT00946647	Myelodysplastic Syndromes ... more >> Chronic Myelomonocytic Leukemia Acute Myeloid Leukemia Collapse <<	Phase 1	Active, not recruiting	June 13, 2019	-
NCT01202877	-	-	Completed	-	-
NCT03701295	Acute Myeloid Leukemia With t(... more >>9;11)(p21.3;q23.3); MLLT3-KMT2A Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Collapse <<	Phase 1 Phase 2	Not yet recruiting	November 1, 2020	-
NCT01305460	Myelodysplastic Syndrome	Phase 1 Phase 2	Unknown	December 2016	France ... more >> Service d'Hématologie Clinique CHU Albert Michallon, Grenoble, France, 38043 CHU d'Amiens Amiens, France, 80054 Centre Hospitalier de La Cote Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93009 CHU de Haut-Lévèque Bordeaux Pessac, France, 33604 Centre henri Mondor Creteil, France, 94010 Centre Hospitalier du Mans Le Mans cedex, France, 72037 Hôpital Huriez Lille, France, 59037 Hôpital Paoli Calmettes Marseille, France, 13273 Centre Hospitalier de Meaux Meaux, France, 77100 CHU Brabois Nancy, France, 54511 CHU de nantes Nantes, France, 44093 Hôpital l'Archet de Nice Nice, France, 06202 Hôpital Cochin Paris, France, 75004 Hôpital Saint Louis Paris, France, 75010 Hopital Saint Louis - AP-HP, Hematology Dpt Paris, France, 75475 CHU de Poitiers Poitiers, France, 86021 CHRU Annecy Hospital Pringy, France, 74374 Hôpital Pontchaillou Rennes, France, 35033 Hopital Purpan Service d'Hématologie Clinique Toulouse, France, 31059 CH de Valence Valence, France, 26953 Collapse <<
NCT01828346	Myelodysplastic Syndrome	Phase 1 Phase 2	Completed	-	United States, Arizona ... more >> Palo Verde Hematology Oncology Glendale, Arizona, United States, 85304 Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259 United States, California California Cancer Associates for Research and Excellence Fresno, California, United States, 93720 United States, Florida Mayo Clinic Jacksonville Jacksonville, Florida, United States, 32224 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Pennsylvania University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Texas The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02323139	MDS	Phase 1	Completed	-	France ... more >> CHU d'Amiens Amiens, France, 80054 CHU d'Angers Angers, France, 49033 CH Henri Duffaut Avignon, France, 84000 CH de la Côte Basque Bayonne, France, 64 100 Hôpital Avicenne Bobigny, France, 93009 Hôpital Henri Mondor Créteil, France, 94010 CHU de Grenoble Grenoble, France, 38043 CH Le Mans Le Mans, France, 72037 IPC-Unité d'Hématologie 3 Marseille, France, 13273 Centre Hospitalier de Meaux Meaux, France, 77100 CHU de Montpellier Montpellier, France, 34295 Hôpital Hôtel Dieu Nantes, France, 44093 Centre Antoine Lacassagne Nice, France, 06189 Hôpital Archet 1 Nice, France, 06202 CHU de Nîmes Nîmes, France, 30029 Hôpital Saint Louis - Service Hématologie Sénior Paris, France, 75010 Hôpital Saint-Louis - Service d'hématologie AJA Paris, France, 75010 Hôpital Cochin Paris, France, 75014 CHU de Haut-Lévèque Pessac, France, 33604 CH Lyon Sud Pierre-Bénite, France, 69495 CH Annecy Genevois Pringy, France, 74374 Hôpital Henri Becquerel Rouen, France, 76038 IUC Oncopole - Médecine interne Toulouse, France, 31059 CHU Nancy-Brabois Vandœuvre-lès-Nancy, France, 54511 Collapse <<
NCT02553941	Chronic Myelomonocytic Leukemi... more >>a de Novo Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Refractory Anemia With Excess Blasts in Transformation Secondary Myelodysplastic Syndrome Collapse <<	Phase 1	Recruiting	November 2020	United States, California ... more >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Gary J. Schiller 888-798-0719 garyjs@ucla.edu Principal Investigator: Gary J. Schiller UC Irvine Health/Chao Family Comprehensive Cancer Center Active, not recruiting Orange, California, United States, 92868 University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Brian A. Jonas 916-734-3772 bajonas@ucdavis.edu Principal Investigator: Brian A. Jonas University of California San Diego Recruiting San Diego, California, United States, 92103 Contact: Matthew J. Wieduwilt 858-822-5354 cancercto@ucsd.edu Principal Investigator: Matthew J. Wieduwilt University of California, San Francisco Recruiting San Francisco, California, United States, 94118 Contact: Aaron C. Logan 415-502-2110 aclogan@medicine.ucsf.edu Principal Investigator: Aaron C. Logan Collapse <<
NCT02017457	Acute Myelogenous Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 2	Active, not recruiting	August 2020	Belgium ... more >> Ziekenhuis Netwerk Antwerpen Antwerpen, Belgium, 2060 AZ Sint-Jan Brugge Brugge, Belgium, 8000 Institut Jules Bordet Brussels, Belgium, 1000 Universitair Ziekenhuis Antwerpen Edegem, Belgium, 2650 Universitair Ziekenhuis Gent Gent, Belgium, 9000 Hopital de Jolimont Haine-St-Paul, Belgium, 7100 Universitair Ziekenhuis Brussel Jette, Belgium, 1090 Universitair Ziekenhuis Leuven Leuven, Belgium, 3000 CHU Liège Liège, Belgium, 4000 Hartziekenhuis Roeselare Menen Roeselare, Belgium, 8800 Cliniques Universitaires Saint-Luc Woluwe-Saint-Lambert, Belgium, 1200 CHU Mont-Godinne Yvoir, Belgium, 5530 Collapse <<
NCT00923234	Myelodysplastic Syndromes ... more >> Acute Myelogenous Leukemia Collapse <<	Phase 1	Terminated(The primary objecti... more >>ve has already been answered with the number of recruited patients.) Collapse <<	-	Germany ... more >> Medizinische Klinik und Poliklinik I, Uniklinik Dresden, Germany Universitätsklinikum Düsseldorf, Klinik für Hämatologie/Onkologie/klinische Immunologie Düsseldorf, Germany, 40225 Klinikum der J.W. Goethe-Universität, Medizinische Klink II Frankfurt, Germany, 60590 Technische Universität München, Klinikum Rechts der Isar München, Germany, 81675 Collapse <<
NCT01861002	Lymphoblastic Leukemia, Acute,... more >> Childhood Myelogenous Leukemia, Acute, Childhood Collapse <<	Phase 1	Completed	-	-
NCT01254890	Leukemia	Phase 1 Phase 2	Completed	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00897130	Myelodysplastic Syndrome	Phase 2	Completed	-	Italy ... more >> University of Bologna Bologna, Italy Chair of Haematology, Bone Marrow Transplant Unit Brescia, Italy, 25123 Cremona Cremona, Italy University of Genova Genova, Italy Mantova Mantova, Italy University of Siena Siena, Italy University of Udine Udine, Italy Collapse <<
NCT03326310	Chronic Myeloid Leukemia ... more >> Myelofibroses Collapse <<	Phase 1	Recruiting	September 4, 2023	United States, Illinois ... more >> The University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Melissa Fridstein 773-702-9885 mfridstein@medicine.bsd.uchicago.edu Collapse <<
NCT03483948	Acute Myeloid Leukemia	Phase 1	Recruiting	November 1, 2020	China, Tianjin ... more >> Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Recruiting Tianjin, Tianjin, China, 300020 Contact: Jianxiang Wang, Prof. Collapse <<
NCT02038816	Myelodysplastic Syndromes	Phase 2	Terminated(accrual too slow, i... more >>nsufficient patients) Collapse <<	-	Canada, Ontario ... more >> Odette Cancer Centre, Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Collapse <<
NCT01254890	-	-	Completed	-	-
NCT00413478	-	-	Terminated(Slow accrual.)	-	-
NCT00413478	Chronic Lymphocytic Leukemia ... more >> Leukemia Collapse <<	Phase 2	Terminated(Slow accrual.)	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00660400	Leukemia	Not Applicable	Completed	-	United States, Florida ... more >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Collapse <<
NCT01202877	Leukemia	Phase 1 Phase 2	Completed	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT03588078	Myelodysplastic Syndrome With ... more >>Gene Mutation Acute Myeloid Leukemia With Gene Mutations Myeloproliferative Neoplasm Chronic Myelomonocytic Leukemia Collapse <<	Phase 1 Phase 2	Recruiting	May 15, 2021	France ... more >> Hôpital Archet 1 Recruiting Nice, France, 06200 Contact: Thomas CLUZEAU, Prof 33492035844 cluzeau.t@chu-nice.fr Principal Investigator: Pierre Fenaux, Pr Hôpital Saint Louis - Hématologie Séniors Recruiting Paris, France, 75010 Contact: Pierre Fenaux, MD 033170207022 pierre.fenaux@sls.aphp.fr Principal Investigator: Pierre Fenaux, MD Collapse <<
NCT03206021	Recurrent Childhood CNS Tumor ... more >> Ependymoma, Recurrent Childhood Childhood Solid Tumor Collapse <<	Phase 1	Recruiting	July 1, 2022	Canada, Alberta ... more >> Alberta Children's Hospital Recruiting Calgary, Alberta, Canada Contact: Lucie Lafay-Cousin, MD Canada, British Columbia BC Children's Hospital Recruiting Vancouver, British Columbia, Canada Contact: Juliette Hukin, MD Canada, Ontario McMaster Children's Hospital Not yet recruiting Hamilton, Ontario, Canada Contact: Adam Fleming, MD London Health Sciences Centre Not yet recruiting London, Ontario, Canada Contact: Shayna Zelcer, MD Hospital for Sick Children Recruiting Toronto, Ontario, Canada, M5G1X8 Contact: Vijay Ramaswamy, MD PhD FRCPC Principal Investigator: Vijay Ramaswamy, MD PhD Principal Investigator: Eric Bouffet, MD Canada, PQ Centre hospitalier universitaire Sainte-Justine Recruiting Montréal, PQ, Canada Contact: Yvan Samson, MD Montreal Children's Hospital Recruiting Montréal, PQ, Canada Contact: Nada Jabado, MD PhD Sub-Investigator: Genevieve Legault, MD Collapse <<
NCT03493646	Myelodysplastic Syndromes ... more >> Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Collapse <<	Phase 2	Recruiting	December 31, 2021	Australia, New South Wales ... more >> Calvary Mater Newcastle Recruiting Newcastle, New South Wales, Australia, 2298 Contact: Anoop Enjeti, MD Nepean Hospital Recruiting Penrith, New South Wales, Australia, 2750 Contact: Stephen Fuller, MD Prince of Wales Hospital Recruiting Sydney, New South Wales, Australia, 2031 Contact: Mark Hertzberg, MD Royal North Shore Hospital Recruiting Sydney, New South Wales, Australia, 2065 Contact: William Stevenson, MD Blacktown Hospital Recruiting Sydney, New South Wales, Australia, 2148 Contact: Patricia Rebeiro, MD Liverpool Hospital Recruiting Sydney, New South Wales, Australia, 2170 Contact: Silvia Ling, MD Gosford and Wyong Hospitals Recruiting Sydney, New South Wales, Australia, 219 Contact: Campbell Tiley, MD St George Hospital Recruiting Sydney, New South Wales, Australia, 2217 Contact: Fernando Roncolato, MD Royal Prince Alfred Hospital Recruiting Sydney, New South Wales, Australia Contact: Stephen Larsen, MD St Vincent's hospital Recruiting Sydney, New South Wales, Australia Contact: Nada Hamad, MD Wollongong Hospital Recruiting Wollongong, New South Wales, Australia, 2500 Contact: Peter Presgrave, MD Collapse <<
NCT00660400	-	-	Completed	-	-
NCT00996515	Advanced Solid Tumor Malignanc... more >>ies Collapse <<	Phase 1	Completed	-	United States, New Mexico ... more >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 Collapse <<
NCT00901537	Non-small Cell Lung Cancer ... more >> Squamous Cell Carcinoma of the Head and Neck Collapse <<	Phase 1	Terminated(Sponsor terminated ... more >>due to no enrollments within last 4 months.) Collapse <<	-	United States, California ... more >> Loma Linda University Cancer Center Loma Linda, California, United States, 92354 Collapse <<
NCT02196857	Leukemia	Phase 2	Active, not recruiting	February 2021	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01488565	Myelodysplastic Syndromes (MDS... more >>) Acute Myeloid Leukaemia (AML) Collapse <<	Phase 2	Completed	-	Australia, Victoria ... more >> Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 Cabrini Hospital Malvern, Victoria, Australia, 3144 Collapse <<
NCT01350947	Chronic Myelomonocytic Leukemi... more >>a Collapse <<	Phase 2	Completed	-	United States, New York ... more >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 Collapse <<
NCT00721214	-	-	Completed	-	-
NCT03666559	Recurrent IDH1/2 Mutated Gliom... more >>a Collapse <<	Phase 2	Not yet recruiting	April 2022	France ... more >> Pitie Salpetriere Hospital Paris, France, 75013 Collapse <<
NCT01038635	Leukemia	Phase 1 Phase 2	Completed	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00721214	Myelodysplastic Syndrome	Phase 2	Completed	-	United States, Virginia ... more >> Massey Cancer Center / Virginia Commonwealth University Richmond, Virginia, United States, 23298 Collapse <<
NCT02096042	-	-	Terminated(Slow accrual.)	-	-
NCT01038635	-	-	Completed	-	-
NCT02096042	Leukemia	Phase 1 Phase 2	Terminated(Slow accrual.)	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01350947	-	-	Completed	-	-
NCT02985190	MDS Systemic ... more >>Autoimmune Diseases Collapse <<	Phase 2	Recruiting	October 2021	-
NCT03466294	Acute Myeloid Leukemia	Phase 2	Recruiting	June 2021	United States, Colorado ... more >> University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Derek Schatz 720-848-0628 derek.schatz@ucdenver.edu Principal Investigator: Dan Pollyea, MD Collapse <<
NCT01537744	Solid Tumors ... more >>Virally Mediated Cancers and Liposarcoma Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> Sidney Kimmel Cancer Center @ Johns Hopkins Baltimore, Maryland, United States, 21231 Collapse <<
NCT03572530	Recurrent Ependymoma	Phase 1	Recruiting	July 1, 2020	United States, Texas ... more >> The University of Texas Health Science Center at Houston Recruiting Houston, Texas, United States, 77030 Contact: Bangning Yu, MD, PhD 713-500-7363 Bangning.Yu@uth.tmc.edu Contact: David I Sandberg, MD 713-500-7370 David.I.Sandberg@uth.tmc.edu Collapse <<
NCT01404741	Myelodysplastic Syndrome ... more >> Chronic Myelomonocytic Leukemia Collapse <<	Phase 2	Active, not recruiting	May 2021	Germany ... more >> Charité Campus Benjamin Franklin Berlin, Germany Uniklinikum Bonn Bonn, Germany Universitätsklinikum Dresden Dresden, Germany, 01307 Universitätsklinikum Düsseldorf Düsseldorf, Germany Universitätsklinikum Essen Essen, Germany, 45122 Universitätsklinikum Essen Essen, Germany Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main, Germany Universitätsklinikum Göttingen Göttingen, Germany University Medical Center Hamburg-Eppendorf Hamburg, Germany Medizinische Hochschule Hannover Hannover, Germany Universität zu Köln Köln, Germany Universitätsklinikum Mannheim Mannheim, Germany Klinikum rechts der Isar München, Germany Universitätsklinikum Münster Münster, Germany Klinikum Nürnberg Nürnberg, Germany Medizinische Universitätsklinik II Tübingen, Germany Universitätsklinikum Ulm Ulm, Germany Collapse <<
NCT00795548	Myelodysplastic Syndrome ... more >> Acute Myeloid Leukemia Collapse <<	Phase 2	Completed	-	Germany ... more >> Universitaetsklinik Heidelberg, Medizinische Klinik und Poliklinik V Heidelberg, Baden-Wuertemberg, Germany, 69120 Klinikum der Johann-Wolfgang-Goethe Universität, Medizinische Klinik II Frankfurt, Hessen, Germany, 60590 Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf Duesseldorf, NW, Germany, 40225 Universitaetsklinikum Dresden, Medizinische Klinik und Poliklinik I Dresden, Sachsen, Germany, 01307 Charite´-Campus Benjamin Franklin, Medizinische Klinik III Berlin, Germany, 01220 Bone Marrow Transplantation Unit, University Hospital Hamburg-Eppendorf Hamburg, Germany, 20246 Collapse <<
NCT02940483	Brain Tumor Recurrent	Early Phase 1	Completed	-	United States, Texas ... more >> UTHealth & Children's Memorial Hermann Hospital Houston, Texas, United States, 77030 Collapse <<
NCT02204020	Acute Myeloid Leukemia (AML) ... more >> Myelodysplastic Syndrome (MDS) Collapse <<	Phase 2	Withdrawn(Lack of interest wit... more >>h investigators - no subjects enrolled) Collapse <<	-	United States, Pennsylvania ... more >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 Collapse <<
NCT00324220	Myelodysplastic Syndrome ... more >> Acute Myelogenous Leukemia Collapse <<	Phase 1 Phase 2	Completed	-	United States, California ... more >> University of Southern California Los Angeles, California, United States, 90033 United States, Indiana St. Francis Hospital & Health Center Beech Grove, Indiana, United States, 46107 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 The Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 United States, Texas University of Texas, MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01928537	Myelodysplastic Syndromes ... more >> Refractory Anemia With Excess Blasts Chronic Myelomonocytic Leukemia Cytopenia Collapse <<	Phase 3	Active, not recruiting	February 2019	-
NCT02281084	Myelodysplastic Syndromes	Phase 2	Active, not recruiting	June 18, 2019	-
NCT03416179	Leukemia, Myeloid, Acute	Phase 3	Recruiting	July 22, 2025	-
NCT03217838	Acute Myeloid Leukaemia ... more >> High-Risk Myelodysplastic Syndrome Collapse <<	Phase 1 Phase 2	Recruiting	August 13, 2021	United States, Colorado ... more >> Research Site Recruiting Denver, Colorado, United States, 80218 United States, Florida Research Site Recruiting Sarasota, Florida, United States, 34232 United States, Michigan Research Site Recruiting Detroit, Michigan, United States, 48201 United States, Oklahoma Research Site Recruiting Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Research Site Recruiting Nashville, Tennessee, United States, 37203 United States, Wisconsin Research Site Recruiting Milwaukee, Wisconsin, United States, 53051 Collapse <<
NCT01209520	Lung Cancer N... more >>on Small Cell Lung Carcinoma Hypermethylation Collapse <<	Not Applicable	Completed	-	United States, Florida ... more >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Collapse <<
NCT01209520	-	-	Completed	-	-
NCT00006019	Leukemia Lung... more >> Cancer Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Prostate Cancer Collapse <<	Phase 2	Completed	-	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Collapse <<
NCT03390296	Acute Myeloid Leukemia	Phase 2	Recruiting	December 2024	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact ndaver@mdanderson.org Collapse <<
NCT00495547	Myelodysplastic Syndrome	Phase 2	Terminated	-	Spain ... more >> Hospital Germans Trias i Pujol Badalona, Spain Hospital Clínic Universitari Barcelona, Spain Hospital del Mar Barcelona, Spain Hospital Reina Sofía Córdoba, Spain Hospital Virgen Blanca Leon, Spain Hospital la Paz Madrid, Spain Hospital Central de Asturias Oviedo, Spain Hospital Son Llatzer Palma de mallorca, Spain Hospital Clinico Universitario Salamanca, Spain Hospital La Fe de Valencia Valencia, Spain Collapse <<
NCT02223052	Hematological Neoplasms ... more >> Non-Hodgkin's Lymphoma Hodgkin's Lymphoma Lymphoma Multiple Myeloma Acute Myeloid Leukemia Leukemia Myelodysplastic Syndromes Neoplasms Melanoma Breast Cancer Metastatic Breast Cancer Non-Small Cell Lung Cancer Small Cell Lung Cancer Renal Cell Carcinoma Glioblastoma Multiforme Osteosarcoma Sarcoma Thyroid Cancer Genitourinary Collapse <<	Phase 1	Active, not recruiting	December 9, 2018	United States, Arizona ... more >> Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States, 85258 Mayo Clinic - Arizona Scottsdale, Arizona, United States, 85259 University of Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202-268 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, South Carolina Greenville Hospital System Greenville, South Carolina, United States, 29605 United States, Tennessee Vanderbilt- Ingram Cancer Center Nashville, Tennessee, United States, 37232-6307 United States, Texas The Methodist Hospital Research Institute l Houston, Texas, United States, 77030 Collapse <<
NCT03383575	Myelodysplastic Syndrome	Phase 2	Recruiting	January 2022	United States, Florida ... more >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Rami Komrokji, MD United States, Maryland John Hopkins Recruiting Baltimore, Maryland, United States, 21218 Contact: Amy DeZern, MD United States, Massachusetts Dana Farber Recruiting Boston, Massachusetts, United States, 02215 Contact: David Steensma, MD United States, New York Weill Cornell Medicin Recruiting New York, New York, United States, 10065 Contact: Gail Roboz, MD United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Mikkael Sekeres, MD United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations cdinardo@mdanderson.org Collapse <<
NCT01004991	-	-	Completed	-	-
NCT01912274	Acute Myeloid Leukemia	Phase 2	Completed	-	United States, California ... more >> City of Hope Comprehensive Cancer Ctr Duarte, California, United States, 91010 USC Norrris Cancer Center Los Angeles, California, United States, 90033 Bay Area Cancer Research Group Pleasant Hill, California, United States, 94523 Stanford University School of Medicine Stanford, California, United States, 94305-5821 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois The University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Inidana Univ Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Mercy Medical Research Center Springfield, Missouri, United States, 65807 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7680 United States, New Jersey Cooper Hospital Camden, New Jersey, United States, 08103 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, South Carolina Medical College of South Carolina-Hollings Cancer Ctr Charleston, South Carolina, United States, 29425 United States, Texas UT Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390-9179 MD Anderson Houston, Texas, United States, 77030 United States, Wisconsin Medical College of Wisconsin-Froedtert Cancer Center Milwaukee, Wisconsin, United States, 53226 Collapse <<
NCT03146871	Acute Myeloid Leukemia Arising... more >> From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Previously Treated Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes Recurrent Adult Acute Myeloid Leukemia Collapse <<	Phase 2	Recruiting	April 20, 2021	United States, California ... more >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Ibrahim L. Syed 323-865-3928 Ibrahim.Syed@med.usc.edu Principal Investigator: Casey L. O'Connell, MD Collapse <<
NCT02942758	Acute Myeloid Leukemia	Phase 2	Recruiting	February 2020	Germany ... more >> University Hospital Regensburg Recruiting Regensburg, Germany, 93053 Collapse <<
NCT01004991	Diffuse Large B Cell Lymphoma	Phase 1 Phase 2	Completed	-	United States, New York ... more >> Weill Cornell Medical College New York, New York, United States, 10065 Collapse <<
NCT03612739	AML, Adult My... more >>elodysplastic Syndromes Collapse <<	Phase 1	Not yet recruiting	August 2021	-
NCT02178072	Head and Neck Squamous Cell Ca... more >>rcinoma Collapse <<	Phase 2	Recruiting	December 2018	United States, Connecticut ... more >> Smilow Cancer Center at Yale New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Hari A Deshpande, MD 203-200-4622 hari.deshpande@yale.edu Contact: Wendell Yarbrough, MD 203-200-4622 wendell.yarbrough@yale.edu Sub-Investigator: Hari A Deshpande, MD Principal Investigator: Wendell Yarbrough, MD Sub-Investigator: Anne Chiang, MD Sub-Investigator: Clarence Sasaki, MD Sub-Investigator: Zain Husain, MD Principal Investigator: Barbara Burtness, MD Collapse <<
NCT03594149	Myelodysplastic Syndromes ... more >> Acute Myeloid Leukemia Collapse <<	Phase 3	Recruiting	July 11, 2022	France ... more >> CHU Amiens Not yet recruiting Amiens, France, 80000 Contact: Gruson Berangere, Md Principal Investigator: Gruson Berangere, Md CHU Caen Not yet recruiting Caen, France, 14033 Contact: Cheze Stephane, Md Principal Investigator: Cheze Stephane, Md CHRU Lille Not yet recruiting Lille, France, 59037 Contact: Berthon Celine, Md Principal Investigator: Berthon Céline, MD Centre Henri Becquerel Recruiting Rouen, France, 76000 Contact: Richard Doriane, PhD +33232082985 doriane.richard@chb.unicancer.fr Principal Investigator: Stamatoullas-Bastard Aspasia, MD Collapse <<
NCT02543879	Acute Myeloid Leukemia ... more >> Acute Myelogenous Leukemia Myelodysplastic Syndrome Non-Hodgkin Lymphoma Collapse <<	Phase 1	Recruiting	October 2019	United States, California ... more >> Cedars Sinai Recruiting Los Angeles, California, United States, 90048 Contact: Clinical Trials Office 310-423-2133 Cancer.Trial.Info@cshs.org United States, Florida Florida Cancer Specialists Recruiting Sarasota, Florida, United States, 34232 Contact: Manish Patel, MD 941-377-9993 DDU@flcancer.com Moffitt Cancer Center Recruiting Tampa, Florida, United States, 23985 Contact: Lisa Nardelli lisa.nardelli@moffitt.org United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Shira Dinner, MD 312-472-1234 shira.dinner@nm.org United States, Maryland University of Maryland, Greenebaum Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Maria Baer, MD mbaer@umm.edu United States, North Carolina Levine Cancer Institute Recruiting Charlotte, North Carolina, United States, 28204 Contact: Deborah Lewis, RN, BSN, CCRP 980-442-2383 Deborah.Lewis@carolinashealthcare.org United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact: Renee Thompson 615-329-7274 United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Ricardo Delumpa RMDelumpa@mdanderson.org Collapse <<
NCT01535456	AML MDS	Not Applicable	Terminated(funding)	-	United States, Wisconsin ... more >> University of Wisconsin Madison, Wisconsin, United States, 53792 Collapse <<
NCT02959437	Solid Tumors ... more >>Advanced Malignancies Metastatic Cancer Collapse <<	Phase 1 Phase 2	Active, not recruiting	October 2021	United States, California ... more >> City of Hope National Medical Center Duarte, California, United States, 91010 University of California San Diego La Jolla, California, United States, 92093 United States, Illinois The University of Chicago Chicago, Illinois, United States, 60637 United States, Pennsylvania University of Pennsylvania Health System Philadelphia, Pennsylvania, United States, 19014 United States, Tennessee Sarah Cannon Nashville, Tennessee, United States, 37203 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington University of Washington Seattle, Washington, United States, 98109 Spain Vall D Hebron Univ Barcelona, Spain, 08035 Univ De Navarra Pamplona, Spain, 31008 United Kingdom University College London Hospitals (Uclh) London, United Kingdom, W1t7ha Churchill Hospital Oxford, United Kingdom, Ox37le Collapse <<
NCT02374099	Breast Neoplasms	Phase 2	Terminated	-	-
NCT02203773	Acute Myelogenous Leukemia ... more >> Myelogenous Leukemia Treatment Naive AML Collapse <<	Phase 1 Phase 2	Active, not recruiting	March 27, 2020	-
NCT02845297	Acute Myeloid Leukemia	Phase 2	Recruiting	July 2020	United States, Maryland ... more >> Johns Hopkins Oncology Center Recruiting Baltimore, Maryland, United States, 21231-2410 Contact: Ivana Gojo, MD 410-502-7726 igojo1@jhmi.edu Contact: Jillian Morrow, RN (410) 502-5396 jmorro16@jhmi.edu United States, North Carolina University of North Carolina Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Joshua Zeidner, MD 984-974-0000 joshua_zeidner@med.unc.edu United States, South Carolina Medical University of South Carolina Hollings Cancer Center Recruiting Charleston, South Carolina, United States, 29425 Contact: Juan Varela, MD 843-792-1158 varela@musc.edu Collapse <<
NCT01110473	Acute Lymphoblastic Leukemia ... more >> Acute Myelogenous Leukemia B-cell Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia Myelodysplasia Collapse <<	Phase 1	Completed	-	United States, Arizona ... more >> Site Reference ID/Investigator# 59324 Scottsdale, Arizona, United States, 85259 United States, Georgia Site Reference ID/Investigator# 26523 Atlanta, Georgia, United States, 30322 United States, Texas Site Reference ID/Investigator# 26522 Houston, Texas, United States, 77030-4009 Collapse <<
NCT02891551	-	-	Active, not recruiting	December 30, 2018	-
NCT03217903	High-risk Myelodysplastic Synd... more >>romes With Excess Blasts Collapse <<	Not Applicable	Not yet recruiting	January 1, 2022	France ... more >> CHRU de Nancy Not yet recruiting Nancy, France, 54035 Contact: Julien BROSEUS, MCU-PH Collapse <<
NCT01155583	Refractory Multiple Myeloma	Phase 1 Phase 2	Active, not recruiting	February 2018	United States, Ohio ... more >> University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Collapse <<
NCT02785900	Acute Myeloid Leukemia	Phase 3	Terminated(Due to safety; spec... more >>ifically a higher rate of deaths, including fatal infections, in the SGN33A arm versus the control arm) Collapse <<	-	-
NCT02785900	-	-	Terminated(Due to safety; spec... more >>ifically a higher rate of deaths, including fatal infections, in the SGN33A arm versus the control arm) Collapse <<	-	-
NCT02469415	Leukemia	Phase 2	Terminated(FDA Clinical Hold)	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00629343	Soft Tissue Sarcoma ... more >> Mesothelioma Collapse <<	Phase 1	Unknown	August 2014	United States, New York ... more >> Columbia University Medical Center New York, New York, United States, 10032 Collapse <<
NCT01235117	Leukemia	Phase 2	Completed	-	United Kingdom ... more >> Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G12 0YN Collapse <<
NCT02374099	-	-	Terminated	-	-
NCT02469415	-	-	Terminated(FDA Clinical Hold)	-	-
NCT00005639	Lymphoma Smal... more >>l Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Collapse <<
NCT00234000	Leukemia Myel... more >>odysplastic Syndromes Collapse <<	Phase 1	Terminated(The study was close... more >>d due to poor enrollment) Collapse <<	-	United States, California ... more >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Collapse <<
NCT00004871	Leukemia Myel... more >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Collapse <<
NCT01342692	MDS	Phase 2	Active, not recruiting	January 2019	France ... more >> Avicenne hospital Bobigny, France, 93009 Collapse <<
NCT00005598	Myelodysplastic Syndromes	Phase 2	Completed	-	United States, Michigan ... more >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 Collapse <<
NCT00118196	Leukemia Myel... more >>odysplastic Syndromes Collapse <<	Phase 2	Terminated(Due to limited reso... more >>urces available to conduct study) Collapse <<	-	United States, South Carolina ... more >> Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 Collapse <<
NCT00398450	Melanoma (Skin)	Phase 1	Unknown	-	United States, California ... more >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Collapse <<
NCT01386346	Esophageal Cancer ... more >> Malignant Neoplasm of Cardio-esophageal Junction of Stomach Collapse <<	Phase 1	Completed	-	United States, New York ... more >> Weill Cornell Medical College New York, New York, United States, 10021 Collapse <<
NCT03151408	Acute Myeloid Leukemia	Phase 3	Recruiting	May 2021	-
NCT02319135	Acute Myeloid Leukemia	Phase 3	Active, not recruiting	October 2019	Spain ... more >> Hospital Universitari i Politècnic La Fe Valencia, Spain, 46026 Collapse <<
NCT00412919	Multiple Myeloma	Phase 2	Terminated(Lack of efficacy)	-	Australia, Victoria ... more >> The Alfred Hospital Melbourne, Victoria, Australia, 3004 Collapse <<
NCT00895934	-	-	Completed	-	-
NCT00381693	Chronic Myeloproliferative Dis... more >>orders Secondary Myelofibrosis Collapse <<	Phase 2	Terminated(Due to lack of accr... more >>ual and trial has demonstrated too little clinical benefit) Collapse <<	-	United States, Arizona ... more >> Mayo Clinic in Arizona Scottsdale, Arizona, United States United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Collapse <<
NCT00381693	-	-	Terminated(Due to lack of accr... more >>ual and trial has demonstrated too little clinical benefit) Collapse <<	-	-
NCT02117219	Myelodysplastic Syndrome	Phase 1	Recruiting	June 17, 2019	-
NCT01121757	-	-	Terminated(The study closed te... more >>mporarily in February 2012 pending analysis of samples collected. In October, 2012, Celgene requested closure of the study.) Collapse <<	-	-
NCT01957644	Myelodysplastic Syndromes ... more >> Leukemia, Myelomonocytic, Chronic Collapse <<	Phase 1	Terminated	-	France ... more >> Boehringer Ingelheim Investigational Site Marseille, France Boehringer Ingelheim Investigational Site Paris, France Germany Boehringer Ingelheim Investigational Site Berlin, Germany Boehringer Ingelheim Investigational Site Dresden, Germany Boehringer Ingelheim Investigational Site Düsseldorf, Germany Boehringer Ingelheim Investigational Site Frankfurt/Main, Germany Boehringer Ingelheim Investigational Site Freiburg, Germany Boehringer Ingelheim Investigational Site Hamburg, Germany Boehringer Ingelheim Investigational Site Hannover, Germany Boehringer Ingelheim Investigational Site Kassel, Germany Boehringer Ingelheim Investigational Site Leipzig, Germany Boehringer Ingelheim Investigational Site Mannheim, Germany Boehringer Ingelheim Investigational Site München, Germany Boehringer Ingelheim Investigational Site Ulm, Germany Collapse <<
NCT01121757	Follicular Lymphoma ... more >> Marginal Zone Lymphoma Collapse <<	Phase 2	Terminated(The study closed te... more >>mporarily in February 2012 pending analysis of samples collected. In October, 2012, Celgene requested closure of the study.) Collapse <<	-	United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT01757535	Leukemia, Myeloid, Acute	Phase 3	Active, not recruiting	April 30, 2019	-
NCT01105377	-	-	Completed	-	-
NCT00895934	Adult Acute Megakaryoblastic L... more >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Collapse <<	Phase 1 Phase 2	Completed	-	United States, California ... more >> Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Washington Harrison HealthPartners Hematology and Oncology-Bremerton Bremerton, Washington, United States, 98310 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 Collapse <<
NCT02351037	-	-	Terminated(Study data do not s... more >>upport development in AML.) Collapse <<	-	-
NCT01105377	Recurrent Colon Cancer ... more >> Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Collapse <<	Phase 2	Completed	-	United States, Arizona ... more >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, California University of Southern California/Norris Cancer Center Los Angeles, California, United States, 90033 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Maryland Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Minnesota Oncology Hematology PA-Maplewood Maplewood, Minnesota, United States, 55109 Mayo Clinic Rochester, Minnesota, United States, 55905 Metro-Minnesota CCOP Saint Louis Park, Minnesota, United States, 55416 United Hospital Saint Paul, Minnesota, United States, 55102 Lakeview Hospital Stillwater, Minnesota, United States, 55082 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Collapse <<
NCT02341495	Acute Myeloid Leukemia	Phase 2	Recruiting	January 2019	United States, Illinois ... more >> Loyola University Cardinal Bernardin Cancer Center Recruiting Maywood, Illinois, United States, 60153 Principal Investigator: Elizabeth Henry, MD Sub-Investigator: Sucha Nand, MD Collapse <<
NCT02351037	Acute Myeloid Leukemia (AML)	Phase 2	Terminated(Study data do not s... more >>upport development in AML.) Collapse <<	-	United States, California ... more >> City of Hope Duarte, California, United States, 91010 UC Davis Medical Center Sacramento, California, United States, 95817 United States, Illinois The University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, New York Montefiore Einstein Center for Cancer Research Bronx, New York, United States, 10461 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Collapse <<
NCT00071799	Myelodysplastic Syndromes	Phase 3	Completed	-	-
NCT02701673	Lymphoma	Phase 1 Phase 2	Withdrawn	-	-
NCT00071799	-	-	Completed	-	-
NCT02319369	Acute Myelogenous Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 1	Recruiting	July 2021	United States, California ... more >> City of Hope National Medical Center Completed Duarte, California, United States, 91010 University of California San Francisco Medical Center Active, not recruiting San Francisco, California, United States, 94143 United States, Texas M D Anderson Recruiting Houston, Texas, United States, 77031 Collapse <<
NCT03092674	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts-2 Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 2 Phase 3	Suspended(Other - Safety data ... more >>review, unscheduled) Collapse <<	August 1, 2023	-
NCT00503984	Prostate Cancer ... more >> Pain Collapse <<	Phase 1 Phase 2	Terminated(Withdrawal of Fundi... more >>ng) Collapse <<	-	United States, Florida ... more >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Collapse <<
NCT02721875	-	-	Terminated	-	-
NCT01453140	Graft Versus Host Disease	Phase 1 Phase 2	Completed	-	United States, New Jersey ... more >> John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Collapse <<
NCT02721875	Myelodysplastic Syndromes	Phase 1	Terminated	-	Japan ... more >> University of Fukui Hospital Fukui, Yoshida-gun, Japan, 910-1193 Collapse <<
NCT01409070	-	-	Completed	-	Korea, Republic of ... more >> SNUH Seoul, Korea, Republic of Collapse <<
NCT00813124	Stem Cell Transplantation ... more >> Leukemia Collapse <<	Phase 2	Completed	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00503984	-	-	Terminated(Withdrawal of Fundi... more >>ng) Collapse <<	-	-
NCT01787487	Myelodysplastic/Myeloprolifera... more >>tive Neoplasm, Unclassifiable Myelofibrosis Transformation in Essential Thrombocythemia Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Primary Myelofibrosis Collapse <<	Phase 2	Recruiting	March 30, 2020	United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Naval Daver 713-794-4392 Principal Investigator: Naval Daver Collapse <<
NCT02775903	Leukemia, Myeloid, Acute ... more >> Myelodysplastic Syndromes Collapse <<	Phase 2	Active, not recruiting	April 16, 2019	-
NCT02367456	Myelodysplastic Syndrome ... more >> Acute Myeloid Leukemia Collapse <<	Phase 2	Recruiting	October 10, 2021	-
NCT02303782	Acute Myeloid Leukemia	Phase 1 Phase 2	Withdrawn	March 2016	-
NCT01908387	Myelodysplastic Syndromes ... more >> Chronic Myelomonocytic Leukemia Acute Myeloid Leukemia Multiple Myeloma Non-Hodgkin Lymphoma Hodgkin Lymphoma Collapse <<	Phase 1	Terminated(Due to Slow Accrual... more >> study was terminated.) Collapse <<	-	Japan ... more >> National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 National Cancer Center Hospital Tokyo, Japan, 104-0045 The Cancer Institute Hospital of JFCR Tokyo, Japan, 135-8550 Collapse <<
NCT01200004	Advanced Cancers	Phase 1	Terminated(Slow Accrual.)	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00102687	Myelodysplastic Syndromes	Phase 2	Completed	-	-
NCT01743859	Acute Myeloid Leukemia	Phase 2	Completed	-	United States, Colorado ... more >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Collapse <<
NCT03586609	Acute Myeloid Leukemia	Phase 2	Recruiting	January 3, 2020	United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Tapan M. Kadia 713-563-3534 Principal Investigator: Tapan M. Kadia Collapse <<
NCT00102687	-	-	Completed	-	-
NCT00658814	Acute Myeloid Leukemia ... more >> Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Erythroleukemia Adult Pure Erythroid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 2	Active, not recruiting	-	-
NCT01481220	Myelodysplastic Syndrome ... more >> Thrombocytopenia Collapse <<	Phase 1	Completed	-	Sweden ... more >> 4 Locations Uppsala, Stockholm, Göteborg, Umeå, Sweden Collapse <<
NCT02752035	Acute Myeloid Leukemia (AML) ... more >> Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Collapse <<	Phase 2 Phase 3	Recruiting	December 2021	-
NCT00313586	-	-	Completed	-	-
NCT00446303	Leukemia, Myelocytic, Acute ... more >> Myelodysplastic Syndromes Collapse <<	Phase 2	Terminated	-	France ... more >> CHU d'Amiens Amiens, France, 80054 CHU Angers Angers, France, 49033 CH d'Avignon Avignon, France, 84000 CHU de Caen Caen, France, 14033 Hopital d'Instruction des Armées Percy Clamart, France, 92140 Hopital Henri Mondor Creteil, France, 94000 CHU de Dijon Dijon, France, 21034 CHU Albert Michallon Grenoble, France, 38043 CHRU Hurriez Lille, France, 59057 CHRU de Limoges Limoges, France, 87046 Hopital Edouard Herriot Lyon, France, 69437 Hopital Paoli Calmette Marseille, France, 13273 Hopital Hotel Dieu Nantes, France, 44093 Hopital Archet Nice, France, 06202 Hopital Saint Louis Paris, France, 75475 Hopital Saint Antoine Paris, France, 75571 Hopital Cochin Paris, France, 75679 Hopital Haut Leveque Pessac, France, 33604 Hopital Jean-Bernard Poitiers, France, 86021 CHRU de Reims Reims, France, 51092 CHU Pontchaillou Rennes, France, 35033 Hopital Hautepierre Strasbourg, France, 67098 Hopital Purpan Toulouse, France, 31031 CHU Brabois Vandoeuvre, France, 54511 CH Versailles Versailles, France, 78000 Collapse <<
NCT00118287	-	-	Completed	-	-
NCT00118287	de Novo Myelodysplastic Syndro... more >>mes Previously Treated Myelodysplastic Syndromes Secondary Myelodysplastic Syndromes Collapse <<	Phase 1 Phase 2	Completed	-	United States, Washington ... more >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Collapse <<
NCT00658814	-	-	Active, not recruiting	-	-
NCT00313586	Acute Myeloid Leukemia Arising... more >> From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA Alkylating Agent-Related Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 2	Completed	-	-
NCT01566695	Myelodysplastic Syndrome	Phase 3	Active, not recruiting	August 31, 2021	-
NCT01522976	-	-	Active, not recruiting	-	-
NCT02677922	Leukemia, Myeloid, Acute	Phase 1 Phase 2	Active, not recruiting	January 28, 2019	-
NCT01522976	Chronic Myelomonocytic Leukemi... more >>a Chronic Myelomonocytic Leukemia-1 Chronic Myelomonocytic Leukemia-2 Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts Myelodysplastic Syndrome With Excess Blasts-1 Myelodysplastic Syndrome With Excess Blasts-2 Previously Treated Myelodysplastic Syndrome Collapse <<	Phase 2	Active, not recruiting	-	-
NCT00748553	-	-	Completed	-	-
NCT01290302	Myelodysplastic Syndrome ... more >> Myelofibrosis Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Collapse <<	Phase 1	Completed	-	United States, Pennsylvania ... more >> Luitpold Pharmaceuticals, Inc. Norristown, Pennsylvania, United States, 19403 Collapse <<
NCT03628209	Osteosarcoma ... more >>Osteosarcoma in Children Osteosarcoma Recurrent Sarcoma Collapse <<	Phase 1 Phase 2	Not yet recruiting	January 2022	United States, Arizona ... more >> Phoenix Children's Hospital Not yet recruiting Phoenix, Arizona, United States, 31867 Principal Investigator: Pooja Hingorani, M.D. United States, California Children's Hospital of Los Angeles, USC Norris Comprehensive Cancer Center Not yet recruiting Los Angeles, California, United States, 90027 Principal Investigator: Leo Mascarenhas, M.D. United States, Connecticut Connecticut Children's Medical Center Not yet recruiting Hartford, Connecticut, United States, 06106 Principal Investigator: Michael Isakoff, M.D. United States, Delaware Alfred I DuPont Hospital for Children Not yet recruiting Wilmington, Delaware, United States, 19803 Principal Investigator: Emi Caywood, M.D. United States, Florida Shand's Hospital for Children at the University of Florida Not yet recruiting Gainesville, Florida, United States, 32610 Principal Investigator: William Slayton, M.D. Principal Investigator: Joanne Lagmay, M.D. Nemours Children's Hospital Not yet recruiting Jacksonville, Florida, United States, 32207 Principal Investigator: Eric Sandler, M.D. Holtz Children's Hospital at the University of Miami Not yet recruiting Miami, Florida, United States, 33136 Principal Investigator: Matteo Trucco, M.D. Nemours Children's Clinic Not yet recruiting Orlando, Florida, United States, 32806 Principal Investigator: Ramamoorthy Nagasubramanian, M.D. Johns Hopkins All Children's Hospital Not yet recruiting Saint Petersburg, Florida, United States, 33701 Principal Investigator: Jonathan Metts, M.D. H. Lee Moffitt Cancer Center and Research Institute, Coordinating Center Not yet recruiting Tampa, Florida, United States, 33612 Principal Investigator: Damon Reed, M.D. United States, Kentucky University of Kentucky, Markey Cancer Center Not yet recruiting Lexington, Kentucky, United States, 40536 Principal Investigator: Lars Wagner, M.D. United States, Maryland Johns Hopkins University, Sidney Kimmel Cancer Center Not yet recruiting Baltimore, Maryland, United States, 21287 Principal Investigator: Brian Ladle, M.D., Ph.D. Principal Investigator: Nicolas J. Llosa, M.D. United States, New York Montefiore Medical Center, Albert Einstein Cancer Center Not yet recruiting Bronx, New York, United States, 10467 Principal Investigator: David Loeb, M.D., Ph.D. Principal Investigator: Daniel Weiser, M.D. United States, North Carolina University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center Not yet recruiting Chapel Hill, North Carolina, United States, 27599 Principal Investigator: Patrick Thompson, M.D. Sub-Investigator: Ian Davis, M.D., Ph.D Carolina Medical Center, Levine Cancer Institute Not yet recruiting Charlotte, North Carolina, United States, 28203 Principal Investigator: Javier Oesterheld, M.D. United States, Ohio Nationwide Children's Hospital Not yet recruiting Columbus, Ohio, United States, 43205 Principal Investigator: Bhuvana Setty, M.D. Principal Investigator: Timothy Cripe, M.D., Ph.D. United States, Tennessee Vanderbilt-Ingram Cancer Center Not yet recruiting Nashville, Tennessee, United States, 37232 Principal Investigator: Scott Borinstein, M.D. United States, Utah Primary Children's Hospital, Huntsman Cancer Institute Not yet recruiting Salt Lake City, Utah, United States, 84113 Principal Investigator: Douglas Fair, M.D. Collapse <<
NCT01545947	Carcinoma, Non-Small-Cell Lung... more >> Non-Small Cell Lung Cancer Collapse <<	Phase 1	Completed	-	United States, California ... more >> Cedars Sinai Medical Center, Inflammatory Bowel Disease Center Los Angeles, California, United States, 90048 University of California, San Francisco San Francisco, California, United States, 9411 United States, New York NYU School of Medicine New York, New York, United States, 10016 United States, South Carolina Cancer Center of the Carolinas Greenville, South Carolina, United States, 29605 United States, Tennessee Henry-Joyce Cancer Clinic Nashville, Tennessee, United States, 37232-5505 United States, Texas Mary Crowley Cancer Research Centers - Medical City Dallas, Texas, United States, 75201 The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Spain Vall d´Hebron University Hospital Barcelona, Spain, 08035 Hospital Virgen del RocíoServicio de Hematologia Sevilla, Spain, 41013 Collapse <<
NCT00748553	Advanced or Metastatic Solid T... more >>umors Advanced or Metastatic Breast Cancer Collapse <<	Phase 1 Phase 2	Completed	-	United States, Utah ... more >> University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Collapse <<
NCT01011283	Myelodysplastic Syndromes	Phase 4	Terminated(The study was stopp... more >>ed due to insufficient enrollment.) Collapse <<	-	United States, Alabama ... more >> Birmingham Hematology and Oncology Associates Birmingham, Alabama, United States, 35205 United States, California Stanford University Cancer Center Stanford, California, United States, 94305 Stockton Hematology Oncology Stockton, California, United States, 95204 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33619 Pasco Pinellas Cancer Center New Port Richey, Florida, United States, 34652 Gulf Coast Oncology St. Petersburg, Florida, United States, 33705 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Iowa Siouxland Haeatology - Oncology Associates Sioux City, Iowa, United States, 51101 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Montana Sletten Cancer Institute Great Falls, Montana, United States, 59405 United States, New York Cornell Medical Center New York, New York, United States, 10021 United States, North Carolina Carolinas Medical Center NorthEast NorthEast Oncology Associates Concord, North Carolina, United States, 28025 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 Oncology and Hematology Care Cincinnati, Ohio, United States, 45242 United States, Pennsylvania University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Charleston Hematology Oncology Associates Charleston, South Carolina, United States, 29403 United States, Tennessee Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 United States, Utah Utah Cancer Specialists Salt Lake City, Utah, United States, 84106 United States, Wisconsin Gunderson Clinic Ltd. La Crosse, Wisconsin, United States, 54601 Collapse <<
NCT00529022	Solid Tumors	Phase 1	Completed	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02129101	Chronic Myelomonocytic Leukemi... more >>a de Novo Myelodysplastic Syndrome Essential Thrombocythemia Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasm Polycythemia Vera Previously Treated Myelodysplastic Syndrome Primary Myelofibrosis Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Active, not recruiting	October 2018	United States, Minnesota ... more >> Mayo Clinic Rochester, Minnesota, United States, 55905 Collapse <<
NCT03238248	Myelodysplastic Syndromes ... more >> Myeloproliferative Neoplasm Collapse <<	Phase 2	Recruiting	July 2023	United States, Florida ... more >> University of Miami Miller School of Medicine Recruiting Miami, Florida, United States, 33136 Principal Investigator: Justin Watts, MD United States, Kansas University of Kansas Cancer Center Recruiting Westwood, Kansas, United States, 66205 Principal Investigator: Barry Skikne, MD United States, New York Memorial Sloan-Kettering Not yet recruiting New York, New York, United States, 10065 Principal Investigator: Virginia Klimek, MD University of Rochester Medical Center Not yet recruiting Rochester, New York, United States, 14642 Principal Investigator: Jason Mendler, MD United States, Tennessee Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Vanderbilt-Ingram Service for Timely Access Contact 800-811-8480 Collapse <<
NCT02750254	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndrome Acute Lymphocytic Leukemia Collapse <<	Phase 1	Active, not recruiting	October 14, 2020	United States, Missouri ... more >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Collapse <<
NCT01892371	FLT3 Gene Mutation ... more >> Recurrent Acute Myeloid Leukemia Recurrent Chronic Myelomonocytic Leukemia Recurrent Myelodysplastic Syndrome Refractory Acute Myeloid Leukemia Refractory Chronic Myelomonocytic Leukemia Refractory Myelodysplastic Syndrome Collapse <<	Phase 1 Phase 2	Recruiting	November 30, 2019	United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Jorge E. Cortes 713-794-5783 Principal Investigator: Jorge E. Cortes Collapse <<
NCT01011283	-	-	Terminated(The study was stopp... more >>ed due to insufficient enrollment.) Collapse <<	-	-
NCT01613976	Myelodysplastic Syndromes (MDS... more >>) Chronic Myelomonocytic Leukemia (CMML) Acute Myeloid Leukemia (AML) Collapse <<	Phase 1	Completed	-	Japan ... more >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 466-8650 Novartis Investigative Site Nagoya, Aichi, Japan, 460-0001 Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0017 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Novartis Investigative Site Kyoto, Japan, 602-8566 Collapse <<
NCT01301820	Acute Myeloid Leukemia	Phase 2	Completed	-	France ... more >> Mathilde HUNAULT BERGER Angers, France, 49033 Collapse <<
NCT01016600	-	-	Completed	-	-
NCT03703375	Lymphoma, T-Cell	Phase 3	Not yet recruiting	December 31, 2021	Japan ... more >> National Hospital Organization Nagoya Medical Center Not yet recruiting Nagoya, Aichi, Japan National Cancer Center Hospital East Not yet recruiting Kashiwa, Chiba, Japan Kyushu University Hospital Not yet recruiting Higashi-ku, Fukuoka, Japan University of Tsukuba Hospital Not yet recruiting Tsukuba, Ibataki, Japan Tokai University Hospital Not yet recruiting Isehara, Kanagawa, Japan National University Corporation Tohoku University Hospital Not yet recruiting Sendai, Miyagi, Japan Kindai University Hospital Not yet recruiting Osaka-Sayama, Osaka, Japan Saitama Medical University International Medical Center Not yet recruiting Hidaka, Saitama, Japan National Cancer Center Hospital Not yet recruiting Chuo-ku, Tokyo, Japan The Cancer Institute Hospital of Japanese Foundation For Cancer Research Not yet recruiting Koto-ku, Tokyo, Japan Collapse <<
NCT02828358	Acute Leukemia of Ambiguous Li... more >>neage Childhood B Acute Lymphoblastic Leukemia KMT2A Gene Rearrangement Mixed Phenotype Acute Leukemia Collapse <<	Phase 2	Suspended(Met accural pending ... more >>evaluation of enrolled pats.) Collapse <<	September 30, 2019	-
NCT00741234	Solid Tumors ... more >>Hematologic Malignancies Myelodysplastic Syndrome Collapse <<	Phase 1	Completed	-	United States, Texas ... more >> MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin-Madison Madison, Wisconsin, United States, 53792 Singapore National University Hospital Singapore, Singapore, 119074 National Cancer Center Singapore, Singapore, 160610 Singapore General Hospital Singapore, Singapore, 169608 Collapse <<
NCT00392353	Acute Erythroid Leukemia ... more >> Acute Megakaryoblastic Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts Myelodysplastic Syndrome With Ring Sideroblasts Recurrent Adult Acute Myeloid Leukemia Refractory Anemia Collapse <<	Phase 1 Phase 2	Active, not recruiting	-	United States, Illinois ... more >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, New York Montefiore Medical Center-Weiler Hospital Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 North Shore University Hospital Manhasset, New York, United States, 11030 Mount Sinai Hospital New York, New York, United States, 10029 Weill Medical College of Cornell University New York, New York, United States, 10065 Collapse <<
NCT02489929	Myeloid Leukemia ... more >> Myelodysplastic Syndromes Collapse <<	Not Applicable	Not yet recruiting	March 2019	France ... more >> Assistance Publique - Hopitaux de Marseille Recruiting Marseille, France Contact: Regis Costello regis.costello@ap-hm.fr Principal Investigator: Regis Costello Collapse <<
NCT03486353	Myelodysplastic Syndrome (MDS)	Phase 2	Not yet recruiting	December 1, 2020	-
NCT01016600	Leukemia, Myeloid, Acute	Phase 1 Phase 2	Completed	-	United States, Missouri ... more >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Collapse <<
NCT01519011	Myelodysplastic Syndromes ... more >> Leukemia, Myelomonocytic, Chronic Leukemia, Myeloid, Acute Collapse <<	Phase 1	Completed	-	United States, California ... more >> Moores UCSD Cancer Center MC-0987 La Jolla, California, United States, 92093 United States, Colorado Rocky Mountain Cancer Center Denver, Colorado, United States, 80218-1210 United States, Nevada Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, Ohio University of Cincinnati Physician's Inc. Cincinnati, Ohio, United States, 45267-0562 United States, Tennessee Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 United States, Texas Texas Oncology Dallas, Texas, United States, 75230 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 United States, Washington Northwest Cancer Specialists, P.C. Vancouver, Washington, United States, 98684 Collapse <<
NCT01292083	Recurrent Breast Cancer ... more >> Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Triple-negative Breast Cancer Collapse <<	Not Applicable	Withdrawn(No accrual last 2 ye... more >>ars) Collapse <<	-	-
NCT00968071	-	-	Completed	-	-
NCT01130844	Ulcerative Colitis	Phase 1	Completed	-	United States, Arkansas ... more >> Arkansas Children's Hospital Little Rock, Arkansas, United States, 72202 United States, California Advanced Clinical Research Institute Anaheim, California, United States, 92801 University of California, San Francisco San Francisco, California, United States, 94143 United States, Connecticut Connecticut Children's Medical Center Hartford, Connecticut, United States, 06106 United States, Maryland University of Maryland Medical Center for Children Baltimore, Maryland, United States, 21201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Australia, Victoria Royal Children's Hospital Melbourne Parkville, Victoria, Australia, 3052 Poland Klinika Pediatrii Gastroenterologii i Zywienia, Uniwersytecki Szpital Dzieciecy w Krakowie Wieliczka, Krakow, Poland, 30-663 Klinika Pediatrii Dzieciecy Szpital Kliniczny im prof Antoniego Gebali Lublin, Poland, 20-093 Kliniczny Oddzial Pediatrii z Pododdzialem Neurologii Dzieciecej Szpital Wojewodzki Rzeszow, Poland, 35-301 Klinika Gastroenterolofii Pediatrii, Instytut Centrum Zdrowia Matki Polki Rzgowska, Poland, 281/289 Oddzial Gastroenterologii i Hepatologii, Instytut Pomnik-Centrum Zdrowia Dziecka Warszawa, Poland, 04-730 Slovakia Gastroenterologicka ambulancia Limbova 2, Bratislava, Slovakia, 824 02 Univerzitna nemocnica Martin Martin, Kollarova 2, Slovakia, 036 01 DFNsP Banska Bystrica Banska Bystrica, Slovakia, 974 09 United Kingdom Alder Hey Children's NHS Foundation Trust Liverpool, United Kingdom, L12 2AP Barts Health NHS Trust/Royal London Hospital London, United Kingdom, E1 1BB Somers Clinical Research Facility/Great Ormond Street Hospital London, United Kingdom, WC1N 3JH Southampton General Hospital Southampton, United Kingdom, SO16 6YD Collapse <<
NCT01130844	-	-	Completed	-	-
NCT02121418	Chronic Myelomonocytic Leukemi... more >>a-2 Myelodysplastic Syndrome Myeloproliferative Neoplasm Untreated Adult Acute Myeloid Leukemia Collapse <<	Not Applicable	Completed	-	United States, Montana ... more >> Bozeman Deaconess Hospital Bozeman, Montana, United States, 59715 United States, Washington Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 EvergreenHealth Medical Center Kirkland, Washington, United States, 98033 Skagit Valley Hospital Mount Vernon, Washington, United States, 98274 Olympic Medical Center Port Angeles, Washington, United States, 98362 Group Health Cooperative Redmond, Washington, United States, 98052 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Multicare Health System Tacoma, Washington, United States, 98415 Wenatchee Valley Hospital and Clinics Wenatchee, Washington, United States, 98801 Collapse <<
NCT02121418	-	-	Completed	-	-
NCT00002980	Chronic Myeloproliferative Dis... more >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous Condition Unspecified Adult Solid Tumor, Protocol Specific Collapse <<	Phase 1	Completed	-	United States, California ... more >> Beckman Research Institute, City of Hope Duarte, California, United States, 91010 USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033-0800 Los Angeles County-University of Southern California Medical Center Los Angeles, California, United States, 90033 University of California Davis Cancer Center Sacramento, California, United States, 95817 Collapse <<
NCT00545519	Relapsed Or Refractory Multipl... more >>e Myeloma Collapse <<	Phase 1	Completed	-	United States, Missouri ... more >> Washington Unvierstiy in St. Louis St. Louis, Missouri, United States, 63110 Collapse <<
NCT02487563	Thrombocytopenia ... more >> Hematologic Diseases Collapse <<	Phase 3	Unknown	August 2017	China, Jiangsu ... more >> The First affiliated Hospital of SooChow University Not yet recruiting Suzhou, Jiangsu, China, 215000 Contact: Xiang Zhang, MD +86-13382108261 lcsy2013@sina.com Contact: Yaqiong Tang, MD +86-18896588075 wuyin177@sina.com Principal Investigator: Depei Wu, PhD Principal Investigator: Yue Han, PhD Sub-Investigator: Jia Chen, MD Sub-Investigator: Xiao Ma, MD Sub-Investigator: Feng Chen, MD Sub-Investigator: Xiaojin Wu, MD Collapse <<
NCT01333449	Myelodysplastic Syndrome	Phase 2	Terminated(Poor subject accrua... more >>l) Collapse <<	-	Singapore ... more >> Singapore General Hospital Singapore, Singapore, 169608 Collapse <<
NCT01329172	Cystic Fibrosis ... more >> Dietary Modification Collapse <<	Not Applicable	Terminated	-	France ... more >> Dunkerque Hospital Dunkerque, France Lens Hospital Lens, France, 62300 Clinical Investigation center Lille, France, 59037 Collapse <<
NCT01809392	Acute Myelocytic Leukemia ... more >> Myelodysplastic Syndromes Collapse <<	Phase 2 Phase 3	Unknown	December 2015	China, Jiangsu ... more >> First Affiliated Hospital, Soochow University Suzhou, Jiangsu, China, 215000 Collapse <<
NCT02712905	Solid Tumors and Hematologic M... more >>alignancy Collapse <<	Phase 1 Phase 2	Recruiting	March 2020	United States, Alabama ... more >> University of Alabama Recruiting Birmingham, Alabama, United States, 35487 United States, California Moores UCSD Cancer Center Recruiting La Jolla, California, United States, 92093 UCLA Medical Center Recruiting Los Angeles, California, United States, 90095 United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60208 United States, Kansas University of Kansas Center for Research, Inc. Recruiting Kansas City, Kansas, United States, 66045 United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Columbia University Recruiting New York, New York, United States, 10027 United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37240 United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Belgium Institut Jules Bordet Recruiting Brussel, Belgium Netherlands Netherland Cancer Institute Not yet recruiting Amsterdam, Netherlands VU Medical Center Not yet recruiting Amsterdam, Netherlands Erasmus MC Not yet recruiting Rotterdam, Netherlands Collapse <<
NCT02577406	Leukemia, Myeloid ... more >> Isocitrate Dehydrogenase Collapse <<	Phase 3	Recruiting	July 28, 2022	-
NCT02265510	Solid Tumors ... more >>Advanced Malignancies Metastatic Cancer Collapse <<	Phase 1 Phase 2	Active, not recruiting	June 2019	United States, Alabama ... more >> Birmingham, Alabama, United States United States, California West Hollywood, California, United States United States, Connecticut New Haven, Connecticut, United States United States, Georgia Atlanta, Georgia, United States United States, Indiana Indianapolis, Indiana, United States United States, North Carolina Greenville, North Carolina, United States United States, Oregon Portland, Oregon, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Dallas, Texas, United States Collapse <<
NCT00968071	Acute Myelogenous Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 2	Completed	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01478685	Urinary Bladder Neoplasms ... more >> Carcinoma, Transitional Cell Ovarian Neoplasms Fallopian Tube Neoplasms Peritoneal Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Pancreatic Ductal Tumor Virus Infections Collapse <<	Phase 1	Completed	-	United States, Arizona ... more >> Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States, 85258 United States, California University of California, San Francisco San Francisco, California, United States, 94115 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201-2014 United States, South Carolina Greenville Hospital Greenville, South Carolina, United States, 29605 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37205 United States, Texas South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 France Centre Georges Francois Leclerc Dijon, France, 21079 Institut Curie Paris, France, 75005 Netherlands The Netherlands Cancer Instiute Antoni Van Leeuwenhoekziekenhuis Amsterdam, Netherlands, 1066 CX Erasmus Medical Center Rotterdam, Netherlands, 3015 CN Spain Hospital General Universitario Gregorio Maranon Madrid, Spain, 28007 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Collapse <<
NCT02348489	Leukemia, Myeloid, Acute	Phase 3	Completed	-	-
NCT00748527	Fallopian Tube Cancer ... more >> Ovarian Cancer Peritoneal Cavity Cancer Collapse <<	Phase 2	Terminated(The study was "with... more >>drawn" due to certain adverse events [hypersensitivity].) Collapse <<	-	United Kingdom ... more >> Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Royal Marsden - London London, England, United Kingdom, SW3 6JJ Hammersmith Hospital London, England, United Kingdom, W12 OHS Mount Vernon Cancer Centre at Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Weston General Hospital Weston-super-Mare, England, United Kingdom, BS23 4TQ Belfast City Hospital Trust Incorporating Belvoir Park Hospital Belfast, Northern Ireland, United Kingdom, BT8 8JR Edinburgh Cancer Centre at Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G12 0YN Collapse <<
NCT00114257	Chronic Myeloproliferative Dis... more >>orders Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Collapse <<	Phase 1	Completed	-	United States, Texas ... more >> M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Collapse <<
NCT02472145	Leukemia, Myeloid, Acute	Phase 3	Completed	-	-
NCT02564536	Chronic Myelomonocytic Leukemi... more >>a Juvenile Myelomonocytic Leukemia Atypical Chronic Myeloid Leukemia Myeloproliferative Neoplasm Myelodysplastic Syndromes Myelofibrosis Collapse <<	Phase 1	Withdrawn(Lack of funding foll... more >>owing full FDA clinical hold) Collapse <<	June 30, 2020	-
NCT00691938	-	-	Completed	-	-
NCT01687400	-	-	Completed	-	-
NCT02446145	Acute Myeloid Leukemia	Phase 2	Recruiting	May 2019	Germany ... more >> Uniklinik RWTH Aachen Recruiting Aachen, Germany Contact: Martina Crysandt, MD Charite Campus Benjamin Franklin Not yet recruiting Berlin, Germany Contact: Claudia Baldus, Prof. Klinikum Chemnitz GmbH Recruiting Chemnitz, Germany Contact: Mathias Hänel, MD Universitätsklinikum Dresden Recruiting Dresden, Germany Contact: Uwe Platzbecker, Prof. Marienhospital Düsseldorf GmbH Not yet recruiting Düsseldorf, Germany Contact: Aristoteles Giagounidis, MD Universitätsklinikum Essen Recruiting Essen, Germany Contact: Richard Noppeney, MD Universitätsklinikum Halle (Saale) Recruiting Halle, Germany Contact: Petra Tschanter, MD St. Marien-Hospital Hamm Not yet recruiting Hamm, Germany Contact: Heinz A Dürk, MD Klinikum rechts der Isar der TU München Not yet recruiting München, Germany Contact: Katharina Götze, MD Klinikum Nürnberg-Nord Recruiting Nürnberg, Germany Contact: Kerstin Schäfer-Eckart, MD Medizinisches Versorgungszentrum für Blut- und Krebserkrankungen Recruiting Potsdam, Germany Contact: Hartmut Linde, MD Wissenschaftskontor Nord GmbH & Co KG Not yet recruiting Rostock, Germany Contact: Andreas Lück, MD Diakonie-Klinikum Schwäbisch Hall gGmbH Recruiting Schwäbisch Hall, Germany Contact: Thomas Geer, MD Rems-Murr-Klinikum Winnenden Recruiting Winnenden, Germany Contact: Stefani Parmentier, MD Universitätsklinikum Würzburg Not yet recruiting Würzburg, Germany Contact: Volker Kunzmann, Prof. Collapse <<
NCT02608437	Metastatic Melanoma	Phase 1	Unknown	October 2018	Italy ... more >> Medical Oncology and Immunotherapy Unit, University Hospital of Siena Recruiting Siena, Italy, 53100 Contact: Anna Maria Di Giacomo, PhD, MD +390577586305 a.m.digiacomo@ao-siena.toscana.it Contact: Giovanni Amato, PhD +390577586326 dataman.immonco@ao-siena.toscana.it Collapse <<
NCT02698124	-	-	Not yet recruiting	December 2022	Korea, Republic of ... more >> Ulsan University Hospital Not yet recruiting Ulsan, Korea, Republic of, 682714 Contact: Hawk Kim, M.D., Ph.D. +82-52-250-8892 kimhawkmd@gmail.com Principal Investigator: Hawk Kim, M.D., Ph.D. Sub-Investigator: Jae-Cheol Cho, M.D., Ph.D. Sub-Investigator: Yunsuk Choi, M.D., Ph.D. Collapse <<
NCT02429466	Germ Cell Tumor ... more >> Testis Cancer Testicular Cancer Collapse <<	Phase 1	Suspended	December 31, 2019	United States, Indiana ... more >> Indiana University Hospital Indianapolis, Indiana, United States, 46202 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Collapse <<
NCT02779569	Myelodysplastic Syndromes (MDS... more >>) Collapse <<	Not Applicable	Recruiting	August 2019	China, Guangxi ... more >> No.303 Hospital of Chinese People's Liberation Army Not yet recruiting Nanning, Guangxi, China, 530021 Contact: Xiaolin Yin 13321717899@163.com Principal Investigator: Xiaolin Yin China, Jiangsu Jiangsu Province Hospital Recruiting Nanjing, Jiangsu, China, 210029 Contact: Guangsheng He Principal Investigator: Guangsheng He Sub-Investigator: Jianping Mao China, Liaoning Shengjing Hospital of China Medical Univercity Recruiting Shenyang, Liaoning, China, 110022 Contact: Wei Yang yangw@sj-hospital.org Principal Investigator: Wei Yang China, Shanxi The First Affiliated Hospital of Xi'an Jiaotong University Not yet recruiting Xi'an, Shanxi, China, 710061 Contact: Mei Zhang zhangmei@medmail.com.cn Principal Investigator: Mei Zhang China, Xinjiang People's Hospital of Xinjiang Uygur Autonomous Region Not yet recruiting Urumqi, Xinjiang, China, 830001 Contact: Xiaomin Wang wxm201304@163.com Principal Investigator: Xiaomin Wang China, Zhejiang Zhejiang Provincial Hospital of TCM Not yet recruiting Hangzhou, Zhejiang, China, 310000 Contact: Jianping Shen ouyangguifang@medmail.com.cn Principal Investigator: Jianping Shen Collapse <<
NCT01687400	Leukemia, Myeloid, Acute ... more >> Myelodysplastic Syndromes Collapse <<	Phase 2	Completed	-	United States, Missouri ... more >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Collapse <<
NCT02901899	Recurrent Fallopian Tube Carci... more >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Collapse <<	Phase 2	Recruiting	March 2020	United States, Illinois ... more >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Daniela E. Matei 312-472-4684 daniela.matei@northwestern.edu Principal Investigator: Daniela E. Matei, MD Sub-Investigator: Emma Barber, MD Sub-Investigator: Shohreh Shahabi, MD Sub-Investigator: Wilberto Nieves-Neira, MD Sub-Investigator: John Lurian, MD The University of Chicago Medicine Recruiting Chicago, Illinois, United States, 60637 Contact: Gini Fleming, MD 773-702-6712 Principal Investigator: Gini Fleming, MD Northwestern Lake Forest Hospital Recruiting Lake Forest, Illinois, United States, 60045 Contact: Valerine Nelson, MD 312-695-6180 Contact: Alok Pant, MD (847)582-2134 Sub-Investigator: Valerine Nelson, MD Sub-Investigator: Alok Pant, MD Collapse <<
NCT03021395	AML	Phase 1 Phase 2	Recruiting	December 2022	China, Tianjin ... more >> Institute of Hematology & Blood Diseases Hospital Recruiting Tianjin, Tianjin, China Contact: lijun Liu 86-22-23909237 bloodgcp@126.com Collapse <<
NCT02998567	Castration-Resistant Prostatic... more >> Cancer Non Small Cell Lung Cancer Collapse <<	Phase 1	Recruiting	December 2019	United Kingdom ... more >> Rpyal Marsden Hospital Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Summen Chauhdry, BSc 02086421326 summen.chaudry@icr.ac.uk Principal Investigator: Johann de Bono, FRCP UCLH Recruiting London, United Kingdom, W1T 7HA Contact: James Wilton James.Wilton@uclh.nhs.uk Principal Investigator: Dionysis Papadatos-Pastos, FRCP Collapse <<
NCT02632721	Leukemia, Myeloid, Acute	Phase 2	Recruiting	November 30, 2020	United States, Florida ... more >> Mayo Clinic Cancer Center Recruiting Jacksonville, Florida, United States, 32224 United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University Completed Chicago, Illinois, United States, 60611 United States, New York Northwell Health Recruiting Lake Success, New York, United States, 11042 United States, Ohio The Ohio State University Wexner Medical Center Recruiting Columbus, Ohio, United States, 43210 Germany Kommunalunternehmen Klinikum Augsburg Recruiting Augsburg, Germany, 86156 Vivantes Netzwerk für Gesundheit GmbH Recruiting Berlin, Germany, 10967 Universitätsklinikum Carl Gustav Carus Dresden Recruiting Dresden, Germany, 01307 Universitätsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Universitätsklinikum Jena Recruiting Jena, Germany, 07740 Universitätsklinikum Münster Recruiting Münster, Germany, 48149 Italy A.O. Spedali Civili di Brescia Recruiting Brescia, Italy, 25123 Spain Hospital Vall d'Hebron Recruiting Barcelona, Spain, 08035 Hospital Clínic de Barcelona Recruiting Barcelona, Spain, 08036 Hospital Politècnic La Fe Recruiting Valencia, Spain, 46026 Collapse <<
NCT03045510	Myelodysplastic Syndromes	Phase 2	Recruiting	July 30, 2020	China, Shandong ... more >> Qilu hospital, Shandong University Recruiting Jinan, Shandong, China, 250012 Contact: Ming Hou houming@medmail.com.cn Principal Investigator: Ming Hou Shandong University Qilu Hospital Recruiting Jinan, Shandong, China, 250012 Contact: Ming Lv Principal Investigator: Ming Hou, Dr Collapse <<
NCT03080766	Acute Myeloid Leukemia ... more >> Complex Karyotype Collapse <<	Phase 2	Recruiting	February 28, 2021	Hong Kong ... more >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Chunxiao Zhang, SC 852-22554361 chunxiao@hku.hk Collapse <<
NCT03250962	Hodgkin Lymphoma	Phase 1 Phase 2	Recruiting	March 21, 2020	China, Beijing ... more >> Biotherapeutic Department of Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Weidong Han, Doctor +86-10-66937463 hanwdrsw@sina.com Contact: Qingming Yang, Doctor +86-10-55499341 yangqm@medmail.com.cn Principal Investigator: Yang Liu, Doctor Principal Investigator: Chunmeng Wang, Master Principal Investigator: Wenying Zhang, Master Principal Investigator: Meixia Chen, Doctor Principal Investigator: Weidong Han, Doctor Principal Investigator: Qingming Yang, Doctor Principal Investigator: Qian Mei, Doctor Principal Investigator: Jing Nie, Doctor Sub-Investigator: Yan Zhang, Doctor Sub-Investigator: Kaichao Feng, Doctor Sub-Investigator: Jingdan Qiu, Doctor Sub-Investigator: Hejin Jia, Doctor Sub-Investigator: Xiang Li, Master Sub-Investigator: Liang Dong, Master Sub-Investigator: Lu Shi, Master Collapse <<
NCT03306264	Myelodysplastic Syndromes ... more >> Chronic Myelomonocytic Leukemia Collapse <<	Phase 3	Recruiting	June 30, 2019	-
NCT03184935	Myelodysplastic Syndromes	Phase 1 Phase 2	Not yet recruiting	September 2018	China, Inner Mongolia ... more >> Inner Mongolia International Mongolian Hospital Not yet recruiting Hohhot, Inner Mongolia, China, 010065 Contact: Wulantuya 864715182155 Collapse <<
NCT03257761	Extrahepatic Bile Duct Adenoca... more >>rcinoma, Biliary Type Gallbladder Adenocarcinoma, Biliary Type Metastatic Pancreatic Adenocarcinoma Recurrent Cholangiocarcinoma Recurrent Gallbladder Carcinoma Recurrent Hepatocellular Carcinoma Recurrent Intrahepatic Cholangiocarcinoma Recurrent Pancreatic Carcinoma Stage III Gallbladder Cancer AJCC V7 Stage III Hepatocellular Carcinoma AJCC v7 Stage III Intrahepatic Cholangiocarcinoma AJCC v7 Stage III Pancreatic Cancer AJCC v6 and v7 Stage IIIA Gallbladder Cancer AJCC v7 Stage IIIA Hepatocellular Carcinoma AJCC v7 Stage IIIB Gallbladder Cancer AJCC v7 Stage IIIB Hepatocellular Carcinoma AJCC v7 Stage IIIC Hepatocellular Carcinoma AJCC v7 Stage IV Gallbladder Cancer AJCC v7 Stage IV Hepatocellular Carcinoma AJCC v7 Stage IV Pancreatic Cancer AJCC v6 and v7 Stage IVA Gallbladder Cancer AJCC v7 Stage IVA Hepatocellular Carcinoma AJCC v7 Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7 Stage IVB Gallbladder Cancer AJCC v7 Stage IVB Hepatocellular Carcinoma AJCC v7 Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7 Unresectable Gallbladder Carcinoma Unresectable Pancreatic Carcinoma Collapse <<	Phase 1	Recruiting	February 20, 2020	United States, California ... more >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Marile Garcia, RN 323-865-0967 Marile.GarciaLeiva@med.usc.edu Principal Investigator: Anthony El-Khoueiry Hoag Memorial Hospital Presbyterian Recruiting Newport Beach, California, United States, 92663 Contact: Alicia Bogardus, MA alicia.bogardus@hoag.org Principal Investigator: Diana Hanna, MD United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Candace Griffin 410-502-5568 cgriff22@jhmi.edu Principal Investigator: Nilofer S. Azad, MD Collapse <<
NCT03663751	Response Rate	Phase 2	Recruiting	March 2021	China, Shanghai ... more >> Blood & Marrow Transplantation Center, RuiJin Hospital Recruiting Shanghai, Shanghai, China, 200025 Contact: Jiong HU, M.D., 86-21-64370045 hujiong@medmail.com.cn Contact: Ling Wang, M.D., 86-21-64370045 cclingjar@163.com Collapse <<
NCT03535753	NHL	Phase 1	Recruiting	November 1, 2020	China, Beijing ... more >> Peking university third hospital Recruiting Peking, Beijing, China, 010 Contact: Xinan Lu, Dr Collapse <<
NCT03752138	Recurrent Acute Myeloid Leukem... more >>ia Refractory Acute Myeloid Leukemia Collapse <<	Phase 1	Not yet recruiting	December 31, 2020	United States, Texas ... more >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Tapan M. Kadia 713-563-3534 Principal Investigator: Tapan M. Kadia Collapse <<
NCT00085293	Recurrent Thyroid Cancer ... more >> Stage IVA Follicular Thyroid Cancer Stage IVA Papillary Thyroid Cancer Stage IVB Follicular Thyroid Cancer Stage IVB Papillary Thyroid Cancer Stage IVC Follicular Thyroid Cancer Stage IVC Papillary Thyroid Cancer Collapse <<	Phase 2	Completed	-	United States, Colorado ... more >> University of Colorado at Denver Aurora, Colorado, United States, 80045 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00085293	-	-	Completed	-	-
NCT01130506	Previously Treated Myelodyspla... more >>stic Syndrome Recurrent Adult Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Completed	-	United States, Ohio ... more >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02626494	Cocaine Addiction	Phase 4	Completed	-	Switzerland ... more >> Psychiatric University Hospital, Zurich Zurich, Switzerland, 8001 Collapse <<
NCT02665065	Acute Myeloid Leukemia ... more >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute Collapse <<	Phase 3	Recruiting	June 2020	United States, Arizona ... more >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada Collapse <<
NCT01234415	Nasal Septum	Phase 2	Completed	-	France ... more >> Service d'Oto-rhino-laryngologie et Chirurgie cervico-faciale - CHU de Bordeaux Bordeaux, France, 330176 Service d'Oto-rhino-laryngologie - Clinique St Augustin Bordeaux, France, 33074 Service d'Oto-rhino-laryngologie - Hôpital Dupuytren Limoges, France, 87042 Collapse <<
NCT03553537	Peripheral T-cell Lymphoma	Phase 3	Not yet recruiting	July 2021	-
NCT00545389	Colitis, Ulcerative	Phase 2	Completed	-	Belgium ... more >> Imelda General Hospital Bonheiden, Belgium Collapse <<
NCT02187393	-	-	Withdrawn(Technical difficulti... more >>es with the wet bench side of proposed studies.) Collapse <<	-	United States, Colorado ... more >> University of Colorado Denver Aurora, Colorado, United States, 80045 Collapse <<
NCT01420926	-	-	Active, not recruiting	-	-
NCT02788201	Urothelial Carcinoma ... more >> Bladder Cancer Urinary Bladder Neoplasms Collapse <<	Phase 2	Recruiting	July 1, 2020	United States, Maryland ... more >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse <<
NCT02634827	Acute Myeloid Leukemia With FL... more >>T3/ITD Mutation Acute Myeloid Leukemia With Gene Mutations FLT3 Tyrosine Kinase Domain Point Mutation Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 2	Active, not recruiting	April 15, 2020	United States, Minnesota ... more >> Mayo Clinic Rochester, Minnesota, United States, 55905 Collapse <<
NCT02890329	Acute Myeloid Leukemia ... more >> Blasts 5 Percent or More of Bone Marrow Nucleated Cells Hematopoietic Cell Transplantation Recipient Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes Recurrent Adult Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Recruiting	July 1, 2020	United States, California ... more >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org Principal Investigator: Samer K. Khaled University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact 916-734-3089 Principal Investigator: Brian A. Jonas United States, Florida Moffitt Cancer Center Active, not recruiting Tampa, Florida, United States, 33612 United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Site Public Contact 877-726-5130 Principal Investigator: Jacqueline S. Garcia Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com Principal Investigator: Jacqueline S. Garcia Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact 617-667-9925 Principal Investigator: Jacqueline S. Garcia Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact 877-442-3324 Principal Investigator: Jacqueline S. Garcia United States, Ohio Case Western Reserve University Recruiting Cleveland, Ohio, United States, 44106 Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org Principal Investigator: Benjamin K. Tomlinson United States, Virginia University of Virginia Cancer Center Recruiting Charlottesville, Virginia, United States, 22908 Contact: Site Public Contact 434-243-6303 PAS9E@virginia.edu Principal Investigator: Michael K. Keng Collapse <<
NCT01752933	Hepatocellular Carcinoma	Phase 2	Completed	-	-
NCT03308396	Advanced Kidney Cancer ... more >> Kidney Cancer Clear Cell Renal Cell Carcinoma Collapse <<	Phase 1 Phase 2	Recruiting	December 1, 2020	United States, Illinois ... more >> Univerisity of Illinois Cancer Center Recruiting Chicago, Illinois, United States, 60612 Contact: Erin Vidra 312-996-7902 evidra@uic.edu Principal Investigator: David Peace, MD United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Ajjai Alva, M.D. 734-936-0091 ajjai@umich.edu Contact: Carolina Fernandez-Castillo 734-763-8373 cefernan@med.umich.edu United States, New Jersey Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Daniel Bell 732-235-9850 dwb90@cinj.rutgers.edu Principal Investigator: Eric Singer, MD Collapse <<
NCT02131597	High Risk Myelodysplastic Synd... more >>rome Collapse <<	Phase 2	Recruiting	November 1, 2019	United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Guillermo Garcia-Manero 713-745-3428 ggarciam@mdanderson.org Principal Investigator: Guillermo Garcia-Manero Collapse <<
NCT02323607	Recurrent Adult Acute Myeloid ... more >>Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Suspended(internal data analys... more >>is) Collapse <<	September 30, 2018	United States, Ohio ... more >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Collapse <<
NCT01420926	Acute Myeloid Leukemia ... more >> Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Therapy-Related Acute Myeloid Leukemia Collapse <<	Phase 2	Active, not recruiting	-	-
NCT02684162	Leukemia Myel... more >>oproliferative Diseases Collapse <<	Phase 2	Recruiting	June 2021	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Collapse <<
NCT01261312	MDS CMML ... more >> AML Collapse <<	Phase 1 Phase 2	Completed	-	United States, Arizona ... more >> Mayo Clinic Scottsdale, Arizona, United States, 85259 United States, California University of Southern California Los Angeles, California, United States, 90033 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Florida Florida Cancer Specialists - South Fort Myers, Florida, United States, 33916 Florida Cancer Specialists - North Saint Petersburg, Florida, United States, 33705 United States, Illinois University of Chicago Cancer Center Chicago, Illinois, United States, 60637 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Cornell University New York, New York, United States, 10021 Columbia University Medical Center New York, New York, United States, 10032 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 United States, Pennsylvania Temple University Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Collapse <<
NCT03165721	Paraganglioma ... more >> Gastrointestinal Stromal Tumors Carcinoma, Renal Cell Renal Neoplasms Pheochromocytoma Collapse <<	Phase 2	Recruiting	December 1, 2021	United States, Maryland ... more >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse <<
NCT02293993	Acute Myeloid Leukemia	Phase 1	Active, not recruiting	December 2019	Japan ... more >> kinki Region Kyoto, Japan Kanto Region, Japan Kyusyu Region, Japan Collapse <<
NCT03454984	Myelodysplastic Syndromes ... more >> Acute Myeloid Leukemia Collapse <<	Phase 2	Not yet recruiting	March 2022	France ... more >> CHU d'Angers Not yet recruiting Angers, France, 49933 Contact: Sylvain THEPOT, md 33241354466 sylvain.thepot@chu-angers.fr Principal Investigator: Sylvain THEPOT, md CHU Estaing Not yet recruiting Clermont-Ferrand, France, 63000 Contact: Benoit DE RENZIS, MD 33473750065 bderenzis@chu-clermontferrand.fr Principal Investigator: Benoit DE RENZIS, MD Hôpital St Vincent de Paul Not yet recruiting Lille, France, 59020 Contact: Christian ROSE, prof 33320874532 Rose.Christian@ghicl.net Principal Investigator: Christian ROSE, prof CHU Nantes Not yet recruiting Nantes, France, 44093 Contact: Pierre PETERLIN, MD 33240083333 pierre.peterlin@chu-nantes.fr Principal Investigator: Pierre PETERLIN, MD Hôpital Archet 1 Not yet recruiting Nice, France, 06200 Contact: Thomas CLUZEAU, Prof 33492035844 cluzeau.t@chu-nice.fr Hôpital St Louis Not yet recruiting Paris, France, 75010 Contact: Marie Robin, MD 33142499660 marie.robin@aphp.fr Principal Investigator: Marie Robin, MD Hôpital Pitié-Salpêtrière Paris, France, 75013 Hôpital Necker Not yet recruiting Paris, France, 75743 Contact: Felipe SUAREZ, MD 33144495368 felipe.suarez@aphp.fr Principal Investigator: Felipe SUAREZ, MD CHU de Haut-Lévèque Not yet recruiting Pessac, France, 33604 Contact: Sophie DIMICOLI-SALAZAR, md 33557656511 sophie.dimicoli-salazar@chu-bordeaux.fr Principal Investigator: Sophie DIMICOLI-SALAZAR, MD Centre Hospitalier Lyon-Sud Not yet recruiting Pierre-Bénite, France, 69495 Contact: Eric WATTEL, Prof 33478862205 eric.wattel@chu-lyon.fr Principal Investigator: Eric WATTEL, Prof CHU Toulouse - IUCT Oncopole Not yet recruiting Toulouse, France, 31059 Contact: Odile BEYNE-RAUZY, Prof 33531156248 beynerauzy.odile@iuct-oncopole.fr Principal Investigator: Odile BEYNE-RAUZY, Prof CHU Brabois Not yet recruiting Vandœuvre-lès-Nancy, France, 54511 Contact: Agnes GUERCI-BRESLER, md 33383153281 a.guerci@chru-nancy.fr Principal Investigator: Agnes GUERCI-BRESLER, md Collapse <<
NCT02711137	Solid Tumors	Phase 1 Phase 2	Active, not recruiting	December 2018	United States, Alabama ... more >> University of Alabama Birmingham, Alabama, United States, 35294-3300 United States, California University of California La Jolla, California, United States, 92093 United States, Colorado Sarah Cannon Research Institute at Health One Denver, Colorado, United States, 80218 United States, Connecticut Yale University New Haven, Connecticut, United States, 06510 United States, Florida Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Hematology - Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States, 34952 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, New York University of Rochester, Wilmot Cancer Center Rochester, New York, United States, 14642 United States, North Carolina University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 United States, Texas Oncology Consultants, P.A. Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 United States, Washington MultiCare Institute for Research and Innovation Tacoma, Washington, United States, 98405 Belgium Institut Jules Bordet, Clinical Trial Conduct Unit Brussels, Belgium, B-1000 France HÔPITAL SAINT-LOUIS, Service Hématologie Adultes Paris, France, 75010 Collapse <<
NCT03603964	Acute Myeloid Leukemia ... more >> Myeloid Dysplastic Syndrome Collapse <<	Phase 2	Not yet recruiting	July 1, 2020	United States, New York ... more >> Roswell Park Enrolling by invitation Buffalo, New York, United States, 14263 United States, North Carolina Duke Cancer Center Enrolling by invitation Durham, North Carolina, United States, 27705 United States, Ohio Ohio State University Enrolling by invitation Columbus, Ohio, United States, 43210 United States, Pennsylvania Temple University Enrolling by invitation Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Center for Blood Cancers Enrolling by invitation Nashville, Tennessee, United States, 37203 Austria Medizinische Universität Graz Enrolling by invitation Graz, Styria, Austria Canada, Ontario The Ottawa Hospital - General Enrolling by invitation Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Cancer Center Enrolling by invitation Toronto, Ontario, Canada, M5G 2M9 Denmark Rigshospitalet-Copenhagen University Hospital Enrolling by invitation Copenhagen, Denmark Italy Azienda Ospedaliera SS. Antonio E. Biagio E. Cesare Arrigo di Alessandria Enrolling by invitation Alessandria, Italy Azienda Ospedaliera Universitaria San Martino Enrolling by invitation Genova, Italy Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Enrolling by invitation Milano, Italy Azienda Ospedaliero Universitaria S. Maria della Misericordia di Udine Enrolling by invitation Udine, Italy Japan Tokai University Hospital Enrolling by invitation Isehara-shi, Japan, 259-1193 Japanese Red Cross Kyoto Daini Hospital Enrolling by invitation Kyoto-shi, Japan, 602-8026 Saga University Hospital Enrolling by invitation Saga-shi, Japan, 849-8501 Korea, Republic of Severance Hospital, Yonsei University Health System Enrolling by invitation Seoul, Korea, Republic of, 03722 Ulsan University Hospital Enrolling by invitation Ulsan, Korea, Republic of, 44033 Spain Hospital Universitario 12 de Octubre Enrolling by invitation Madrid, Spain Taiwan Mackay Memorial Hospital Enrolling by invitation Taipei, Taiwan National Taiwan University Hospital Enrolling by invitation Taipei, Taiwan Collapse <<
NCT03236857	Malignancies ... more >>Acute Lymphoblastic Leukemia (ALL) Acute Myeloid Leukemia (AML) Non-Hodgkin's Lymphoma Neuroblastoma Collapse <<	Phase 1	Recruiting	April 7, 2022	-
NCT01902329	Acute Myelogenous Leukemia ... more >> Acute Myeloid Leukemia Acute Promyelocytic Leukemia Collapse <<	Phase 1	Completed	-	United States, Alabama ... more >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California City of Hope National Medical Center Duarte, California, United States, 91010-3000 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Georgia Winship Cancer Institute / Emory University School of Medicine Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Cleveland Clinic, The Cleveland, Ohio, United States, 44195 United States, Texas Charles A. Sammons Cancer Center / Baylor University Medical Center Dallas, Texas, United States, 75246 MD Anderson Cancer Center / University of Texas Houston, Texas, United States, 77030-4095 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Collapse <<
NCT03009240	Recurrent Adult Acute Myeloid ... more >>Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Collapse <<	Phase 1	Recruiting	July 2019	United States, California ... more >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Guido Marcucci 626-256-4673 ext 62705 gmarcucci@coh.org Principal Investigator: Guido Marcucci Collapse <<
NCT03075826	Myeloproliferative Neoplasms	Phase 2	Recruiting	December 2019	United States, New York ... more >> New York Weill Cornell Cancer Center at Cornell University Recruiting New York, New York, United States, 10021 Contact: Tania Curcio, NP 212-746-2571 tjc9003@med.cornell.edu Collapse <<
NCT03661307	Acute Myeloid Leukemia With FL... more >>T3/ITD Mutation Blasts More Than 10 Percent of Bone Marrow Nucleated Cells Blasts More Than 10 Percent of Peripheral Blood White Cells Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia Recurrent Myelodysplastic Syndrome Collapse <<	Phase 1 Phase 2	Recruiting	January 1, 2020	United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Musa Yilmaz 713-745-9945 Principal Investigator: Musa Yilmaz Collapse <<
NCT03709550	Castration Levels of Testoster... more >>one Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma in the Soft Tissue Prostate Carcinoma Metastatic in the Bone PSA Level Greater Than or Equal to Two PSA Progression Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8 Collapse <<	Phase 1 Phase 2	Not yet recruiting	August 31, 2020	United States, New York ... more >> Roswell Park Cancer Institute Not yet recruiting Buffalo, New York, United States, 14263 Contact: Gurkamal S. Chatta 716-845-3117 Gurkamal.Chatta@roswellpark.org Principal Investigator: Gurkamal S. Chatta Collapse <<
NCT03041688	Acute Myeloid Leukemia ... more >> Blasts 5 Percent or More of Bone Marrow Nucleated Cells Recurrent Adult Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia TP53 wt Allele Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Recruiting	October 31, 2019	United States, California ... more >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org Principal Investigator: Samer K. Khaled Los Angeles County-USC Medical Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact 323-865-0451 Principal Investigator: Kevin R. Kelly USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact 323-865-0451 Principal Investigator: Kevin R. Kelly Keck Medical Center of USC Pasadena Recruiting Pasadena, California, United States, 91105 Contact: Site Public Contact 323-865-0451 Principal Investigator: Kevin R. Kelly University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact 916-734-3089 Principal Investigator: Brian A. Jonas United States, Kentucky University of Kentucky/Markey Cancer Center Recruiting Lexington, Kentucky, United States, 40536 Contact: Site Public Contact 859-257-3379 Principal Investigator: Reshma Ramlal United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Site Public Contact 410-955-8804 jhcccro@jhmi.edu Principal Investigator: Jonathan A. Webster United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Site Public Contact 877-726-5130 Principal Investigator: Myrna R. Nahas Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com Principal Investigator: Myrna R. Nahas Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact 617-667-9925 Principal Investigator: Myrna R. Nahas Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact 877-442-3324 Principal Investigator: Myrna R. Nahas United States, Ohio Ohio State University Comprehensive Cancer Center Active, not recruiting Columbus, Ohio, United States, 43210 Collapse <<
NCT01165996	-	-	Completed	-	-
NCT01165996	Chronic Myelomonocytic Leukemi... more >>a de Novo Myelodysplastic Syndromes Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Ringed Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Thrombocytopenia Collapse <<	Phase 1 Phase 2	Completed	-	United States, Ohio ... more >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Collapse <<
NCT03063944	Acute Myeloid Leukemia ... more >> Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Suspended(second DLT in cohort... more >> experience. Cohort is closed and study is being amended in order to re-open) Collapse <<	November 2019	United States, Pennsylvania ... more >> Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19171 Collapse <<
NCT02257138	Blasts More Than 20 Percent of... more >> Bone Marrow Nucleated Cells Blasts More Than 20 Percent of Peripheral Blood White Cells Myelodysplastic/Myeloproliferative Neoplasm Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Collapse <<	Phase 1 Phase 2	Recruiting	February 1, 2019	United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Farhad Ravandi-Kashani 713-745-0394 Principal Investigator: Farhad Ravandi-Kashani Collapse <<
NCT03453255	Chemotherapy	Phase 1 Phase 2	Recruiting	December 31, 2020	China ... more >> Chinese PLA General Hospital Recruiting Beijing, China, 100853 Contact: Li Yu, M.D. Ph.D. 86-010-55499003 chunhuiliyu@yahoo.com Principal Investigator: Li Yu, M.D. Ph.D. Collapse <<
NCT00492401	Adult Acute Myeloid Leukemia W... more >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 2	Completed	-	United States, Ohio ... more >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Collapse <<
NCT00095784	-	-	Active, not recruiting	-	-
NCT00492401	-	-	Completed	-	-
NCT00903422	Myelodysplastic Syndrome	Phase 1	Completed	-	-
NCT02029417	Acute Myeloid Leukemia With Mu... more >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 2	Terminated(Major revisions nee... more >>ded in study) Collapse <<	-	United States, New York ... more >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Collapse <<
NCT00095784	Primary Myelofibrosis ... more >> Secondary Myelofibrosis Collapse <<	Phase 2	Active, not recruiting	-	United States, Illinois ... more >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Loyola University Medical Center Maywood, Illinois, United States, 60153 Illinois CancerCare-Peoria Peoria, Illinois, United States, 61615 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62702 Southern Illinois University School of Medicine Springfield, Illinois, United States, 62702 United States, Indiana Fort Wayne Medical Oncology and Hematology Inc-Parkview Fort Wayne, Indiana, United States, 46845 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46628 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Michigan Oncology Care Associates PLLC Saint Joseph, Michigan, United States, 49085 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Collapse <<
NCT02029417	-	-	Terminated(Major revisions nee... more >>ded in study) Collapse <<	-	-
NCT01567059	Acute Myeloid Leukemia With Mu... more >>ltilineage Dysplasia Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 2	Completed	-	United States, Washington ... more >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Collapse <<
NCT00372437	Tumors	Phase 1 Phase 2	Completed	-	United States, Indiana ... more >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Kansas Veterans Affairs Medical Center Kansas City, Kansas, United States, 64128 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, Pennsylvania Pennsylvania Presbyterian Medical Center Philadelphia, Pennsylvania, United States, 19104-4283 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-6307 Canada, Quebec McGill University/Dept Oncology Montreal, Quebec, Canada, H2W 1S6 CHUS Hopital Fleurimont Sherbrooke, Quebec, Canada, J1H 5N4 Collapse <<
NCT00906334	Myelodysplastic Syndrome	Phase 2	Completed	-	United States, California ... more >> Stanford Cancer Center Stanford, California, United States, 94305 Collapse <<
NCT01607645	Adult Acute Megakaryoblastic L... more >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Collapse <<	Phase 2	Terminated(The study was termi... more >>nated early because there were other competing protocols.) Collapse <<	-	United States, Washington ... more >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Collapse <<
NCT01607645	-	-	Terminated(The study was termi... more >>nated early because there were other competing protocols.) Collapse <<	-	-
NCT01846624	Acute Myeloid Leukemia (AML) W... more >>ith Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults AML (Adult) With 11q23 (MLL) Abnormalities AML (Adult) With Del (5q) AML (Adult) With Inv (16) (p13; q22) AML (Adult) With t (16;16) (p13; q22) AML (Adult) With t (8; 21) (q22; q22) Secondary AML (Adult) Untreated AML (Adult) Collapse <<	Phase 2	Terminated(Accrual factor)	-	United States, California ... more >> Stanford University School of Medicine Stanford, California, United States, 94305 Collapse <<
NCT01846624	-	-	Terminated(Accrual factor)	-	-
NCT02228525	Myelodysplastic Syndromes	Phase 2	Active, not recruiting	August 2019	United States, New York ... more >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Collapse <<
NCT00477386	Ovarian Cancer	Phase 1 Phase 2	Completed	-	United States, Indiana ... more >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Collapse <<
NCT02363491	Myelodysplastic Syndrome	Phase 1 Phase 2	Active, not recruiting	April 2019	United States, Florida ... more >> Research Site Tampa, Florida, United States, 33613 United States, New York Research Site Bronx, New York, United States, 10467 Research Site New York, New York, United States, 10021 United States, Texas Research Site Houston, Texas, United States, 77030 Collapse <<
NCT03013998	Previously Untreated Acute Mye... more >>loid Leukemia Collapse <<	Phase 1 Phase 2	Recruiting	December 2021	United States, Arizona ... more >> Mayo Clinic Arizona Recruiting Phoenix, Arizona, United States, 85054 Principal Investigator: Lisa Sproat, MD United States, California UCLA Ronald Reagan Medical Center Recruiting Los Angeles, California, United States, 90095 Principal Investigator: Gary Schiller, MD University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Principal Investigator: Gabriel Mannis, MD United States, Colorado University of Colorado Recruiting Denver, Colorado, United States, 80203 Principal Investigator: Dan Pollyea, MD United States, Florida Mayo Clinic Florida Recruiting Jacksonville, Florida, United States, 32224 Principal Investigator: James Foran, MD United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30308 Principal Investigator: William Blum, MD United States, Illinois University of Chicago Recruiting Chicago, Illinois, United States, 60637 Principal Investigator: Wendy Stock, MD United States, Maryland University of Maryland Medical Center Recruiting Baltimore, Maryland, United States, 21201 Principal Investigator: Maria Baer, MD United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Principal Investigator: Eytan M Stein, MD United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43210 Principal Investigator: John C Byrd, MD Principal Investigator: Alice Mims, MD Principal Investigator: Alison R Walker, MD, MPH United States, Oregon Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Principal Investigator: Uma Borate, MD United States, Texas University of Texas Southwestern Recruiting Dallas, Texas, United States, 75390 Principal Investigator: Prapti Patel, MD United States, Utah Huntsman Cancer Institute, University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Principal Investigator: Michael Deininger, MD, PhD Collapse <<
NCT00079378	Adult Acute Myeloid Leukemia W... more >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Completed	-	United States, Ohio ... more >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Collapse <<
NCT01286038	Myelodysplastic Syndrome (MDS)... more >> Thrombocytopenia Collapse <<	Phase 1 Phase 2	Active, not recruiting	April 2020	United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Collapse <<
NCT01883284	Cystic Fibrosis ... more >> Healthy Subjects Collapse <<	Not Applicable	Completed	-	France ... more >> Respiratory Diseases Department Montpellier, France, 34295 Collapse <<
NCT00703300	Adult Acute Myeloid Leukemia W... more >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Completed	-	United States, Ohio ... more >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Collapse <<
NCT00109824	Recurrent Adult Burkitt Lympho... more >>ma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Mantle Cell Lymphoma Collapse <<	Phase 1	Completed	-	United States, Ohio ... more >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Collapse <<
NCT00357708	Adult Acute Myeloid Leukemia W... more >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Chronic Myelomonocytic Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Philadelphia Chromosome Negative Chronic Myelogenous Leukemia Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Relapsing Chronic Myelogenous Leukemia Collapse <<	Phase 1	Completed	-	United States, Texas ... more >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT03337451	Myelodysplastic Syndrome	Phase 1 Phase 2	Active, not recruiting	April 2019	United States, Texas ... more >> Research Site Houston, Texas, United States, 77030 Collapse <<
NCT00477386	-	-	Completed	-	-
NCT01520805	Acute Myeloid Leukemia (AML) ... more >> Myelodysplastic Syndrome (MDS) Collapse <<	Phase 2	Withdrawn	December 2018	United States, New Jersey ... more >> Cornerstone Pharmaceuticals, Inc Cranbury, New Jersey, United States, 08512 Collapse <<
NCT01798901	Adult Acute Myeloid Leukemia W... more >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Completed	-	United States, Ohio ... more >> Cincinnati Children's Hospital Cincinnati, Ohio, United States, 45229 Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Collapse <<
NCT02878785	Acute Myeloid Leukemia	Phase 1 Phase 2	Recruiting	December 2022	United States, Maryland ... more >> University of Maryland Greenebaum Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Sunita Philip, MPH, CCRP 410-328-8199 sphilip1@umm.edu Contact: Gary Saum 410-328-1180 gary.saum@umm.edu Principal Investigator: Maria Baer, MD Collapse <<
NCT02954653	Acute Myeloid Leukemia	Phase 1	Terminated	-	United States, Arizona ... more >> The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States, 85719 Banner-University Medical Center Tucson Tucson, Arizona, United States, 85724 United States, Illinois The University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, North Carolina Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 Collapse <<
NCT03125174	-	-	Completed	-	United States, North Carolina ... more >> Center for Environmental Medicine Asthma and Lung Biology Chapel Hill, North Carolina, United States, 27599 Marsico Research Institure at Meadowmont Chapel Hill, North Carolina, United States, 27599 Collapse <<
NCT00084981	Recurrent Non-small Cell Lung ... more >>Cancer Stage IV Non-small Cell Lung Cancer Collapse <<	Phase 1	Completed	-	United States, Ohio ... more >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Collapse <<
NCT02093403	Acute Myeloid Leukemia ... more >> Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Completed	-	United States, Ohio ... more >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Collapse <<
NCT00691938	Leukemia, Myeloid, Acute ... more >> Myelodysplastic Syndromes Collapse <<	Phase 1 Phase 2	Completed	-	United States, Missouri ... more >> Washington University St. Louis, Missouri, United States, 63110 Collapse <<
NCT02951156	Diffuse Large B-Cell Lymphoma	Phase 3	Active, not recruiting	May 29, 2021	-
NCT02316964	Adult Acute Myeloid Leukemia W... more >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Collapse <<	Phase 1	Active, not recruiting	December 31, 2019	United States, Ohio ... more >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Collapse <<
NCT01893372	Leukemia	Phase 2	Active, not recruiting	October 2019	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02343939	Acute Myeloid Leukemia	Phase 1 Phase 2	Active, not recruiting	February 2020	United States, California ... more >> UCLA Los Angeles, California, United States United States, Illinois University of Chicago Chicago, Illinois, United States Loyola University Medical Center Maywood, Illinois, United States United States, Indiana Indiana University Indianapolis, Indiana, United States United States, Kansas University of Kansas Medical Center Research Institute, Inc Fairway, Kansas, United States United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States United States, Michigan Henry Ford Health System Detroit, Michigan, United States Karmanos Cancer Institute Detroit, Michigan, United States United States, New York Weill Cornell Medical College - New York - Presbyterian Hospital New York, New York, United States United States, North Carolina Duke Cancer Center Durham, North Carolina, United States United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States Ohio State University Columbus, Ohio, United States United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, South Carolina Saint Francis Cancer Center Greenville, South Carolina, United States Canada, Ontario Princess Margaret Toronto, Ontario, Canada Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada Germany Universitätsklinikum Frankfurt Medizinische Klinik II Frankfurt, Germany, 60590 Collapse <<
NCT00275080	Adult Acute Myeloid Leukemia W... more >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Blastic Phase Chronic Myelogenous Leukemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Secondary Acute Myeloid Leukemia Splenic Marginal Zone Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Completed	-	Canada, Ontario ... more >> Chedoke-McMaster Hospitals Hamilton, Ontario, Canada, L8S 4L8 Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada, M5G 2M9 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Collapse <<
NCT02421939	Leukemia, Acute Myeloid (AML)	Phase 3	Active, not recruiting	December 2020	-
NCT00882102	-	-	Completed	-	-
NCT00882102	Acute Myelogenous Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 2	Completed	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01356875	Myelodysplastic Syndrome	Phase 2	Unknown	January 2015	Spain ... more >> Txagorritxu Hospital Not yet recruiting Vitoria-Gasteiz, Alava, Spain, 01009 Contact: Breno Moreno de Gusmao, MD +34 945 007000 breno.morenodegusmao@osakidetza.net Collapse <<
NCT00866073	Acute Myeloid Leukemia	Phase 2	Completed	-	Germany ... more >> Medizinische Hochschule Hannover Hannover, Niedersachsen, Germany, 30625 Klinikum der Technischen Universität Aachen Aachen, Germany Universitätsklinikum Düsseldorf Düsseldorf, Germany Katholisches Krankenhaus Hagen Hagen, Germany Klinikum Lüdenscheid Luedenscheid, Germany Universitätsklinikum Ulm Ulm, Germany Klinikum Villingen-Schwenningen Villingen-Schwenningen, Germany Netherlands Leyenburg Hospital The Hague, Netherlands Collapse <<
NCT00042796	Childhood Acute Myeloblastic L... more >>eukemia With Maturation (M2) Childhood Acute Promyelocytic Leukemia (M3) Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Collapse <<	Phase 1	Terminated(Administratively co... more >>mplete.) Collapse <<	-	United States, California ... more >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Collapse <<
NCT02109744	Acute Myelogenous Leukemia	Phase 1 Phase 2	Recruiting	December 2020	United States, New York ... more >> University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Haley Misch 585-275-9485 Haley_Misch@urmc.rochester.edu Contact: Robin Boerman 585-273-1507 Robin_Boerman@urmc.rochester.edu Principal Investigator: Jane Liesveld, MD Sub-Investigator: Kristen O'Dwyer, MD Collapse <<
NCT00542828	Myelodysplastic Syndrome (MDS)	Phase 2	Terminated(Study terminated du... more >>e to slow enrollment.) Collapse <<	-	France ... more >> Hopital Avicenne/University Paris, France, 93009 Germany St. Johannes-Hospital Duisburg Duisburg, Germany, 47166 Medizinische Hochschule Hannover Hannover, Germany, 30625 Netherlands UMC St Radboud Centraal Nijmegen, Netherlands, 6525 GA United Kingdom Royal Bournemouth Hospital Bournemouth, England, United Kingdom, BH7 7DW St. James Hospital Leeds, England, United Kingdom, LS9 7TF King's College Hospital London, England, United Kingdom, SE5 9RS Collapse <<
NCT00542828	-	-	Terminated(Study terminated du... more >>e to slow enrollment.) Collapse <<	-	-
NCT01685515	Sickle Cell Disease	Phase 1	Completed	-	United States, Illinois ... more >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 Collapse <<
NCT02562443	Myelodysplastic Syndrome ... more >> MDS Refractory Anemia With Excess Blasts RAEB Collapse <<	Phase 3	Recruiting	September 2019	-
NCT02907359	Myelodysplastic Syndromes ... more >> Leukemia, Myelomonocytic, Chronic Collapse <<	Phase 3	Recruiting	December 2019	-
NCT02250326	-	-	Active, not recruiting	-	-
NCT01241162	Neuroblastoma ... more >> Ewings Sarcoma Osteogenic Sarcoma Rhabdomyosarcoma Synovial Sarcoma Collapse <<	Phase 1	Completed	-	United States, Kentucky ... more >> University of Louisville, Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States, 40202 Collapse <<
NCT00075010	Leukemia Myel... more >>odysplastic Syndromes Collapse <<	Phase 1 Phase 2	Completed	-	United States, Texas ... more >> M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02250326	Carcinoma, Non-Small-Cell Lung	Phase 2	Active, not recruiting	April 30, 2019	-
NCT03358719	Acute Myeloid Leukemia ... more >> Blasts 30 Percent or Less of Bone Marrow Nucleated Cells Chronic Myelomonocytic Leukemia High Risk Myelodysplastic Syndrome Myelodysplastic Syndrome Refractory Anemia Collapse <<	Phase 1	Recruiting	September 13, 2020	United States, New York ... more >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Elizabeth A. Griffiths 716-845-3996 Elizabeth.Griffiths@roswellpark.org Principal Investigator: Elizabeth A. Griffiths Collapse <<
NCT00321711	MDS Myelodysp... more >>lastic Syndromes Thrombocytopenia Collapse <<	Phase 2	Completed	-	-
NCT01758367	Recurrent Adult Acute Myeloid ... more >>Leukemia Collapse <<	Phase 1 Phase 2	Unknown	June 2018	China, Beijing ... more >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Li Yu, MD, PhD 86-010-55499003 chunhuiliyu@yahoo.com Contact: Li-Xin Wang, MD, PhD 86-010-66958509 wanglixin1991@sohu.com Principal Investigator: Li Yu, MD, PhD Sub-Investigator: Li-Xin Wang, MD, PhD Collapse <<
NCT03063203	Acute Myeloid Leukemia ... more >> Acute Myeloid Leukemia, Relapsed, Adult Collapse <<	Phase 2	Recruiting	July 31, 2025	United States, Illinois ... more >> University of Chicago Withdrawn Chicago, Illinois, United States, 60637 United States, Iowa University of Iowa Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Carlos Vigil, M.D. carlos-vigil@uiowa.edu Principal Investigator: Carlos Vigil, M.D. United States, Massachusetts Massachusetts General Hospital Withdrawn Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Withdrawn Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: John Welch, M.D., Ph.D. 314-362-2626 jwelch@wustl.edu Principal Investigator: John Welch, M.D., Ph.D. United States, Texas The University of Texas MD Anderson Cancer Center Withdrawn Houston, Texas, United States, 77030 United States, Washington Fred Hutchinson Cancer Research Center Not yet recruiting Seattle, Washington, United States, 98109 Contact: Elihu Estey, M.D. 206-288-7176 eestey@u.washington.edu Principal Investigator: Elihu Estey, M.D. Collapse <<
NCT00321711	-	-	Completed	-	-
NCT03558412	T-lymphoblastic Lymphoma	Phase 4	Recruiting	June 1, 2020	China, Henan ... more >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr 13838565629 mingzhi_zhang@126.com Contact: Mingzhi Zhang, Pro,Drc 13838565629 mingzhi_zhang@126.com Collapse <<
NCT03579082	Diffuse Large B Cell Lymphoma	Phase 4	Recruiting	December 1, 2019	China, Henan ... more >> Oncology Department of The First Affilliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr 13838565629 mingzhi_zhang@126.com Contact: Mingzhi Zhang, Pro,Drc 13838565629 mingzhi_zhang@126.com Collapse <<
NCT01673217	Recurrent Fallopian Tube Cance... more >>r Recurrent Ovarian Epithelial Cancer Recurrent Primary Peritoneal Cavity Cancer Collapse <<	Phase 1	Completed	-	United States, New York ... more >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Collapse <<
NCT03066648	Leukemia Leuk... more >>emia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Preleukemia Bone Marrow Diseases Hematologic Diseases Collapse <<	Phase 1	Recruiting	April 1, 2020	United States, Massachusetts ... more >> Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02114 Contact: Meghan Burke 617-726-5131 Mburke19@partners.org Principal Investigator: Andrew M. Brunner United States, Oregon Novartis Investigative Site Recruiting Portland, Oregon, United States, 97239 United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Recruiting Melbourne, Victoria, Australia, 3004 Finland Novartis Investigative Site Recruiting Helsinki, Finland, FIN-00290 France Novartis Investigative Site Recruiting Marseille, France, 13273 Germany Novartis Investigative Site Recruiting Jena, Germany, 07740 Netherlands Novartis Investigative Site Recruiting Amsterdam, Netherlands, 1081 HV Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 United Kingdom Novartis Investigative Site Recruiting Cardiff, United Kingdom, CF4 4XN Collapse <<
NCT00067808	-	-	Completed	-	-
NCT01834248	Acute Myeloid Leukemia ... more >> Alkylating Agent-Related Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Refractory Anemia With Excess Blasts in Transformation Collapse <<	Phase 1	Completed	-	United States, New York ... more >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Collapse <<
NCT00067808	Myelodysplastic Syndrome ... more >> Chronic Myelomonocytic Leukemia Collapse <<	Phase 2	Completed	-	United States, Texas ... more >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02892318	Acute Myeloid Leukemia	Phase 1	Suspended(Study enrollment on ... more >>hold to evaluate safety and efficacy data.) Collapse <<	January 31, 2019	United States, California ... more >> City of Hope Duarte, California, United States, 91010 United States, Connecticut Yale University New Haven, Connecticut, United States, 06511 United States, New York The NewYork-Presbyterian Hospital Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 United States, Pennsylvania Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 United States, Wisconsin The University of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States, 53705 Collapse <<
NCT02920008	Acute Myeloid Leukemia	Phase 3	Active, not recruiting	December 2019	-
NCT03226418	Adult Acute Myeloid Leukemia ... more >> Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Collapse <<	Phase 2	Recruiting	July 7, 2023	United States, California ... more >> USC / Norris Comprehensive Cancer Center Not yet recruiting Los Angeles, California, United States, 90033 Contact: Mojtaba Akhtari mojtaba.akhtari@med.usc.edu Principal Investigator: Mojtaba Akhtari United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198 Contact: Vijaya R. Bhatt 402-559-8008 vijaya.bhatt@unmc.edu Principal Investigator: Vijaya R. Bhatt Collapse <<
NCT01729845	Previously Treated Myelodyspla... more >>stic Syndrome Recurrent Adult Acute Myeloid Leukemia Collapse <<	Phase 1 Phase 2	Completed	-	United States, Washington ... more >> Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 EvergreenHealth Medical Center Kirkland, Washington, United States, 98033 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Collapse <<
NCT03513458	Asthma	Phase 1 Phase 2	Enrolling by invitation	December 2021	United States, North Carolina ... more >> Center for Environmental Medicine, Asthma, and Lung Biology Chapel Hill, North Carolina, United States, 27599 Collapse <<
NCT01729845	-	-	Completed	-	-
NCT02265731	Non-Hodgkin Lymphoma (NHL) ... more >> Multiple Myeloma (MM) Chronic Lymphocytic Leukemia (CLL) Small Lymphocytic Lymphoma (SLL) Acute Myeloid Leukemia (AML) Collapse <<	Phase 1 Phase 2	Active, not recruiting	February 6, 2020	Japan ... more >> Aichi Cancer Center Hospital /ID# 129061 Nagoya-shi, Aichi, Japan, 464-8681 Nagoya City University Hospital /ID# 129278 Nagoya-shi, Aichi, Japan, 467-8602 University of Fukui Hospital /ID# 165801 Yoshida-gun, Fukui, Japan, 910-1193 National Hospital Organization Kyushu Cancer Center /ID# 149741 Fukuoka-shi, Fukuoka, Japan, 811-1395 Kyushu University Hospital /ID# 163202 Fukuoka-shi, Fukuoka, Japan, 812-8582 Kobe City Medical Center General Hospital /ID# 170919 Kobe-shi, Hyogo, Japan, 650-0047 Tohoku University Hospital /ID# 129275 Sendai-shi, Miyagi, Japan, 980-8574 Kinki University -Osakasayama Campus /ID# 169554 Osakasayama-shi, Osaka, Japan, 589-8511 Osaka University Hospital /ID# 169862 Suita-shi, Osaka, Japan, 565-0871 National Cancer Center Hospital /ID# 129044 Chuo-ku, Tokyo, Japan, 104-0045 The Cancer Institute Hosp JFCR /ID# 129277 Koto-ku, Tokyo, Japan, 135-8550 Toranomon Hospital /ID# 148229 Minato-ku, Tokyo, Japan, 105-8470 NTT Medical Center Tokyo /ID# 166281 Shinagawa-ku, Tokyo, Japan, 141-8625 NHO Nagoya Medical Center /ID# 129222 Nagoya, Japan, 460-0001 Collapse <<
NCT03513471	Asthma	Phase 1 Phase 2	Enrolling by invitation	December 2021	United States, North Carolina ... more >> Center for Environmental Medicine, Asthma, and Lung Biology Chapel Hill, North Carolina, United States, 27599 Collapse <<
NCT01707004	Acute Myeloid Leukemia With Mu... more >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Collapse <<	Phase 2	Completed	-	United States, Wisconsin ... more >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Collapse <<
NCT00382200	Myelodysplastic Syndromes	Phase 1 Phase 2	Suspended	July 2019	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse <<
NCT00260832	-	-	Completed	-	-
NCT00479232	Leukemia, Myelocytic, Acute My... more >>elodysplastic Syndromes Myelodysplastic Syndromes Collapse <<	Phase 1	Completed	-	-
NCT01829503	Acute Myeloid Leukemia	Phase 2	Active, not recruiting	October 2017	United States, Pennsylvania ... more >> University of PIttsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Collapse <<
NCT00479232	-	-	Completed	-	-
NCT02088541	Acute Myeloid Leukemia (AML)	Phase 2	Completed	-	-
NCT01966289	Metastatic Colorectal Cancer	Phase 1	Active, not recruiting	December 2019	United States, Maryland ... more >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Collapse <<
NCT00879385	Colorectal Cancer	Phase 1	Completed	-	United States, Utah ... more >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Collapse <<
NCT00260832	Acute Myeloid Leukemia	Phase 3	Completed	-	-
NCT00903760	Myelodysplastic Syndrome	Phase 2	Completed	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01001143	Leukemia, Myeloid, Acute	Phase 1	Completed	-	United States, Missouri ... more >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Collapse <<
NCT01853228	Acute Myeloid Leukemia	Phase 2	Completed	-	Belgium ... more >> Gent, Belgium Denmark Copenhagen Ø, Denmark France Paris, France Toulouse Cedex 9, France Vandoeuvre-Lès-Nancy, France Germany Essen, Germany Hamburg, Germany Hannover, Germany Stuttgart, Germany Netherlands Rotterdam, Netherlands Spain Barcelona, Spain Madrid, Spain Valencia, Spain United Kingdom Birmingham, United Kingdom Cambridge, United Kingdom Glasgow, United Kingdom Sutton, United Kingdom Collapse <<
NCT00903760	-	-	Completed	-	-
NCT01829503	-	-	Active, not recruiting	-	-
NCT02532010	Acute Myeloid Leukemia (AML)	Phase 2	Terminated(The study was put o... more >>n clinical hold by the sponsor since Feb 9th 2016, and was later decided not to re-open due to financial constraints.) Collapse <<	-	United States, New York ... more >> Weill Cornell Medical College New York, New York, United States, 10021 Collapse <<
NCT02532010	-	-	Terminated(The study was put o... more >>n clinical hold by the sponsor since Feb 9th 2016, and was later decided not to re-open due to financial constraints.) Collapse <<	-	-
NCT02488408	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndromes Collapse <<	Phase 1 Phase 2	Recruiting	August 2018	United States, Iowa ... more >> University of Iowa Hospitals and Clinics Recruiting Iowa City, Iowa, United States, 52242 Contact: Karen Parrott 319-353-6347 karen-parrott@uiowa.edu Principal Investigator: Carlos E Vigil, MD United States, Ohio James Cancer Hospital & Solove Research Institute Recruiting Columbus, Ohio, United States, 43210 Contact: Molly Vittorio 614-293-7940 molly.vittorio@osumc.edu Principal Investigator: William Blum, Professor United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Cora Cheung 713-792-3461 cmcheung@mdanderson.org Principal Investigator: Jorge Cortes, Professor Germany Universitätsklinikum Frankfurt, Medizinische Klinik II Recruiting Frankfurt, Germany, 60596 Contact: Laura Hefermehl +49 69 6301 86708 Laura.Hefermehl@kgu.de Principal Investigator: Jörg Chromik, Dr University Medical Center Hamburg-Eppendorf Martinistrasse Recruiting Hamburg, Germany, 20246 Contact: Sonja T Loges, MD, PhD +49 407-410-51969 s.loges@uke.de Principal Investigator: Sonja Loges, MD, PhD Medizinische Hochschule Hannover Recruiting Hannover, Germany, 30625 Contact: Gabriele Samson +49 (511) 532 9321 samson.gabriele@mh-hannover.de Principal Investigator: Michael Heuser, Dr Universitätsklinikum Ulm, Oberer Eselsberg, Zentrum für Innere Medizin III Recruiting Ulm, Germany, 89081 Contact: Manuela Wetzel +49 (0) 731 500 45709 manuela.wetzel@uniklinik-ulm.de Principal Investigator: Peter Paschka, Dr Norway Haukeland University Hospital Recruiting Bergen, Norway, 5021 Contact: Marianne Emblem Lehmann +47 59972890/ 95975516 marianne.emblem.lehmann@helse-bergen.no Principal Investigator: Bjørn Tore Gjertsen, Professor Collapse <<
NCT01352650	Acute Myeloid Leukemia	Phase 1	Completed	-	United States, New York ... more >> Weill Cornell Medical College New York, New York, United States, 10021 Collapse <<
NCT02073838	Acute Myeloid Leukemia	Phase 2	Recruiting	June 2018	Canada, Quebec ... more >> Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T1E2 Contact: Eftihia Cocolakis, PhD 5143408222 ext 3628 ecocolakis@jgh.mcgill.ca Principal Investigator: Sarit Assouline, MD Collapse <<
NCT02685228	Pancreatic Cancer	Not Applicable	Unknown	December 2018	-
NCT02959164	Pancreatic Ductal Adenocarcino... more >>ma Sarcoma Collapse <<	Phase 1	Recruiting	July 2020	United States, Iowa ... more >> University of Iowa Hospitals and Clinics Recruiting Iowa City, Iowa, United States, 52242 Contact: Varun Monga, MD 319-384-9497 varun-monga@uiowa.edu Collapse <<
NCT02996474	Relapsed Acute Myeloid Leukemi... more >>a Collapse <<	Phase 1 Phase 2	Active, not recruiting	July 1, 2019	United States, Maryland ... more >> National Institutes of Health Clinical Center Bethesda, Maryland, United States, 20892 Collapse <<
NCT02985372	Acute Myeloid Leukemia, Adult	Phase 3	Enrolling by invitation	December 2019	-
NCT01498445	Leukemia	Phase 1 Phase 2	Active, not recruiting	June 2021	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT03295552	Breast Neoplasm	Phase 2	Recruiting	November 2020	China, Shanghai ... more >> Ruijin Hospital, Shanghai Jiaotong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Min Lu, PHD 0086-21-64370045 ext 610805 min.lu@shsmu.edu.cn Contact: Xiaosong Chen, MD 0086-21-64370045 ext 602102 chenxiaosong0156@hotmail.com Principal Investigator: Kunwei Shen, MD Principal Investigator: Min Lu, PHD Collapse <<
NCT01628471	Non Small Cell Lung Cancer	Phase 1 Phase 2	Completed	-	Canada, Quebec ... more >> Hôpital Notre Dame du CHUM Montreal, Quebec, Canada, H2L 4M1 Collapse <<
NCT03303339	Acute Myeloid Leukemia	Phase 1 Phase 2	Recruiting	May 31, 2020	United States, California ... more >> University of California Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact 310-206-5511 United States, Connecticut Yale University Recruiting New Haven, Connecticut, United States, 06510 Contact 203-200-4363 United States, Kansas University of Kansas Cancer Center Recruiting Westwood, Kansas, United States, 66205 Contact 585-957-4381 United States, Minnesota Allina Health Virginia Piper Cancer Institute Recruiting Minneapolis, Minnesota, United States, 55407 Contact 612-884-6300 United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact 716-845-3544 United States, Texas University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact 214-648-1906 MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact 713-794-5783 United States, Virginia Virginia Cancer Specialists - Fairfax Office Recruiting Fairfax, Virginia, United States, 22031 Contact 703-208-3173 United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact 855-557-0555 Collapse <<
NCT03445858	Childhood Solid Tumor ... more >> Childhood Lymphoma Relapsed Cancer Refractory Cancer Adult Solid Tumor Adult Lymphoma Collapse <<	Early Phase 1	Recruiting	May 12, 2022	United States, Ohio ... more >> Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Laura Fossett 513-636-2799 cancer@cchmc.org Collapse <<
NCT03679650	Acute Myelogenous Leukemia	Phase 1	Recruiting	August 31, 2024	United States, Massachusetts ... more >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Emma Logan, BSN 617-667-5984 eklogan@bidmc.harvard.edu Principal Investigator: Jacalyn Rosenblatt, MD Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Robert J Soiffer, MD Robert_soiffer@dfci.harvard.edu Principal Investigator: Robert J Soiffer, MD Collapse <<
NCT01876641	Metastatic Melanoma ... more >> Melanoma BRAF-mutated Metastatic Melanoma V600EBRAF-mutated Metastatic Melanoma Collapse <<	Phase 1	Terminated(Loss of funding)	-	United States, Iowa ... more >> University of Iowa Hospitals & Clinics Iowa City, Iowa, United States, 52242 Collapse <<
NCT02141477	Leukemia	Phase 1	Terminated(Slow Accrual-2 pati... more >>ents were registered Phase I and none in Phase II) Collapse <<	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02272478	Acute Myeloid Leukaemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 2 Phase 3	Recruiting	October 2020	United Kingdom ... more >> UHW Recruiting Cardiff, United Kingdom, CF14 4XN Principal Investigator: Steve Knapper Nottingham University Hospital Recruiting Nottingham, United Kingdom Contact: Nigel Russell, MD Collapse <<
NCT03085849	Extensive-stage Small Cell Lun... more >>g Cancer Collapse <<	Phase 1	Completed	-	United States, New York ... more >> Columbia University Medical Center New York, New York, United States, 10032 Collapse <<
NCT02662647	AML	Phase 2	Recruiting	December 2019	China, Beijing ... more >> Navy General Hospital Recruiting Beijing, Beijing, China, 100048 Contact: Li-Xin Wang, M.D Ph.D 86-010-66958509 wanglixin1991@sohu.com Principal Investigator: Li-Xin Wang, M.D. Ph.D. Collapse <<
NCT02846935	T-cell Lymphoma ... more >> Aggressive B-cell Lymphoma Non-Hodgkin's Lymphomas Indolent B-cell Lymphoma Collapse <<	Early Phase 1	Recruiting	August 2021	United States, Ohio ... more >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Withdrawn Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Mitchell R Smith, MD, PhD 216-444-4366 smithm14@ccf.org Principal Investigator: Mitchell R Smith, MD, PhD Collapse <<
NCT03701451	Nasopharyngeal Carcinoma	Phase 1 Phase 2	Recruiting	December 1, 2020	China, Guangxi ... more >> Guilin Hospital of Traditional Chinese Medicine Recruiting Guilin, Guangxi, China, 541002 Contact: Ruihua Xiong, Ph.D. Guilin Medical University Recruiting Guilin, Guangxi, China Contact: Rongjun Zhang, Mster +8618977330177 41974954@qq.com Contact: Wei Jiang, Ph.D +8613788561863 Collapse <<
NCT03113071	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndromes Collapse <<	Phase 1 Phase 2	Recruiting	January 2022	United States, Pennsylvania ... more >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Philip Pancari, MD Jeans Hospital Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Philip Pancari, MD Collapse <<
NCT02847000	Metastatic Pancreatic Adenocar... more >>cinoma Collapse <<	Early Phase 1	Active, not recruiting	December 2018	United States, Ohio ... more >> University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Collapse <<
NCT02935361	Chronic Myelomonocytic Leukemi... more >>a Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes Collapse <<	Phase 1 Phase 2	Recruiting	November 2, 2021	United States, California ... more >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Casey L. O'Connell 323-865-3950 coconnel@usc.edu Principal Investigator: Casey L. O'Connell United States, Maryland University of Maryland Medical Center Not yet recruiting Baltimore, Maryland, United States, 21201 Contact: Maria R. Baer MBaer@umm.edu Principal Investigator: Maria R. Baer United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Patricia L. Kropf, MD 215-214-3119 Patricia.Kropf@tuhs.temple.edu Contact: Lilanee Chanyothi, RN 215-214-3035 Lilanee.Chanyothi@tuhs.temple.edu Principal Investigator: Patricia L. Kropf, MD Temple University Hospital Not yet recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Patricia L. Kropf Patricia.Kropf@tuhs.temple.edu Principal Investigator: Patricia L. Kropf Collapse <<
NCT03220477	Lung Cancer	Phase 1	Recruiting	July 2020	United States, Maryland ... more >> John Hopkins Medical Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Jarushka Naidoo, M.B.B.Ch. 410-955-8866 Jhcccro@jhmi.edu Principal Investigator: Jarushka Naidoo, M.B.B.Ch. United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Matthew Hellmann, MD 646-888-4863 Contact: Charles Rudin, MD, PhD 646-888-4527 Principal Investigator: Matthew Hellmann, MD United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Contact: Hossein Borghaei, MS, DO 888-369-2427 Collapse <<
NCT03377725	Myelodysplastic Syndromes ... more >> P53 Mutation Collapse <<	Phase 3	Not yet recruiting	November 2020	China ... more >> Ruijin Hospital North Not yet recruiting Shanghai, China Contact: Sujiang Zhang, MD 0086-21-67888761 zbruce.zhang@hotmail.com Principal Investigator: Sujiang Zhang, MD Ruijin Hospital Not yet recruiting Shanghai, China Contact: Junmin Li, MD 86-21-64370045 ext 665251 drlijunming@126.com Principal Investigator: Junming Li, MD Shanghai Institute of Hematology Not yet recruiting Shanghai, China Contact: Min Lu, Ph.D. 86-21-64370045 ext 610805 min.lu@shsmu.edu.cn Principal Investigator: Min Lu, Ph.D. Collapse <<
NCT02499861	Cancer	Phase 1 Phase 2	Completed	-	Canada, Quebec ... more >> St. Justine's Hospital Montreal, Quebec, Canada, H3T 1C5 Collapse <<
NCT03404193	Other Diseases of Blood and Bl... more >>ood-forming Organs Acute Myeloid Leukemia Myelodysplastic Syndrome Collapse <<	Phase 2	Recruiting	December 2020	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact mkonople@mdanderson.org Collapse <<
NCT03417427	Leukemia, Myeloid	Phase 2	Recruiting	January 31, 2025	China, Guangdong ... more >> Nanfang Hospital of Southern Medical University Recruiting Guanzhou, Guangdong, China, 510515 Contact: Xuejie Jiang, doctor +8618688869522 jxj3331233@163.com Collapse <<
NCT01861314	Acute Myeloid Leukemia ... more >> Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Active, not recruiting	-	United States, Ohio ... more >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Collapse <<
NCT03179943	Urothelial Carcinoma	Phase 2	Recruiting	July 2022	United States, Pennsylvania ... more >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Elizabeth Plimack, MD 215-214-1515 Collapse <<
NCT00075634	Recurrent Neuroblastoma ... more >> Unspecified Childhood Solid Tumor, Protocol Specific Collapse <<	Phase 1	Completed	-	United States, California ... more >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Collapse <<
NCT03395873	Acute Myeloid Leukemia	Phase 1	Recruiting	December 31, 2020	United States, Pennsylvania ... more >> Penn State Cancer Institute Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Clinical Research Nurse 717-531-7309 hzheng@pennstatehealth.psu.edu Contact: Michelle Knapp, RN 717-531-0003 mknapp1@pennstatehealth.psu.edu Principal Investigator: Hong Zheng, MD Collapse <<
NCT00454480	Leukemia Myel... more >>odysplastic Syndromes Collapse <<	Phase 2 Phase 3	Completed	-	-
NCT03576963	Colorectal Adenocarcinoma ... more >> CpG Island Methylator Phenotype Metastatic Microsatellite Stable Colorectal Carcinoma Refractory Colorectal Carcinoma Stage IV Colorectal Cancer AJCC v8 Stage IVA Colorectal Cancer AJCC v8 Stage IVB Colorectal Cancer AJCC v8 Stage IVC Colorectal Cancer AJCC v8 Collapse <<	Phase 1 Phase 2	Not yet recruiting	February 25, 2022	United States, California ... more >> USC / Norris Comprehensive Cancer Center Not yet recruiting Los Angeles, California, United States, 90033 Contact: Dana Agafitei 323-865-0467 Raluca.Agafitei@med.usc.edu Principal Investigator: Heinz-Josef Lenz, MD Hoag Memorial Hospital Presbyterian Not yet recruiting Newport Beach, California, United States, 92658 Contact: Alicia Bogardus, MA 949-764-6755 Alicia.bogardus@hoag.org Principal Investigator: Diana Hanna, MD Collapse <<
NCT03593915	Myelodysplastic Syndromes (MDS... more >>) Collapse <<	Phase 1 Phase 2	Recruiting	May 2022	United States, Maryland ... more >> Johns Hopkins Not yet recruiting Baltimore, Maryland, United States, 21218 Contact: Amy DeZern, MD Principal Investigator: Amy DeZern, MD United States, Texas US Oncology - Texas Oncology - Austin Midtown Recruiting Austin, Texas, United States, 78705 Contact: Jason Melear, MD 512-421-4163 Principal Investigator: Jason Melear, MD US Oncology - Texas Oncology - San Antonio Medical Center Recruiting San Antonio, Texas, United States, 78240 Contact: Roger Lyons, MD Principal Investigator: Roger Lyons, MD US Oncology - Texas Oncology - Tyler Recruiting Tyler, Texas, United States, 75702 Contact: Habte Yimer, MD 903-579-9800 Principal Investigator: Habte Yimer, MD United States, Washington US Oncology - Northwest Cancer Specialists, P.C. Recruiting Vancouver, Washington, United States, 98684 Contact: David A Smith, MD Principal Investigator: David A Smith, MD Collapse <<
NCT01627041	Acute Myeloid Leukemia ... more >> Adult Acute Basophilic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 2	Active, not recruiting	-	United States, Maine ... more >> Lafayette Family Cancer Center-EMMC Brewer, Maine, United States, 04412 United States, New York Montefiore Medical Center-Weiler Hospital Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Columbia University/Herbert Irving Cancer Center New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Collapse <<
NCT02085408	Acute Myeloid Leukemia With Mu... more >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 3	Active, not recruiting	-	-
NCT01595295	-	-	Recruiting	December 2018	Austria ... more >> LKH Feldkirch Recruiting Feldkirch, Austria, 6807 LKH Fürstenfeld Recruiting Fürstenfeld, Austria, 8280 UK Graz: Universitätsklinik für Innere Medizin; Klinische Abteilung für Hämatologie Recruiting Graz, Austria, 8036 Universitätsklinik für Innere Medizin V Recruiting Innsbruck, Austria, 6020 Klinikum Klagenfurt: 1. Medizinische Abteilung Recruiting Klagenfurt, Austria, 9020 UK Krems: Innere Medizin II Recruiting Krems an der Donau, Austria, 3500 LKH Leoben Recruiting Leoben, Austria, 8700 BHS Linz: Interne I Recruiting Linz, Austria, 4010 Elisabethinen Linz: I. Interne Abteilung Recruiting Linz, Austria, 4020 AKH Linz Recruiting Linz, Austria, 4021 Universitätsklinik für Innere Medizin III Universitätsklinik für Innere Medizin III der PMU Salzburg Recruiting Salzburg, Austria, 5020 Klinikum Wels Grieskirchen Recruiting Wels, Austria, 600 Rudolfstiftung: 4. Medizinische Abteilung Recruiting Wien, Austria, 1030 AKH Meduni Wien: Universitätsklinik für Innere Medizin I: Klinische Abteilung für Hämatologie und Hämostaseologie Recruiting Wien, Austria, 1090 Krankenhaus Hietzing Recruiting Wien, Austria, 1130 Hanusch Krankenhaus Recruiting Wien, Austria, 1140 Wilhelminenspital Wien Recruiting Wien, Austria, 1160 Donauspital: 3. Medizinische Abteilung Recruiting Wien, Austria, 1220 Croatia Clinical Hospital Merkur Recruiting Zagreb, Croatia, 10000 Collapse <<
NCT00019825	Esophageal Cancer ... more >> Lung Cancer Malignant Mesothelioma Metastatic Cancer Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Center for Cancer Research Bethesda, Maryland, United States, 20892 Collapse <<
NCT00043134	Leukemia Myel... more >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Collapse <<	Phase 3	Unknown	-	-
NCT00260065	Myelodysplastic Syndrome	Phase 2	Completed	-	-
NCT03017131	Recurrent Fallopian Tube Carci... more >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Collapse <<	Phase 1	Recruiting	August 15, 2020	United States, New York ... more >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park 877-275-7724 ASKRPCI@roswellpark.org Principal Investigator: Kunle Odunsi Collapse <<
NCT03680677	Leukemia, Acute ... more >> MDS Collapse <<	Not Applicable	Not yet recruiting	November 2025	United States, Pennsylvania ... more >> Abramson Cancer Center of the University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Collapse <<
NCT00260065	-	-	Completed	-	-
NCT00358644	Acute Myeloid Leukemia	Phase 2	Completed	-	United States, California ... more >> Duarte, California, United States, 91010 Los Angeles, California, United States, 90095-1678 United States, Missouri St. Louis, Missouri, United States, 63110 Collapse <<
NCT02863458	-	-	Not yet recruiting	September 30, 2020	United States, Ohio ... more >> Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Collapse <<
NCT00358644	-	-	Completed	-	-
NCT00282399	Myelodysplastic Syndrome	Phase 1	Terminated	-	United States, Arizona ... more >> University of Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, Florida H Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, New York Albert Einstein College of Medicine Bronx, New York, United States, 10461 Collapse <<
NCT00398983	-	-	Completed	-	-
NCT00619099	-	-	Completed	-	-
NCT00619099	Myelodysplastic Syndrome	Phase 2	Completed	-	United States, Ohio ... more >> Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, Rhode Island Landmark Medical Center Woonsocket, Rhode Island, United States, 02895 United States, Tennessee Sarah Cannon Research Nashville, Tennessee, United States, 37203 United States, Texas M. D. Anderson Houston, Texas, United States, 77030 Collapse <<
NCT00760084	Acute Myelogenous Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 2	Completed	-	United States, Missouri ... more >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Collapse <<
NCT00538876	Acute Myeloid Leukemia	Phase 1	Completed	-	United States, New York ... more >> Weill Medical College of Cornell University New York, New York, United States, 10021 Collapse <<
NCT00796003	Myelodysplastic Syndrome	Phase 1	Completed	-	Japan ... more >> Fukuoka, Japan Hamamatsu, Japan Hidaka, Japan Nagasaki, Japan Nagoya, Japan Shinjuku, Japan Tokyo, Japan Collapse <<
NCT00760084	-	-	Completed	-	-
NCT00398983	Acute Myelogenous Leukemia	Phase 2 Phase 3	Completed	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00941109	Myelodysplastic Syndrome	Phase 1	Completed	-	United States, Arizona ... more >> Scottsdale, Arizona, United States United States, Colorado Denver, Colorado, United States United States, Minnesota Rochester, Minnesota, United States United States, New York Bronx, New York, United States United States, Texas Houston, Texas, United States United States, Washington Tacoma, Washington, United States Collapse <<
NCT00796003	-	-	Completed	-	-
NCT00943553	Acute Myelogenous Leukemia (AM... more >>L) Collapse <<	Phase 2	Withdrawn(Terminated by Sponso... more >>r) Collapse <<	-	India ... more >> New Delhi, India, 110085 Collapse <<
NCT00986804	Leukemia, Myeloid, Acute ... more >> Myelodysplastic Syndromes Collapse <<	Phase 1	Completed	-	United States, Missouri ... more >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Collapse <<
NCT01026376	-	-	-	-	Brazil ... more >> Belo Horizonte, Brazil Botucatu, Brazil Brasilia, Brazil Campinas, Brazil Fortaleza, Brazil Pinheiros, Brazil Rio De Janeiro, Brazil Sao Paulo, Brazil São Paulol, Brazil Hong Kong Hong Kong, Hong Kong Thailand Bangkok, Thailand Collapse <<
NCT01098084	Chronic Myelomonocytic Leukemi... more >>a Collapse <<	Phase 2	Completed	-	France ... more >> CHU de Bicêtre Le Kremlin-Bicêtre, Ile de France, France, 94275 CHU d'Amiens Amiens, France, 80054 CH Angers Angers, France, 49 000 Hôpital Avignon Avignon, France, 84000 Hopital de la Cote Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93009 CHU Haut-Lévèque Bordeaux, France, 33604 Hôpital Boulogne Sur Mer Boulogne Sur Mer, France, 62321 Hopital d'Instruction des Armées Percy Clamart, France, 92140 CHU de Clermont Ferrand, France, 63058 Centre Hospitalier Sud-Francilien Corbeil-Essonnes, France, 91106 Hopital Henri Mondor Creteil, France, 94000 CHU de Dijon Dijon, France, 21034 Hôpital Versailles Le Chesnay, France, 78157 Centre Hospitalier du Mans Le Mans cedex, France, 72037 Institut Paoli Calmettes Marseille, France, 13009 CHU de nantes Nantes, France, 44093 Hôpital Archet1 Nice, France, 06202 CHU Caremeau Nimes, France, 30029 CHR La Source orléans Orléans, France, 45067 Hôpital Saint-Antoine. Paris-Cedex 12, France, 75571 Hopital Cochin Paris, France, 75014 Hopital Necker Paris, France, 75015 Hopital Hotel Dieu Paris, France, 75181 Hoiptal St Louis Paris, France, 75475 Centre Hospitalier Joffre Perpignan, France, 66046 CHU de Reims Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Hematology Dpt, Hopital Purpan Toulouse, France, 40031 CHU Bretoneau Tours, France, 37044 Institut gustave Roussy Villejuif, France, 94805 Collapse <<
NCT01211457	Acute Myeloid Leukemia	Phase 1 Phase 2	Active, not recruiting	June 2020	United States, Illinois ... more >> Rush University Medical Center Chicago, Illinois, United States, 60612 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-3387 Collapse <<
NCT01177540	Pediatric Acute Myelogenous Le... more >>ukemia (AML) Collapse <<	Phase 2	Completed	-	-
NCT01251627	Chronic Myelomonocytic Leukemi... more >>a Collapse <<	Phase 2	Completed	-	Italy ... more >> Ematologia, Ospedale SS Antonio e Biagio e Cesare Arrigo Alessandria, Italy, 15121 AOU Ospedali Riuniti di Ancona Ancona, Italy, 60131 Ematologia AOU Policlinico di Bari Bari, Italy, 70124 Istituto di Ematologia e Oncologia Medica, Policlinico S.Orsola Bologna, Italy, 40100 Ematologia - Spedali Civili Brescia, Italy, 25100 Ematologia- Ospedale Businco Cagliari, Italy, 09121 Centro di ricerca e formazione ad alta tecnologia nelle Scienze, Università Cattolica Campobasso, Italy, 86100 Cattedra di Ematologia Policlino Careggi Firenze, Italy, 50134 Dipartimento Emato-Oncologia AOU San Martino Genova Genova, Italy, 16132 Fondazione IRCCS Caà Granda-Ospedale Maggiore policlinico Milano, Italy, 20121 Divisione di Ematologia, Ospedale S.Gerardo di Monza Monza, Italy, 20052 Divisione di Ematologia, Università Avogadro Novara, Italy, 28100 Medicina interna II Divisione di Ematologia Ospedale S.Luigi Gonzaga Orbassano, Italy, 10043 Azienda Ospedaliera di Padova Padova, Italy, 35128 Ospedale S.Maria della Misericordia Perugia, Italy, 06122 AOU San Salvatore Pesaro, Italy, 61122 AO Bianchi Melacrino Morelli Reggio Calabria, Italy, 89125 IRCCS Centri di riferimento oncologico Rionero in Vulture, Italy, 85028 SC Ematologia AOU S.Andrea Roma, Italy, 00183 Ematologia 2-Ospedale S.Giovanni Battista Torino, Italy, 10126 U.O.Ematologia 2 Torino, Italy, 10126 Collapse <<
NCT01303796	Acute Myeloid Leukemia	Phase 3	Completed	-	-
NCT01277484	Myelodysplastic Syndrome ... more >> Acute Myeloid Leukemia Collapse <<	Phase 1	Unknown	December 2015	Korea, Republic of ... more >> Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 Collapse <<
NCT01375608	Neutropenia S... more >>ickle Cell Disease Collapse <<	Phase 2	Completed	-	United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse <<
NCT01378416	Leukemia	Phase 1	Completed	-	United States, Missouri ... more >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Collapse <<
NCT01400633	-	-	Completed	-	Korea, Republic of ... more >> Ansan, Korea, Republic of Anyang, Korea, Republic of Busan, Korea, Republic of Cheonan, Korea, Republic of Chungcheongbuk-Do, Korea, Republic of Chungnam, Korea, Republic of Daegu, Korea, Republic of Daejeon, Korea, Republic of Gyeonggi-Do, Korea, Republic of Hwasun Gun, Korea, Republic of Incheon, Korea, Republic of Jinju-Si, Korea, Republic of Kwanju, Korea, Republic of Pusan, Korea, Republic of Seoul, Korea, Republic of Suwon, Korea, Republic of Collapse <<
NCT01568333	Immune Thrombocytopenia	Phase 2	Completed	-	China, Shandong ... more >> Shandong University Qilu hospital Jinan, Shandong, China, 250012 Collapse <<
NCT01149408	Acute Myeloid Leukemia ... more >> AML Collapse <<	Phase 1	Completed	-	United States, Utah ... more >> University of Utah, Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Collapse <<
NCT02845232	-	-	Completed	-	France ... more >> Hospices Civils de Lyon - Centre Hospitalier Lyon Sud, 165 Chemin du Grand Revoyet Pierre-benite, France, 69310 Collapse <<
NCT01751867	Myelodysplastic Syndrome	Phase 3	Completed	-	China ... more >> Beijing, China Chengdu, China Guangdong, China Hangzhou, China Nanjing, China Shanghai, China Suzhou, China Tianjin, China Collapse <<
NCT01378416	-	-	Completed	-	-
NCT01633099	Untreated Adult Acute Myeloid ... more >>Leukemia Effect of Drugs Drug Safety Collapse <<	Phase 3	Unknown	July 2016	-
NCT01375608	-	-	Completed	-	-
NCT01806116	Higher-risk Myelodysplastic Sy... more >>ndrome Relapsed /Refractory Acute Myeloid Leukemia Collapse <<	Phase 4	Unknown	May 2014	-
NCT01786343	Leukemia	Phase 2	Active, not recruiting	February 2019	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01799083	Solid Tumors ... more >>B Cell Lymphoma Collapse <<	Phase 1 Phase 2	Unknown	December 2017	China, Beijing ... more >> Biotherapeutic Department of Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Wei D Han, Doctor +86-10-66937463 hanwdrsw@sina.com Contact: Xue C Lu, Doctor +86-10-66876237 luxuechun@126.com Sub-Investigator: Yang Liu, Master Sub-Investigator: Bo Yang, Doctor Sub-Investigator: Yao Wang, Master Sub-Investigator: Yan Zhang, Doctor Principal Investigator: Wei D Han, Doctor Sub-Investigator: Xue C Lu, Doctor Collapse <<
NCT02003573	Leukemia, Myeloid, Acute	Phase 1	Terminated	-	United States, Connecticut ... more >> Boehringer Ingelheim Investigational Site New Haven, Connecticut, United States United States, Missouri Boehringer Ingelheim Investigational Site St. Louis, Missouri, United States United States, New York Boehringer Ingelheim Investigational Site Lake Success, New York, United States United States, Texas Boehringer Ingelheim Investigational Site Houston, Texas, United States Collapse <<
NCT01882660	Colon Cancer	Not Applicable	Terminated(Inclusion of patien... more >>ts was slow. Could not reach the target within the studyperiod.) Collapse <<	-	Netherlands ... more >> Academic Medical Center Amsterdam, Netherlands, 1105 AZ Collapse <<
NCT01893320	Leukemia	Phase 1 Phase 2	Active, not recruiting	July 2020	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02013102	Myelodysplastic Syndrome	Phase 4	Unknown	December 2015	China, Tianjin ... more >> Tianjin Medical University General Hospital Recruiting Tianjin, Tianjin, China, 300052 Contact: LIU HUI, MD Principal Investigator: Shao Zonghong, MD Collapse <<
NCT02076191	Myeloproliferative Neoplasms	Phase 1 Phase 2	Active, not recruiting	December 2018	United States, Missouri ... more >> Washington University of St. Louis Saint Louis, Missouri, United States, 63110 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Taussig Cancer Center Institute Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse <<
NCT02096055	Leukemia	Phase 2	Active, not recruiting	April 2026	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02172872	Acute Myeloid Leukemia (AML)	Phase 3	Recruiting	December 2019	-
NCT02234037	Leukemia	Phase 1	Terminated(Slow accrual)	-	United States, Georgia ... more >> Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 Collapse <<
NCT02010645	Leukemia	Phase 2	Active, not recruiting	March 2019	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00003361	Leukemia Myel... more >>odysplastic Syndromes Collapse <<	Phase 2	Completed	-	United States, Maryland ... more >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21231-2410 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Collapse <<
NCT02316028	Liver Metastasis ... more >> Colorectal Cancer Collapse <<	Phase 1 Phase 2	Completed	-	Belgium ... more >> UZ Brussel Jette, Brabant, Belgium, 1090 UZ Brussel Brussels, Belgium, 1090 Collapse <<
NCT02103478	Myelodysplastic Syndrome ... more >> MDS Collapse <<	Phase 1 Phase 2	Active, not recruiting	December 2018	United States, Arizona ... more >> Mayo Clinic Phoenix, Arizona, United States, 85054 United States, California University of Southern California Los Angeles, California, United States, 90024 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Horizon Oncology Lafayette, Indiana, United States, 47905 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Faber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New Jersey John Theurer Cancer Center/ Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Weill Cornell Medical College - New York Presbyterian Hospital New York, New York, United States, 10021 United States, Tennessee Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas M. D. Anderson Houston, Texas, United States, 77030 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Alberta University of Alberta Hospital Edmonton, Alberta, Canada, T6G 2G3 Canada, Ontario Sunnybrook Health Sciences Centre, Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Cancer Center Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Hôpital Maisonneuve-Rosemont Montréal, Quebec, Canada, H1T 2M4 Collapse <<
NCT00414310	Myelodysplastic Syndrome ... more >> Acute Myelogenous Leukemia Collapse <<	Phase 2	Completed	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02512172	Colorectal Cancer	Phase 1	Recruiting	January 2019	United States, Maryland ... more >> Johns Hopkins Recruiting Baltimore, Maryland, United States, 21205 Principal Investigator: Nilofer Azad, MD Collapse <<
NCT02264873	Leukemia, Lymphoblastic, Acute... more >> Leukemia, Myeloid Acute Hematopoetic Myelodysplasia Collapse <<	Phase 1	Completed	-	United States, Florida ... more >> UF Health Shands Hospital Gainesville, Florida, United States, 32610 Collapse <<
NCT00414310	-	-	Completed	-	-
NCT01291745	-	-	Unknown	September 2015	Italy ... more >> U.O. Medicina Interna Universitaria 2 ed Ematologia Ospedale Civile San Salvatore Not yet recruiting Coppito, L'Aquila, Italy, 67010 Contact: Alessandro Lucchesi, MD +390862368589 ale.lucchesi@gmail.com Sub-Investigator: Alessandro Lucchesi, MD Unità di Ematologia e Trapianto di Midollo Osseo, IRCCS-CROB, Centro di Riferimento Oncologico della Basilicata Not yet recruiting Rionero in Vulture, Potenza, Italy Contact: Pellegrino Musto, MD +390972726225 p.musto@crob.it Sub-Investigator: Pellegrino Musto, MD U. O. C. Ematologia - Azienda Ospedaliera Sant'Andrea Not yet recruiting Rome, Roma, Italy, 00189 Contact: Maria A Aloe Spiriti, MD +390633775052 aloespiritisapienza@gmail.com Sub-Investigator: Maria A Aloe Spiriti, MD U.O. Ematologia - A.O. Spedali Civili di Brescia Not yet recruiting Brescia, Italy Contact: Giuseppe Rossi, MD +390303996573 ematologia@spedalicivili.brescia.it Sub-Investigator: Giuseppe Rossi, MD Divisione di Ematologia Presidio Ospedaliero "A. Perrino" Not yet recruiting Brindisi, Italy Contact: Giovanni Quarta, MD +390831537507 quarta.gianni@gmail.com Sub-Investigator: Giovanni Quarta, MD Divisione Clinicizzata di Ematologia con Trapianto di Midollo Osseo. Ospedale Ferrarotto. Azienda Policlinico Not yet recruiting Catania, Italy Contact: Giuseppe Palumbo, MD ga.palumbo@gmail.com Sub-Investigator: Giuseppe Palumbo, MD S.O.C. Ematologia Azienda Ospedaliera di Catanzaro"Pugliese-Ciaccio" Not yet recruiting Catanzaro, Italy Contact: Domenico Magro, MD +390961883120 magro.dom@virgilio.it Sub-Investigator: Domenico Magro, MD Unità Operativa Complessa di Ematologia- Azienda Ospedaliera di Cosenza Recruiting Cosenza, Italy, 87100 Contact: Fortunato Morabito, MD +390984681329 omdsprotocol@fondazioneameliascorza.it Principal Investigator: Fortunato Morabito, MD Unità di Ematologia, Ospedale Madonna delle Grazie, ASM Not yet recruiting Matera, Italy Contact: Alberto Fragasso, MD alberto.fragasso@libero.it Sub-Investigator: Alberto Fragasso, MD Dipartimento di Oncologia, Oncoematologia e Unità Trapianto di Midollo Osseo, 'La Maddalena' Not yet recruiting Palermo, Italy Contact: Maurizio Musso, MD +390916806814 mamusso@libero.it Sub-Investigator: Maurizio Musso, MD U.O. di Ematologia Azienda Ospedaliera Universitaria Pisana Not yet recruiting Pisa, Italy Contact: Mario Petrini, MD Contact: Sara Galimberti, MD s.galimberti@med.unipi.it Sub-Investigator: Sara Galimberti, MD Divisione Ematologia - Azienda Ospedaliera "Bianchi-Melacrino-Morelli" Not yet recruiting Reggio Calabria, Italy Contact: Esther Oliva, MD estheroliva@hotmail.com Sub-Investigator: Esther Oliva, MD Dipartimento di Biotecnologie Cellulari ed Ematologia, Università La Sapienza Not yet recruiting Roma, Italy, 00161 Contact: Giuliana Alimena, MD alimena@bce.uniroma1.it Sub-Investigator: Giuliana Alimena, MD U.O.C. di Ematologia - Policlinico Agostino Gemelli- Not yet recruiting Roma, Italy Contact: Maria T Voso, MD 0630154278 ext 0039 mtvoso@rm.unicatt.it Sub-Investigator: Maria T Voso, MD Collapse <<
NCT01751867	-	-	Completed	-	-
NCT03259516	Myelodysplastic Syndromes	Phase 1 Phase 2	Recruiting	December 25, 2021	Russian Federation ... more >> First Pavlov State Medical University of St. Petersburg Recruiting Saint-Petersburg, Russian Federation, 197089 Contact: Ivan S. Moiseev, MD, PhD +79217961951 moisiv@mail.ru Contact: Elena V Morozova, MD, PhD +79119278229 dr_morozova@mail.ru Principal Investigator: Boris V Afanasyev, MD, Prof Sub-Investigator: Elena V Morozova, MD, PhD Sub-Investigator: Yulia V Rudnizkaya, MD, PhD Sub-Investigator: Ivan S Moiseev, MD, PhD Sub-Investigator: Nikolai Yu Tcvetkov, MD Collapse <<
NCT03164057	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndromes Collapse <<	Phase 2	Recruiting	June 2027	United States, California ... more >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Weili Sun, MD,PhD 800-826-4673 weilisun@coh.org Principal Investigator: Weili Sun, MD,PhD Children's Hospital of Central California Recruiting Madera, California, United States, 93636 Contact: Faisal Razzaqi, MD 866-353-5437 frazzaqi@valleychildrens.org Principal Investigator: Faisal Razzaqi, MD Children's Hospital of Orange County Recruiting Orange, California, United States, 92968 Contact: Jamie Frediani, MD 714-509-4348 jfrediani@choc.org Principal Investigator: Jamie Frediani, MD Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD 650-497-8953 lacayon@stanford.edu Principal Investigator: Norman J. Lacayo, MD Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD 858-966-5983 dschiff@chsd.org Principal Investigator: Deborah Schiff, MD United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD 866-278-5833 tanja.gruber@stjude.org Contact: Referral Office 866-278-5833 referralinfo@stjude.org Principal Investigator: Tanja A. Gruber, MD, PhD United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD 682-885-4007 kenneth.heym@cookchildrens.org Principal Investigator: Kenneth M. Heym, MD Collapse <<
NCT00801489	Acute Myeloid Leukemia With In... more >>v(16)(p13.1q22); CBFB-MYH11 Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 de Novo Myelodysplastic Syndrome High Risk Myelodysplastic Syndrome Inv(16) Myelodysplastic Syndrome With Excess Blasts t(16;16) t(8;21) Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 2	Recruiting	April 30, 2020	United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Gautam Borthakur 713-563-1586 Principal Investigator: Gautam Borthakur Collapse <<
NCT01135511	Dry Eye Syndromes	Phase 2	Completed	-	Japan ... more >> Pfizer Investigational Site Ichinomiya, Aichi, Japan Pfizer Investigational Site Narashino, Chiba, Japan Pfizer Investigational Site Urayasu, Chiba, Japan Pfizer Investigational Site Yokohama, Kanagawa, Japan Pfizer Investigational Site Yokohama, Kangawa, Japan Pfizer Investigational Site Fuji, Shizuoka, Japan Pfizer Investigational Site Numazu, Shizuoka, Japan Pfizer Investigational Site Susono, Shizuoka, Japan Pfizer Investigational Site Chiyoda-ku, Tokyo, Japan Pfizer Investigational Site Hamura, Tokyo, Japan Pfizer Investigational Site Minato-ku, Tokyo, Japan Pfizer Investigational Site Ohta-ku, Tokyo, Japan Pfizer Investigational Site Sumida-ku, Tokyo, Japan Pfizer Investigational Site Tachikawa, Tokyo, Japan Pfizer Investigational Site Taito-ku, Tokyo, Japan Pfizer Investigational Site Chiba, Japan Pfizer Investigational Site Fukuoka, Japan Pfizer Investigational Site Kyoto, Japan Pfizer Investigational Site Osaka, Japan Pfizer Investigational Site Shizuoka, Japan Pfizer Investigational Site Tokyo, Japan Korea, Republic of Pfizer Investigational Site Gwangju, Korea, Republic of, 501-757 Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 120-752 Pfizer Investigational Site Seoul, Korea, Republic of, 136-705 Pfizer Investigational Site Seoul, Korea, Republic of, 137-701 Pfizer Investigational Site Seoul, Korea, Republic of Collapse <<
NCT02900560	Epithelial Ovarian Cancer	Phase 2	Recruiting	September 2019	United States, California ... more >> UCLA Recruiting Los Angeles, California, United States, 90095 Principal Investigator: John A Glaspy, MD United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21287 Principal Investigator: Deborah K Armstrong, MD United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Principal Investigator: Boris Winterhoff, MD Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Principal Investigator: Wahner Hendrickson, MD Collapse <<
NCT00882206	-	-	Terminated(Slow accrual)	-	-
NCT00882206	Leukemia Lymp... more >>homa Collapse <<	Phase 2	Terminated(Slow accrual)	-	United States, Minnesota ... more >> University of Minnesota Amplatz Children's Hospital Minneapolis, Minnesota, United States, 55455 Collapse <<
NCT01483690	Acute Lymphoblastic Leukemia ... more >> Precursor B-Cell Lymphoblastic Leukemia Precursor T-Cell Lymphoblastic Leukemia Collapse <<	Phase 1 Phase 2	Terminated(Toxicity)	-	-
NCT01696032	Ovarian Cancer	Phase 2	Completed	-	-
NCT00661726	Thalassemia	Phase 2	Completed	-	United States, California ... more >> Children's Hospital and Research Center at Oakland Oakland, California, United States, 94609 United States, Pennsylvania Children's Hospital Philadelphia Philadelphia, Pennsylvania, United States, 19104 Canada University Health Network Toronto, Canada, M5G 2C4 Collapse <<
NCT02441803	Leukemia	Phase 2	Active, not recruiting	September 2023	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02957968	Breast Adenocarcinoma ... more >> Estrogen Receptor- Negative Breast Cancer Estrogen Receptor-positive Breast Cancer HER2/Neu Negative Invasive Breast Carcinoma Progesterone Receptor Negative Progesterone Receptor Positive Tumor Stage II Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Triple-negative Breast Carcinoma Collapse <<	Phase 2	Recruiting	January 31, 2029	United States, Virginia ... more >> Virginia Commonwealth University/Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Mary Beth Tombes, ACNP-BC 804-628-1357 masseysiit@vcu.edu Contact: Harry D. Bear, M.D., Ph.D. 804-628-3242 harry.bear@vcuhealth.org Collapse <<
NCT03132454	Hematopoietic/Lymphoid Cancer ... more >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Collapse <<	Phase 1	Recruiting	July 2021	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact tkadia@mdanderson.org Collapse <<
NCT02951728	Diffuse Large B Cell Lymphoma	Phase 1 Phase 2	Recruiting	October 2019	China ... more >> Shanghai Ruijin Hospital Recruiting Shanghai, China, 20025 Contact: Weili Zhao, MD,PhD 64370045 ext 610707 zhao.weili@yahoo.com Contact: Pengpeng Xu, MD 64370045 ext 610707 xpproc@msn.com Collapse <<
NCT03206047	Recurrent Fallopian Tube Carci... more >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Collapse <<	Phase 1 Phase 2	Suspended(Pending outcome of t... more >>he DLT period) Collapse <<	March 31, 2020	United States, Arizona ... more >> University of Arizona Cancer Center-North Campus Tucson, Arizona, United States, 85719 The University of Arizona Medical Center-University Campus Tucson, Arizona, United States, 85724 United States, California University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 UC Comprehensive Cancer Center at Silver Cross New Lenox, Illinois, United States, 60451 University of Chicago Medicine-Orland Park Orland Park, Illinois, United States, 60462 United States, Kansas University of Kansas Clinical Research Center Fairway, Kansas, United States, 66205 United States, Nebraska Nebraska Medicine-Village Pointe Omaha, Nebraska, United States, 68118 University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 Collapse <<
NCT03467178	Recurrent, Platinum-resistant ... more >>Ovarian Cancer Collapse <<	Phase 2	Not yet recruiting	April 2021	-
NCT03026842	Acute Myeloid Leukemia	Phase 4	Active, not recruiting	October 2024	China, Jilin ... more >> First Hospital of Jilin University Changchun, Jilin, China, 130021 Collapse <<
NCT02136550	Smoking Smoki... more >>ng Cessation Collapse <<	Not Applicable	Active, not recruiting	November 2018	Brazil ... more >> Faculdade de Medicina da Universidade de Sao Paulo Sao Paulo, Brazil, 01246-903 Collapse <<
NCT03256071	Acute Myeloid Leukemia ... more >> Allogeneic Hematopoietic Stem Cell Transplantation Conditioning Collapse <<	Phase 2 Phase 3	Recruiting	September 2021	China, Jiangsu ... more >> The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215000 Contact: Xiaowen Tang, MD +86-512-67781851 xwtang1020@163.com Principal Investigator: Depei Wu, MD Collapse <<
NCT03530085	Acute Myeloid Leukemia ... more >> Allogeneic Hematopoietic Stem Cell Transplantation Conditioning Elderly Collapse <<	Phase 2 Phase 3	Recruiting	April 2022	China, Guangdong ... more >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan +86-020-62787883 356135708@qq.com Principal Investigator: Qifa Liu Collapse <<
NCT02262169	Non-Bleeding Peptic Ulcers	Phase 3	Recruiting	March 2019	Indonesia ... more >> Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Udayana Sanglah General Hospital Recruiting Denpasar, Bali, Indonesia, 80114 Contact: IDN Wibawa Prof. DR. Dr., SpPD-KGEH agusbobwibawa@yahoo.com Principal Investigator: IDN Wibawa Prof. DR. Dr., SpPD-KGEH Sub-Investigator: Nyoman Purwadi dr., Sp.PD-KGEH Sub-Investigator: I Gusti Agung Suryadarma dr., Sp.PD-KGEH Sub-Investigator: I Ketut Mariadi dr., Sp.PD Sub-Investigator: Gde Somayana dr., Sp.PD Sub-Investigator: Putu Prathiwi Primadharsini dr., M. Biomed, Sp.PD Sub-Investigator: Anak Agung Ayu Ngurah Susraini dr., Sp.PA (K) Sub-Investigator: Herman Saputra dr., Sp.PA (K) Collapse <<
NCT00416598	-	-	Active, not recruiting	-	-
NCT00416598	Acute Myeloid Leukemia ... more >> Acute Myeloid Leukemia With Myelodysplasia-Related Changes Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 2	Active, not recruiting	-	-
NCT02249312	Asthma	Phase 2	Completed	-	-
NCT01135511	-	-	Completed	-	-
NCT00002832	Leukemia Myel... more >>odysplastic Syndromes Collapse <<	Phase 1 Phase 2	Completed	-	United States, Texas ... more >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT03252457	Purpura, Thrombocytopenic, Idi... more >>opathic Immune Thrombocytopenia Collapse <<	Phase 3	Not yet recruiting	December 1, 2021	China, Shandong ... more >> Qilu hospital, Shandong University Jinan, Shandong, China, 250012 Collapse <<
NCT00925132	Metastatic Melanoma	Phase 1 Phase 2	Terminated(Change in the numbe... more >>r of approved drugs for metastatic melanoma) Collapse <<	-	United States, Iowa ... more >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 Collapse <<
NCT01690507	MDS AML	Phase 1 Phase 2	Completed	-	China, Beijing ... more >> Navy General Hospital Beijing, Beijing, China, 100048 China Chinese PLA General Hospital Beijing, China, 100853 Collapse <<
NCT02159820	Primary Malignant Neoplasm of ... more >>Ovary FIGO Stages II to IV Collapse <<	Phase 2 Phase 3	Recruiting	June 2024	China, Beijing ... more >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Yan Zhang, Dr. 86-10-55499341 zhangyan@163.com Principal Investigator: Yuanguang Meng, Professor Collapse <<
NCT01455506	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 1	Completed	-	United States, New Jersey ... more >> Hackensack University Medical Center - John Theurer Cancer Center Hackensack, New Jersey, United States, 07601 Collapse <<
NCT01794702	Leukemia	Phase 1 Phase 2	Completed	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00925132	-	-	Terminated(Change in the numbe... more >>r of approved drugs for metastatic melanoma) Collapse <<	-	-
NCT00867672	Acute Myeloid Leukemia	Phase 2	Completed	-	Germany ... more >> Klinikum der Technischen Universität Aachen Aachen, Germany, 52074 Vivantes Klinikum Neukölln Berlin, Germany, 12351 Augusta-Kranken-Anstalt gGmbH Bochum, Germany, 44791 Klinikum Braunschweig Braunschweig, Germany, 38126 DIAKO Ev. Diakonie-Krankenhaus gGmbH Bremen, Germany, 28239 Universitätsklinikum Düsseldorf Düsseldorf, Germany, 40225 Marien Hospital Düsseldorf Düsseldorf, Germany, 40479 Klinikum Esslingen GmbH Esslingen, Germany, 73730 Universität Frankfurt Frankfurt, Germany Medizinische Universitätsklinik Freiburg Freiburg, Germany, 79106 St. Marien-Hospital Hagen Hagen, Germany, 58095 Universitätsklinikum Halle Halle, Germany, 06120 Evangelisches Krankenhaus Hamm gGmbH Hamm, Germany, 59063 Med. Hochschule Hannover Hannover, Germany, 30625 Universitätsklinikum Jena Jena, Germany, 07747 Ortenau Klinikum Lahr-Ettenheim Lahr, Germany, 77933 Caritas Krankenhaus Lebach Lebach, Germany, 66822 Universitätsklinikum Leipzig AöR Leipzig, Germany, 04103 Klinikum Lüdenscheid Lüdenscheid, Germany, 58515 Philipps-Universität Marburg Marburg, Germany, 35032 TU München München, Germany, 86175 University of Münster Medical Center Münster, Germany, 48149 Ortenau Klinikum Offenburg, Germany, 77654 Studienzentrum Onkologie Ravensburg Ravensburg, Germany, 88212 Eberhard Karls Universität Tübingen Tübingen, Germany, 72076 Universitätsklinikum Ulm Ulm, Germany, 89081 Klinikum Villingen-Schwenningen Villingen-Schwenningen, Germany, 78050 Collapse <<
NCT03356080	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 2	Recruiting	July 7, 2020	China ... more >> Beijing Friendship Hospital Not yet recruiting Beijing, China Fujian Medical University Union Hospital Not yet recruiting Fuzhou, China The People's Hospital of Guangxi Zhuang Autonomous Region Not yet recruiting Nanning, China Shanghai Tong Ren hospital Recruiting Shanghai, China Contact: Ligen Liu 18017337037 llg3532@shtrhospital.com The center hospital of Shanghai Fengxian District Not yet recruiting Shanghai, China First Affiliated Hospital of Zhengzhou University. Not yet recruiting Zhengzhou, China Collapse <<
NCT02664181	Lung Cancer N... more >>on-small Cell Lung Cancer Collapse <<	Phase 2	Recruiting	January 2019	United States, Florida ... more >> Cleveland Clinic Florida Active, not recruiting Weston, Florida, United States, 33331 United States, Maryland Center for Cancer Research Recruiting Bethesda, Maryland, United States, 20892 Contact: David S Schrump, MD 301-496-2128 david_schrump@nih.gov United States, Ohio University Hospitals Cleveland Medical Center, Seidman Cancer Center Case Comprehensive Cancer Center Withdrawn Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Active, not recruiting Cleveland, Ohio, United States, 44118 Collapse <<
NCT02146261	Healthy	Phase 1	Completed	-	Japan ... more >> Sagamihara, Kanagawa, Japan Collapse <<
NCT02744742	Myelodysplastic Syndrome ... more >> Allogeneic Hematopoietic Stem Cell Transplantation Conditioning Collapse <<	Phase 2 Phase 3	Recruiting	March 2020	China, Guangdong ... more >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan +86-020-61641613 356135708@qq.com Principal Investigator: Qifa Liu Collapse <<
NCT02551718	Acute Leukemia of Ambiguous Li... more >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Collapse <<	Not Applicable	Recruiting	-	United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker 206-616-1589 pbecker@u.washington.edu Principal Investigator: Pamela S. Becker Collapse <<
NCT02921061	Mixed Phenotype Acute Leukemia... more >> Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent High Risk Myelodysplastic Syndrome Refractory Acute Myeloid Leukemia Refractory High Risk Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1 Phase 2	Recruiting	-	United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Sarah A. Buckley 206-416-5066 sbuckley@fredhutch.org Principal Investigator: Sarah A. Buckley Collapse <<
NCT00715793	Malignant Melanoma	Phase 1 Phase 2	Completed	-	United States, Pennsylvania ... more >> UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 Collapse <<
NCT00037817	Advanced Esophageal Cancers ... more >> Primary Small Cell Lung Cancers Non-Small-Cell Lung Carcinoma Pleural Mesotheliomas Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse <<
NCT00715793	-	-	Completed	-	-
NCT00828802	Myelodysplastic Syndromes	Phase 1	Completed	-	United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT00778375	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 2	Completed	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00778375	-	-	Completed	-	-
NCT02214407	MDS	Phase 3	Recruiting	December 2020	France ... more >> CHU La Réunion - Site nord Not yet recruiting Saint-Denis, La Réunion, France, 97400 Contact: Tahar Touahri, MD tahar.touahri@chu-reunion.fr Principal Investigator: Tahar Touahri, MD CHU La Réunion-Site Sud Not yet recruiting Saint-Pierre, La Réunion, France, 97410 Contact: Patricia Zunic, MD patricia.zunic@chu-reunion.fr Principal Investigator: Patricia Zunic, MD Chu Amiens Recruiting Amiens, France, 80054 Contact: Lavinia Merlusca, MD 0322455915 merlusca.lavinia@chu-amiens.fr Principal Investigator: Lavinia Merlusca, MD CHU d'Angers Recruiting Angers, France, 49 000 Contact: Mathilde Hunault +33 2 41 35 44 75 MaHunault@chu-angers.fr Principal Investigator: Mathilde Hunault, Professor CH Victor Dupouy Not yet recruiting Argenteuil, France, 95107 Contact: Ahmad Al Jijakli, MD +33134232339 ahmad.aljijakli@ch-argenteuil.fr Principal Investigator: Ahmad Al Jijakli, MD Ch Avignon Recruiting Avignon, France, 84000 Contact: Bohrane Slama, MD 0432753132 bslama@ch-avignon.fr Principal Investigator: Bohrane Slama, MD Centre Hospitalier de La Cote Basque Not yet recruiting Bayonne, France, 64100 Contact: Anne Banos, MD 033559443832 abanos@ch-cotebasque.fr Principal Investigator: Anne Banos, MD Hôpital Nord Franche-Comté Not yet recruiting Belfort, France, 90015 Contact: Marius Moldovan, MD +33 3 84 98 23 17 marius.moldovan@hnfc.fr Principal Investigator: Marius Moldovan, MD Hôpital Avicenne Recruiting Bobigny, France, 93009 Contact: Thorsten Braun, MD (0) 33 1 48 95 70 51 thorsten.braun@avc.aphp.fr Principal Investigator: Thorsten Braun, MD CHU de Brest - Hôpital Morvan Not yet recruiting Brest, France, 29609 Contact: Jean-Richard Eveillard, MD 33 2 98 22 33 33 jean-richard.eveillard@chu-brest.fr Principal Investigator: Jean-Richard Eveillard, MD CHU Côte de Nacre Recruiting Caen, France, 14033 Contact: Stéphane CHEZE, MD 0033231272360 cheze-s@chu-caen.fr Principal Investigator: Stéphane CHEZE, MD Hôpital privé Sévigné Recruiting Cesson-Sévigné, France, 35510 Contact: Benoît Bareau, MD +33 2 23 21 05 50 benoit.bareau@gmail.com Principal Investigator: Benoît Bareau, MD CHU Estaing Recruiting Clermont-Ferrand, France, 63058 Contact: Benoit De RENZIS, MD 0334 73 75 00 65 bderenzis@chu-clermontferrand.fr Principal Investigator: Benoit De RENZIS, MD CH de Compiègne Not yet recruiting Compiègne, France, 60321 Contact: Sophie Dennetière, MD +33 3 44 23 63 47 s.dennetiere@ch-compiegnenoyon.fr Principal Investigator: Sophie Dennetière, MD Centre Hospitalier Sud-Francilien Not yet recruiting Corbeil-Essonnes, France, 91106 Contact: Célia Salanoubat, MD +33 1 60 90 31 78 celia.salanoubat@ch-sud-francilien.fr Principal Investigator: Célia Salanoubat, MD Centre Henri Mondor Recruiting Créteil, France, 94010 Contact: Andrea Toma, MD 0033149812057 andrea.toma@hmn.aphp.fr Principal Investigator: Andrea Toma, MD CHU Albert Michallon Recruiting Grenoble, France, 38043 Contact: Stéphane COURBY, MD 033 4 76 76 57 12 SCourby@chu-grenoble.fr Principal Investigator: Stéphane COURBY, MD Principal Investigator: Sophie Park, PHD CH Le Mans Recruiting Le Mans, France, 72000 Contact: Kamel Laribi, MD 0243434361 klaribi@ch-lemans.fr Principal Investigator: Kamel Laribi, MD Clinique Victor Hugo Not yet recruiting Le Mans, France, 72000 Contact: Anne Parcelier, MD +33 2 43 47 94 93 a.parcelier@i-l-c.fr Principal Investigator: Anne Parcelier, MD Hôpital Saint Vincent de Paul Not yet recruiting Lille, France, 59020 Contact: Laurent Pascal, MD, PHD +33320874532 pascal.laurent@ghicl.net Principal Investigator: Laurent Pascal, MD, PHD CHRU de Limoges Recruiting Limoges, France, 87046 Contact: Marie-Pierre Gourin, MD 0033555056651 marie-pierre.gourin@chu-limoges.fr Principal Investigator: Marie Pierre Gourin, MD Centre Hospitalier Lyon Sud Recruiting Lyon, France, 69495 Contact: Eric WATTEL, PHD,MD 033 4 72 11 74 01 eric.wattel@chu-lyon.fr Principal Investigator: Eric WATTEL, PHD,MD Institut Paoli-Calmette Recruiting Marseille, France, 13009 Contact: Norbert VEY, PHD,MD 033 4 91 22 37 54 veyn@marseille.fnclcc.fr Principal Investigator: Norbert VEY, PHD,MD Centre Hospitalier de Meaux Not yet recruiting Meaux, France, 77100 Contact: Loïc Fouillard, MD 033164653876 l-fouillard@ch-meaux.fr Principal Investigator: Loïc Fouillard, MD Clinique Beausoleil Not yet recruiting Montpellier, France, 34000 Contact: Sophie Auger-Quittet, MD +33467759999 s.auger-quittet@languedoc-mutualite.fr Principal Investigator: Sophie Auger-Quittet, MD Hôpital Saint Eloi Recruiting Montpellier, France, 34295 Contact: Robert Navarro, MD +33467338362 r-navarro@chu-montpellier.fr Principal Investigator: Robert Navarro, MD Hopital de l'Hotel Dieu Recruiting Nantes, France, 44093 Contact: Pierre Peterlin, MD +33 2 40 08 32 71 pierre.peterlin@chu-nantes.fr Principal Investigator: Pierre Peterlin, MD Hopital Archet I Not yet recruiting Nice, France, 06202 Contact: Laurence LEGROS, MD 00 33 4 92 03 58 44 legros.l@chu-nice.fr Principal Investigator: Laurence LEGROS, MD CHU de Nîmes Recruiting Nîmes, France, 30029 Contact: Stefan Wickenhauser, MD +33 4 66 68 40 33 stefan.wickenhauser@chu-nimes.fr Principal Investigator: Stefan Wickenhauser, MD CHR d'Orléans Recruiting Orléans, France, 45067 Contact: Ali Arar, MD +33238229546 ali.arar@chr-orleans.fr Principal Investigator: Ali Arar, MD Hopital St Louis T4 Recruiting Paris, France, 75475 Contact: Pierre Fenaux, PHD 0171207022 pierre.fenaux@sls.aphp.fr Principal Investigator: Pierre Fenaux, PHD Principal Investigator: ITZYKSON Raphael, MD Centre Hospitalier Joffre Recruiting Perpignan, France, 66046 Contact: Laurence Sanhes, MD 00 33 468616448 laurence.sanhes@ch-perpignan.fr Principal Investigator: Laurence Sanhes, MD CHU de Haut-Lévèque Not yet recruiting Pessac, France, 33604 Contact: Sophie Dimicoli-Salazar, MD 033557656511 sophie.dimicoli-salazar@chu-bordeaux.fr Principal Investigator: Sophie Dimicoli-Salazar, MD CHU Poitiers Recruiting Poitiers, France, 86021 Contact: Jose Miguel Torregrosa Diaz, MD +33548444444 jose-miguel.torregrosa-diaz@chu-poitiers.fr Principal Investigator: Jose Miguel Torregrosa Diaz, MD CH René Dubos Not yet recruiting Pontoise, France, 95000 Contact: Riad Benramdane, MD +33156831442 benramdaner@yahoo.fr Principal Investigator: Riad Benramdane, MD CH Annecy Genevois Not yet recruiting Pringy, France, 74374 Contact: Pascale Cony-Makhoul, MD +33 4 50 63 64 31 pconymakhoul@ch-annecygenevois.fr Principal Investigator: Pascale Cony-Makhoul, MD CHU de Reims Not yet recruiting Reims, France, 51092 Contact: Chantal HIMBERLIN, MD 003326783644 chimberlin@chu-reims.fr Principal Investigator: Chantal HIMBERLIN, MD CHU Pontchaillou Recruiting Rennes, France, 35033 Contact: Stanislas Nimubona, MD 33299289521 stanislas.nimubona@chu-rennes.fr Principal Investigator: Stanislas Nimubona, MD Centre Henri Bequerel Recruiting Rouen, France, 76038 Contact: Aspasia STAMATOULLAS, MD 00 33 2 32 08 22 88 aspasia.stamatoullas@chb.unicancer.fr Principal Investigator: Aspasia STAMATOULLAS, MD Hôpital Hautepierre Not yet recruiting Strasbourg, France, 67098 Contact: Shanti Natarajan-Ame, MD +33388121670 shanti.ame@chru-strasbourg.fr Principal Investigator: Shanti Natarajan-Ame, MD IUCT Oncopole - Département d'hématologie Not yet recruiting Toulouse, France, 31059 Contact: Christian RECHER, MD, PHD 05 61 77 20 78 recher.christian@iuct-oncopole.fr Principal Investigator: Christian RECHER, MD Iuct Oncopole Recruiting Toulouse, France, 31059 Contact: Odile BEYNE-RAUZY, MD, PHD +33(0)5 31 15 62 64 beynerauzy.odile@iuct-oncopole.fr Principal Investigator: Odile Beyne-Rauzy, PHD CH Valence Not yet recruiting Valence, France, 26953 Contact: Jixing Liu, MD +33475757566 jliu@ch-valence.fr Principal Investigator: Jixing Liu, MD CHU Brabois Not yet recruiting Vandœuvre-lès-Nancy, France, 54511 Contact: Agnès GUERCI-BRESLER, MD 0033383153281 a.guerci@chu-nancy.fr Principal Investigator: Agnès GUERCI-BRESLER, MD Institut gustave Roussy Not yet recruiting Villejuif, France, 94805 Contact: Eric Solary, MD +33142114507 eric.solary@igr.fr Principal Investigator: ERIC SOLARY, MD Collapse <<
NCT01515527	Leukemia	Phase 2	Recruiting	February 2021	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Collapse <<
NCT03691376	HLA-A*0201 Positive Cells Pres... more >>ent HLA-DP4 Positive Cells Present Platinum-Resistant Ovarian Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Refractory Fallopian Tube Carcinoma Refractory Ovarian Carcinoma Refractory Primary Peritoneal Carcinoma Collapse <<	Phase 1	Not yet recruiting	October 1, 2020	United States, New York ... more >> Roswell Park Cancer Institute Not yet recruiting Buffalo, New York, United States, 14263 Contact: Kunle Odunsi 716-845-8376 kunle.odunsi@roswellpark.org Principal Investigator: Kunle Odunsi Collapse <<
NCT02332889	-	-	Terminated(Transition to a dif... more >>ferent immunotherapy strategy in the future at our institution) Collapse <<	-	-
NCT02190695	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Collapse <<	Phase 2	Recruiting	April 2018	United States, Pennsylvania ... more >> Temple BMT Program at Jeanes Hospital Recruiting Philadelphia, Pennsylvania, United States, 19111 Principal Investigator: Patricia Kropf, MD Principal Investigator: Jean-Pierre Issa, MD Sub-Investigator: Stefan Barta, MD Sub-Investigator: Philip Pancari, MD Sub-Investigator: Henry Fung, MD United States, Texas M.D. Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Alexandra Thackrey, RN- BC 713-745-2238 AMThackrey@mdanderson.org Principal Investigator: Hagop Kantarjian, MD Collapse <<
NCT02332889	Gliomas Medul... more >>loblastoma Neuroectodermal Tumors, Primitive Collapse <<	Phase 1 Phase 2	Terminated(Transition to a dif... more >>ferent immunotherapy strategy in the future at our institution) Collapse <<	-	United States, Kentucky ... more >> Pediatric Hematology/Oncology University of Louisville Louisville, Kentucky, United States, 40202 University of Louisville, Kosair Children's Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States, 40202 University of Louisville Louisville, Kentucky, United States, 40202 Collapse <<
NCT00621023	Myelodysplastic Syndrome	Phase 2	Completed	-	United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT02252107	Acute Myeloid Leukemia (AML)	Phase 2	Active, not recruiting	October 2019	Belgium ... more >> University of Liège Liège, Belgium Netherlands University Medical Center Groningen (UMCG) Groningen, Netherlands Radboud university medical center Nijmegen, Netherlands, 6500 HB Collapse <<
NCT00621023	-	-	Completed	-	-
NCT00671697	Myelodysplastic Syndromes and ... more >>Leukemia, Myeloid, Acute Collapse <<	Phase 1	Completed	-	United States, Missouri ... more >> Washington University St. Louis, Missouri, United States, 63110 Collapse <<
NCT01546038	Acute Myeloid Leukemia	Phase 2	Active, not recruiting	June 2019	-
NCT01546038	-	-	Active, not recruiting	-	-
NCT01896856	Previously Treated Metastatic ... more >>Colorectal Cancer Collapse <<	Phase 2	Recruiting	September 2019	United States, California ... more >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Anthony El-Khoueiry, MD 323-865-3967 elkhouei@med.usc.edu United States, Maryland Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Ellen Lilly-Foreman, RN 443-287-4961 lillyel@jhmi.edu Contact: Tearra Miles tlawre18@jhmi.edu Principal Investigator: Nilo Azad, MD United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Derek Alexander 646-888-1381 alexandd@mskcc.org Principal Investigator: Andrea Cercek, MD Netherlands VU Medisch Centrum Recruiting Amsterdam, Netherlands, 1081 HV Contact: Henk Verheul, MD h.verheul@vumc.nl Contact: Elske Gootjes, MD e.gootjes@vumc.nl Collapse <<
NCT03346642	Primary Mediastinal Large B-ce... more >>ll Lymphoma Collapse <<	Phase 1 Phase 2	Recruiting	October 1, 2019	China, Beijing ... more >> Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Weidong Han, Doctor 86-10-66937463 hanwdrsw@sina.com Contact: Qingming Yang, Doctor 86-10-55499341 yangqm@medmail.com.cn Principal Investigator: Wenying Zhang Principal Investigator: Qian Mei Principal Investigator: Yang Liu Principal Investigator: Weidong Han Principal Investigator: Qingming Yang Principal Investigator: Hejin Jia Principal Investigator: Jing Nie Principal Investigator: Chunmeng Wang Principal Investigator: Yan Zhang Sub-Investigator: Kaichao Feng Sub-Investigator: Meixia Chen Sub-Investigator: Lu Shi Sub-Investigator: Xiang Li Sub-Investigator: Liang Dong Biotherapeutic Department of Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Weidong Han, Doctor 86-10-66937463 hanwdrsw@sina.com Contact: Qingming Yang, Doctor 86-10-55499341 yangqm@medmail.com.cn Collapse <<
NCT03282825	Advanced Breast Cancer	Phase 1	Active, not recruiting	May 2018	Korea, Republic of ... more >> Yonsei University Health System, Severance Hospital Seoul, Korea, Republic of, 03722 Collapse <<
NCT02084563	Acute Myeloid Leukemia ... more >> Myeloproliferative Neoplasms Myelodysplastic Syndromes Myeloproliferative/Myelodysplastic Neoplasm Collapse <<	Phase 2	Completed	-	Brazil ... more >> Hospital Israelita Albert Einstein Sao Paulo, SP, Brazil, 05651901 Collapse <<
NCT03596892	Allogeneic Hematopoietic Stem ... more >>Cell Transplantation Conditions Mixed-lineage-leukemia (MLL)-Rearranged Acute Leukemia Collapse <<	Phase 2 Phase 3	Recruiting	June 2022	China, Guangdong ... more >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan +86-020-62787883 356135708@qq.com Principal Investigator: Qifa Liu Collapse <<
NCT01130662	Acute Myeloid Leukemia	Phase 1	Completed	-	United States, Kansas ... more >> University of Kansas Medical Center, Westwood Campus Kansas City, Kansas, United States, 66205 Collapse <<
NCT02961101	Malignancies Multiple	Phase 1 Phase 2	Recruiting	May 2020	China, Beijing ... more >> Biotherapeutic Department of Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Weidong Han, Doctor +86-10-66937463 hanwdrsw@sina.com Contact: Qingming Yang, Doctor +86-10-55499341 yangqm@medmail.com.cn Principal Investigator: Yang Liu, Doctor Principal Investigator: Chunmeng Wang, Master Principal Investigator: Wenying Zhang, Master Principal Investigator: Meixia Chen, Doctor Principal Investigator: Weidong Han, Doctor Principal Investigator: Qingming Yang, Doctor Principal Investigator: Qian Mei, Doctor Principal Investigator: Jing Nie, Doctor Sub-Investigator: Yan Zhang, Doctor Sub-Investigator: Kaichao Feng, Doctor Sub-Investigator: Jingdan Qiu, Doctor Sub-Investigator: Hejin Jia, Doctor Sub-Investigator: Xiang Li, Master Sub-Investigator: Liang Dong, Master Sub-Investigator: Lu Shi, Master Collapse <<
NCT01194908	Breast Cancer ... more >> Breast Tumors Breast Neoplasms Collapse <<	Phase 1 Phase 2	Terminated(Slow accrual)	-	United States, Georgia ... more >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30329 Collapse <<
NCT00861874	Acute Myeloid Leukemia	Phase 1	Completed	-	United States, New York ... more >> University of Rochester Rochester, New York, United States, 14642 Collapse <<
NCT02839694	Neoplasm Metastasis ... more >> Sarcoma Neoplasms, Germ Cell and Embryonal Melanoma Collapse <<	Phase 1	Withdrawn	-	-
NCT01194908	-	-	Terminated(Slow accrual)	-	-
NCT03233724	Carcinoma, Non-Small-Cell Lung... more >> Lung Cancer Non-Small Cell Lung Cancer Collapse <<	Phase 1 Phase 2	Recruiting	December 31, 2020	United States, Maryland ... more >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse <<
NCT02412475	Leukemia, Acute Myeloid	Phase 1	Active, not recruiting	February 2019	United States, Minnesota ... more >> Children's Hospitals and Clinics of Minnesota Minneapolis, Minnesota, United States, 55404 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Collapse <<
NCT03240211	PTCL CTCL	Phase 1	Recruiting	December 2020	United States, New York ... more >> 51 West 51st Street, Suite 200 Recruiting New York, New York, United States, 10019 Contact: Michelle Malanga 212-326-5731 mm4629@cumc.columbia.edu Italy University of Bologna Not yet recruiting Bologna, Italy Principal Investigator: Pier Luigi Zinzani, MD, PhD Korea, Republic of Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of Principal Investigator: Won Seog Kim, MD, PhD Collapse <<
NCT03381781	Acute Myeloid Leukemia ... more >> P53 Mutation Collapse <<	Phase 2	Not yet recruiting	November 2020	China ... more >> Ruijin Hospital North Not yet recruiting Shanghai, China Contact: Sujiang Zhang, MD 0086-21-67888761 zbruce.zhang@hotmail.com Principal Investigator: Sujiang Zhang, MD Ruijin Hospital Not yet recruiting Shanghai, China Contact: Junmin Li 021-86-64370045 ext 665251 drlijunming@126.com Principal Investigator: Junming Li Shanghai Institute of Hematology Not yet recruiting Shanghai, China Contact: Min Lu, Ph.D. 86-21-64370045 ext 610805 min.lu@shsmu.edu.cn Principal Investigator: Min Lu, Ph.D. Collapse <<
NCT00422890	Myeloid Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 3	Completed	-	Germany ... more >> University hospital Dresden, department of medicine Dresden, Saxony, Germany, 01307 Collapse <<
NCT01593670	Myelodysplastic Syndrome	Phase 2	Terminated	-	United States, Minnesota ... more >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Mayo Clinic Rochester, Minnesota, United States, 55901 Collapse <<
NCT01241500	Myelodysplastic Syndromes ... more >> MDS RAEB Chronic Myelomonocytic Leukemia Collapse <<	Phase 3	Active, not recruiting	February 2019	-
NCT01593670	-	-	Terminated	-	-
NCT00751699	Healthy	Phase 1	Completed	-	United States, Florida ... more >> Research Site Miami, Florida, United States Collapse <<
NCT03030612	Acute Myeloid Leukemia ... more >> High Risk Myelodysplastic Syndrome Collapse <<	Phase 1 Phase 2	Recruiting	May 2021	France ... more >> Recruiting Marseille, France Contact: Norbert Vey, Prof. VEYN@ipc.unicancer.fr Recruiting Pierre-Bénite, France Contact: Xavier Thomas, Dr. xavier.thomas@chu-lyon.fr Recruiting Toulouse, France Contact: Christian Recher, Prof. recher.christian@iuct-oncopole.fr Italy Recruiting Novara, Italy Contact: Gianluca GAIDANO, Prof 'gianluca.gaidano@med.uniupo.it Switzerland Kantonsspital Aarau (University Clinic for Medicine, Center of Oncology/Hematology and Transfusion Medicine) Recruiting Aarau, Switzerland Contact: Mario Bargetzi, Prof. Dr. Mario.Bargetzi@ksa.ch Inselspital/University Hospital Recruiting Bern, Switzerland, 3010 Contact: Thomas Pabst, Prof. dr. Thomas.PabstMueller@insel.ch UniversitätsSpital Recruiting Zürich, Switzerland Contact: Rouven Müller, dr. Rouven.Mueller@usz.ch Collapse <<
NCT01063257	Myelodysplastic Syndrome	Phase 1 Phase 2	Completed	-	France ... more >> Hôpital Avicenne Bobigny, France, 93009 Institut Paoli-Calmettes Marseille, France, 13009 Hôpital Saint-Louis Paris, France, 75475 Hopital Cochin Service d'Hématologie Paris, France, 75679 Centre Henri Becquerel Rouen, France, 76038 Collapse <<
NCT00661726	-	-	Completed	-	-
NCT00054431	Accelerated Phase Chronic Myel... more >>ogenous Leukemia Blastic Phase Chronic Myelogenous Leukemia Childhood Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Relapsing Chronic Myelogenous Leukemia Collapse <<	Phase 2	Completed	-	United States, Texas ... more >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00089089	Hematopoietic/Lymphoid Cancer ... more >> Unspecified Adult Solid Tumor, Protocol Specific Collapse <<	Phase 1	Terminated	-	United States, Texas ... more >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00049582	Adult Acute Myeloid Leukemia W... more >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative de Novo Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Terminated	-	Canada, Ontario ... more >> Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada, M5G 2M9 Collapse <<
NCT01813838	SMD	Phase 1 Phase 2	Terminated(Renal toxicity)	-	France ... more >> Centre hospitalier de la côte Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93009 CHU de Haut-Lévèque Bordeaux Pessac, France, 33604 Centre henri Mondor Creteil, France, 94010 CHU de Grenoble Grenoble, France, 38043 CHU de Limoges Limoges, France, 87042 Institut paoli calmettes Marseille, France, 13273 centre hospitalier de Meaux Meaux, France, 77100 CHU de nantes Nantes, France, 44093 Centre Antoine Lacassagne Nice, France, 06189 Hôpital L'archet 1, Nice Nice, France, 06202 cedex 3 Hôpital Saint Louis Paris, France, 75010 Hôpital Saint Antoine Paris, France, 75012 Hôpital Saint-Louis Paris, France, 75475 cedex 10 Hôpital Cochin Paris, France, 75679 cedex14 Centre henri Becquerel Rouen, France, 76038 Hôpital Bretonneau de Tours Tours, France, 37000 Collapse <<
NCT00030615	Male Breast Cancer ... more >> Recurrent Bladder Cancer Recurrent Breast Cancer Recurrent Melanoma Stage III Melanoma Stage IV Bladder Cancer Stage IV Breast Cancer Stage IV Melanoma Unspecified Adult Solid Tumor, Protocol Specific Collapse <<	Phase 1	Completed	-	United States, California ... more >> University of Southern California Los Angeles, California, United States, 90033-0804 Collapse <<
NCT00791271	Melanoma	Phase 1	Terminated	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01417767	Myelodysplastic Syndromes	Phase 2 Phase 3	Unknown	September 2013	China, Shanghai ... more >> Shanghai 6th People's Hospital Not yet recruiting Shanghai, Shanghai, China, 200233 Contact: Xiao Li lixiao3326@yahoo.com.cn Principal Investigator: Xiao Li Collapse <<
NCT00398047	Leukemia Myel... more >>odysplastic Syndromes Collapse <<	Phase 2	Terminated(Slow accrual)	-	United States, North Carolina ... more >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Collapse <<
NCT00398047	-	-	Terminated(Slow accrual)	-	-
NCT00561912	-	-	Terminated(Low accrual.)	-	-
NCT03723135	-	-	-	-	United States, New Jersey ... more >> Celgene Summit, New Jersey, United States, 07901 Collapse <<
NCT03542266	Previously Untreated Periphera... more >>l T-cell Lymphoma Collapse <<	Phase 2	Recruiting	May 30, 2022	United States, New York ... more >> Weill Cornell Medicine Recruiting New York, New York, United States, 10065 Contact: Amelyn Rodriguez, RN 212-746-1362 amr2017@med.cornell.edu Contact: Rita Vaccaro, RN 212-746-0702 rig9021@med.cornell.edu Collapse <<
NCT03765541	Relapsed or Refractory Acute M... more >>yeloid Leukemia Collapse <<	Phase 3	Not yet recruiting	January 2024	France ... more >> CHU de Grenoble Not yet recruiting Grenoble, France Contact: Jean-Yves CAHN, PhD CHU de Limoges Not yet recruiting Limoges, France Contact: Pascal TURLURE, MD Institut Paoli Calmettes Not yet recruiting Marseille, France Contact: Norbert VEY, PhD CHU de Montpellier Not yet recruiting Montpellier, France Contact: Hicheri Yosr, MD CHU de Nantes Not yet recruiting Nantes, France Contact: Pierre PETERLIN, MD CHU de Nîmes Not yet recruiting Nîmes, France Contact: Eric JOURDAN, MD CHU de Bordeaux Not yet recruiting Pessac, France Contact: Arnaud PIGNEUX, PhD CHU de Poitiers Not yet recruiting Poitiers, France Contact: Maria-Pilar GALLEGO-HERMANZ, MD Collapse <<
NCT00561912	Renal Cell Carcinoma	Phase 2	Terminated(Low accrual.)	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01812252	Chronic Myelomonocytic Leukemi... more >>a de Novo Myelodysplastic Syndrome Myelodysplastic Syndrome Secondary Myelodysplastic Syndrome Collapse <<	Phase 2	Recruiting	-	United States, Arizona ... more >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Mayo Clinic Clinical Trials Office 855-776-0015 cancerclinicaltrials@mayo.edu Principal Investigator: Nandita Khera United States, Ohio Cleveland Clinic Foundation Recruiting Cleveland, Ohio, United States, 44195 Contact: Aaron T. Gerds 216-444-6833 gerdsa@ccf.org Principal Investigator: Aaron T. Gerds United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Bart L. Scott 206-667-1990 bscott@fhcrc.org Principal Investigator: Bart L. Scott Kaiser Permanente Washington Terminated Seattle, Washington, United States, 98112 Collapse <<
NCT00349596	Acute Lymphocytic Leukemia	Phase 1	Completed	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00911066	Acute Myelogenous Leukemia ... more >> Acute Lymphoblastic Leukemia Myelodysplastic Syndrome Collapse <<	Phase 1	Completed	-	United States, California ... more >> Stanford University Medical Center Stanford, California, United States, 94305 United States, Illinois Robert H. Lurie Comprehensive Cancer Center Northwestern University Chicago, Illinois, United States, 60657 United States, Maryland Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Texas Institute for Drug Development San Antonio, Texas, United States, 78229 Collapse <<
NCT00041990	Chronic Myelogenous Leukemia	Phase 2	Completed	-	United States, California ... more >> City of Hope Medical Center Duarte, California, United States Scripps Clinic Escondido, California, United States USC/Norris Cancer Center Los Angeles, California, United States United States, Minnesota Metro-Minnesota CCOP St. Louis Park, Minnesota, United States United States, New York New York Medical College Valhalla, New York, United States United States, South Carolina Liberty Hematology/Oncology Columbia, South Carolina, United States United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada Collapse <<
NCT00042016	Chronic Myelogenous Leukemia	Phase 2	Completed	-	United States, California ... more >> City of Hope Medical Center Duarte, California, United States Scripps Clinic Escondido, California, United States USC/Norris Cancer Center Los Angeles, California, United States United States, Minnesota Metro-Minnesota CCOP St. Louis Park, Minnesota, United States United States, New York New York Medical College Valhalla, New York, United States United States, South Carolina Liberty Hematology/Oncology Columbia, South Carolina, United States United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada Collapse <<
NCT00744757	Myelodysplastic Syndrome	Phase 2	Completed	-	Taiwan ... more >> Changhua, Taiwan Kaohsiung, Taiwan Taichung, Taiwan Tainan, Taiwan Taipei, Taiwan Tau-Yuan County 333, Taiwan Collapse <<
NCT01333046	Hodgkin Lymphoma ... more >> Non-Hodgkin Lymphoma Hodgkin Disease Collapse <<	Phase 1	Recruiting	January 2026	United States, Texas ... more >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: George Carrum, MD 713-441-1450 gcarrum@bcm.edu Contact: Munu Bilgi 832-824-1518 mxbilgi@txch.org Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: George Carrum, MD 713-441-1450 gcarrum@bcm.edu Contact: Munu Bilgi 832-824-1518 mxbilgi@txch.org Collapse <<
NCT03545568	N-Acetylneuraminic Acid Storag... more >>e Disease Collapse <<	Not Applicable	Completed	-	Italy ... more >> Struttura Semplice Dipartimentale di Genetica Clinica Reggio Emilia, Italy, 42123 Switzerland Lausanne University Hospital Lausanne, Vaud, Switzerland, 1011 Collapse <<
NCT00744757	-	-	Completed	-	-
NCT00043381	Myelodysplastic Syndrome	Phase 3	Completed	-	United States, California ... more >> Alta Bates Comprehensive Cancer Center Berkeley, California, United States City of Hope National Medical Center Duarte, California, United States Scripps Clinic Escondido, California, United States Loma Linda Univ. Cancer Center Loma Linda, California, United States Univ. California San Francisco Medical School San Francisco, California, United States United States, Florida University of Florida Gainsville, Florida, United States H. Lee Moffitt Cancer Center Tampa, Florida, United States James A. Haley Veteran's Hospital Tampa, Florida, United States United States, Illinois Rush Medical Center Chicago, Illinois, United States University of Illinois at Chicago Chicago, Illinois, United States United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States New England Medical Center Hospital Boston, Massachusetts, United States University of Massachusetts Medical School Worcester, Massachusetts, United States United States, Minnesota VA Medical Center Minneapolis, Minnesota, United States United States, Missouri Washington Univ. School of Medicine St. Louis, Missouri, United States United States, New York Roswell Park Cancer Institute Buffalo, New York, United States Memorial Sloan Kettering Cancer Center New York, New York, United States Mount Sinai Medical Center New York, New York, United States United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States Duke University Medical Center Durham, North Carolina, United States United States, Tennessee The Memphis Cancer Center Memphis, Tennessee, United States United States, Texas SW Regional Cancer Center (dba Central Texas Oncology Associates) Austin, Texas, United States Texas Oncology Dallas, Texas, United States MD Anderson Cancer Center Houston, Texas, United States Collapse <<
NCT02587598	Solid Tumors	Phase 1 Phase 2	Recruiting	January 2020	-
NCT00636922	Acute Myeloid Leukemia	Phase 1	Unknown	January 2014	Australia, Victoria ... more >> BaysideHealth, The Alfred Hospital Melbourne, Victoria, Australia, 3004 Collapse <<
NCT02071927	Acute Myeloid Leukemia (AML) ... more >> Acute Lymphocytic Leukemia (ALL) Collapse <<	Phase 1	Completed	-	United States, Colorado ... more >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Illinois Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37203 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT03684811	Cohort 1a and 1b: Glioma ... more >> Cohort 1a and 1b: Glioblastoma Multiforme Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) Cohort 3a and 3b: Chondrosarcoma Cohort 4a and 4b: Intrahepatic Cholangiocarcinoma Cohort 5a: Other Solid Tumors With IDH1 Mutations Collapse <<	Phase 1 Phase 2	Recruiting	April 1, 2022	United States, Florida ... more >> University of Miami, Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Tamara Leon 305-243-0865 txl351@med.miami.edu Collapse <<
NCT03614728	Neoplasms	Phase 2	Not yet recruiting	December 15, 2022	United States, Florida ... more >> GSK Investigational Site Not yet recruiting Miami, Florida, United States, 33136 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Collapse <<
NCT00042003	Chronic Myelogenous Leukemia	Phase 2	Completed	-	United States, California ... more >> City of Hope Medical Center Duarte, California, United States Scripps Clinic Escondido, California, United States USC/Norris Cancer Center Los Angeles, California, United States United States, Minnesota Metro-Minnesota CCOP St. Louis Park, Minnesota, United States United States, New York New York Medical College Valhalla, New York, United States United States, South Carolina Liberty Hematology/Oncology Columbia, South Carolina, United States United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada Collapse <<
NCT02269943	-	-	Completed	-	-
NCT02944955	Myelodysplastic Syndrome (MDS)	Phase 2	Not yet recruiting	-	-
NCT02038777	Acute Myeloid Leukemia	Phase 1	Recruiting	October 31, 2019	Japan ... more >> Japanese Red Cross Nagoya First Hospital Recruiting Nagoya, Aichi, Japan, 453-8511 Kobe University Hospital Recruiting Kobe-shi, Hyogo, Japan, 650-0017 Tohoku University Hospital Recruiting Sendai, Miyagi, Japan, 980-8574 National Cancer Center Hospital Recruiting Chuo-ku, Tokyo, Japan, 104-0045 Akita University Hospital Recruiting Akita, Japan, 010-8543 Kyushu University Hospital Recruiting Fukuoka, Japan, 812-8582 Tokyo Medical University Hospital Recruiting Tokyo, Japan, 160-0023 Collapse <<
NCT00701298	Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse <<	Phase 1	Terminated	-	United States, Nevada ... more >> Nevada Cancer Institute-Summerlin Campus Las Vegas, Nevada, United States, 89135 Collapse <<
NCT02269943	Nasopharyngeal Neoplasms	Phase 2	Completed	-	-
NCT03366116	Neoplasms Sol... more >>id Tumors Collapse <<	Phase 1	Recruiting	September 23, 2021	United States, Maryland ... more >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse <<
NCT00004062	Head and Neck Cancer	Phase 1	Completed	-	United States, Kentucky ... more >> Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States, 40536-0084 Collapse <<
NCT01192945	-	-	Completed	-	Germany ... more >> iOMEDICO AG Freiburg, Baden-Wuerttemberg, Germany, 79106 Collapse <<
NCT00886457	Cancer	Phase 1	Terminated(low accrual)	-	United States, Nevada ... more >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Collapse <<
NCT01993641	Myelodysplastic Syndrome ... more >> MDS Collapse <<	Phase 2	Completed	-	United States, Alabama ... more >> Southern Cancer Center Mobile, Alabama, United States, 36608 United States, California City of Hope Duarte, California, United States, 91010 USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Sutter Medical Group Sacramento, California, United States, 95816 United States, Colorado Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Connecticut Yale School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Florida Cancer Specialist South Fort Myers, Florida, United States, 33916 Florida Cancer Specialist North St Petersburg, Florida, United States, 33705 United States, Illinois Northwestern University Chicago, Illinois, United States, 60601 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 United States, New Jersey John Theurer Cancer Center Hackensak, New Jersey, United States, 07601 United States, Ohio Oncology Hematology Care Cincinati, Ohio, United States, 45242 Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Oklahoma University of Oklahoma Health Science Center Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Tennessee Oncology-Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 University of Texas Southwestern Dallas, Texas, United States, 75390 MD Anderson Cancer Center Houston, Texas, United States, 77030 Cancer Care Centers of South Texas San Antonio, Texas, United States, 78229 Collapse <<
NCT02546986	Carcinoma, Non-Small-Cell Lung	Phase 2	Active, not recruiting	May 1, 2019	-
NCT01928576	Non-Small Lung Cancer, Epigene... more >>tic Therapy Collapse <<	Phase 2	Recruiting	August 2022	United States, California ... more >> University of Southern California Completed Los Angeles, California, United States, 90033 United States, Maryland Julie Brahmer, MD Recruiting Baltimore, Maryland, United States, 21224 Contact: Julie Brahmer, MD 410-502-7159 brahmju@jhmi.edu Contact: Jessica Wakefield 410-502-3696 jrober31@jhmi.edu Julie Brahmer, MD Recruiting Baltimore, Maryland, United States, 21287 Contact: Julie Brahmer, MD 410-502-7159 jbrahmju@jhmi.edu Contact: Jessica Wakefield 410-502-3696 jrober31@jhmi.edu United States, Pennsylvania UPMC Cancer Center- Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: James G Herman, MD 412-692-4724 hermanj3@upmc.edu Collapse <<
NCT01369368	Acute Myeloid Leukemia	Phase 1 Phase 2	Recruiting	October 2020	Norway ... more >> Haukeland University Hospital Recruiting Bergen, Norway, N-5021 Principal Investigator: Oystein Bruserud, MD Collapse <<
NCT01067274	Acute Myeloid Leukemia	Phase 3	Withdrawn(Study abandoned)	-	France ... more >> Chu Amiens Sud Amiens, France, 80054 CH Argenteuil, France, 95107 Hopital Avicenne Bobigny, France Chu Boulogne Sur Mer Boulogne Sur Mer, France, 62321 CH Caen, France, 14033 Hopital Percy Clamart, France, 92141 Ch Sud Francilien Corbeil Essonnes, France, 94010 Hopital Henri Mondor Creteil, France Ch Dunkerque Dunkerque, France, 59385 CH Lens, France, 62307 CHU Lille, France, 59037 CH Limoges, France, 87042 Hopital Edouard Herriot Lyon, France CH Meaux, France, 77104 Centre Antoine Lacassagne Nice, France, 06189 Necker Hospital Paris 15, France, 75015 St Antoine Hospital Paris, France, 75012 Hopital Pitie-Salpetriere Paris, France, 75651 Hopital Saint-Louis Paris, France Ch Rene Dubos Pontoise, France, 95303 CH Roubaix, France, 59100 CHU Rouen, France, 76038 CNLCC Saint-Cloud, France, 92210 CH Valenciennes, France, 59322 CH Versailles, France IGR Villejuif, France Collapse <<
NCT02343536	Lymphoma, Large B-Cell, Diffus... more >>e Lymphoma, Follicular Collapse <<	Phase 1	Active, not recruiting	March 1, 2020	United States, Florida ... more >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02117 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Weill Cornell Medicine New York, New York, United States, 10065 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02903 Collapse <<
NCT02782468	Leukemia, Myeloid, Acute ... more >> Myelodysplastic Syndromes Collapse <<	Phase 1	Active, not recruiting	September 20, 2019	Japan ... more >> Maebashi City, Japan Nagoya, Japan Sendai City, Japan Tokyo, Japan Korea, Republic of Chonnam National University Hwasun Hospital Jeonnam, Korea, Republic of, 519-763 Severance Hospital Yonsei University Health System - PPDS Seoul, Korea, Republic of, 120-752 The Catholic University of Korea, Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137701 Taiwan National Taiwan University Hospital Taipei, Taiwan, 10048 Taipei Veterans General Hospital Taipei, Taiwan, 112 Collapse <<
NCT02546986	-	-	Active, not recruiting	-	-
NCT02197676	MDS	Phase 2	Completed	-	France ... more >> CH Angers Angers, France, 49 000 CH Avignon Avignon, France, 84000 Centre Hospitalier de La Cote Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93 000 CHU Clémenceau Caen, France, 14033 CHU Henri Mondor Créteil, France, 94010 CHU de Grenoble Grenoble, France, 38043 Centre Hospitalier du Mans Le Mans, France, 72000 CHRU Limoges Limoges, France, 87046 CH Lyon Sud Lyon, France, 69495 Hôpital Paoli Calmettes Marseille, France, 13273 Centre Hospitalier de Meaux Meaux, France, 77100 Clinique Beausoleil (Montpellier) Montpellier, France, 34000 CHU de nantes Nantes, France, 44093 Centre Catherine de Sienne (Nantes) Nantes, France, 44277 CHU de Nice - Hopital de l'Archet 1 Nice, France, 06 202 CHR Orléans Orléans, France, 45000 Hopital St Louis T4 Paris, France, 75475 Centre Hospitalier Joffre Perpignan, France, 66046 CHU de Haut-Lévèque Pessac, France, 33604 CHU de Poitiers Poitiers, France, 86000 Centre Hospitalier de la région d'Annecy Pringy, France, 74374 Centre Henri Becquerel Rouen, France, 76038 Chu Purpan Toulouse, France, 31059 Hopital Purpan Service d'Hématologie Clinique Toulouse, France CHU Bretonneau Tours, France, 37044 CHU Brabois Vandœuvre-lès-Nancy, France, 54511 Collapse <<
NCT01935947	Recurrent Non-Small Cell Lung ... more >>Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Collapse <<	Phase 2	Terminated	-	United States, California ... more >> USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States, 92663 United States, Maryland Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 Collapse <<
NCT01935947	-	-	Terminated	-	-
NCT02807558	Acute Myeloid Leukemia ... more >> Myelodysplastic Syndrome Collapse <<	Phase 2	Recruiting	December 2021	United States, Iowa ... more >> Recruiting Iowa City, Iowa, United States United States, Massachusetts Recruiting Boston, Massachusetts, United States United States, Michigan Recruiting Ann Arbor, Michigan, United States United States, New York Recruiting New York, New York, United States Recruiting Rochester, New York, United States United States, North Carolina Recruiting Durham, North Carolina, United States United States, Ohio Recruiting Cleveland, Ohio, United States United States, Oregon Recruiting Portland, Oregon, United States United States, Pennsylvania Recruiting Pittsburgh, Pennsylvania, United States United States, Tennessee Recruiting Nashville, Tennessee, United States United States, Texas Recruiting Houston, Texas, United States France Centre Hospitalier Universitaire Nancy Recruiting Vandoeuvre les nancy, France, 54511 Institut Gustave Roussy Recruiting Villejuif, France, 94805 Collapse <<
NCT01210274	-	-	Recruiting	September 2018	France ... more >> CH d'Antibes Recruiting Antibes, France Contact: Vanina OLIVERI, Project Manaer oliveri.v@chu-nice.fr Principal Investigator: Daniel RE, PH CHU de Nice - Hôpital de l'Archet Recruiting Nice, France, 06200 Contact: Vanina OLIVERI, Project Manager oliveri.v@chu-nice.fr Principal Investigator: Thomas CLUZEAU, PH Centre Antoine Lacassagne Recruiting Nice, France Contact: Vanina OLIVERI, Project Manager oliveri.v@chhu-nice.fr Principal Investigator: Antoine THYSS, PU-PH Sub-Investigator: Frederic PEYRADE, PH Sub-Investigator: Lauris GASTAUD, PH Monaco CH Princesse Grace Recruiting Monaco, Monaco Contact: Vanina OLIVERI, Project Manager oliveri.v@chu-nice.fr Principal Investigator: Georges GARNIER, PH Sub-Investigator: Philippe HEUDIER, PH Collapse <<
NCT02400281	Acute Myeloid Leukemia	Phase 1 Phase 2	Active, not recruiting	April 2020	United States, Texas ... more >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT03284593	-	-	Active, not recruiting	December 2030	France ... more >> University Hospital Bordeaux Bordeaux, France University Hospital Toulouse Toulouse, France, 31052 Collapse <<
NCT00113321	Myelodysplastic Syndrome ... more >> Chronic Myelomonocytic Leukemia Collapse <<	Phase 2	Terminated(Low Accrual)	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00113321	-	-	Terminated(Low Accrual)	-	-
NCT02981615	Prevention	Phase 3	Recruiting	December 2019	Israel ... more >> Chim Sheba Medical Center Recruiting Tel Hashomer, Israel, 52621 Contact: Merkel Drorit, MD 972526669168 drorit.merkel@sheba.health.gov.il Collapse <<
NCT01983969	Advanced Cancers ... more >> Lymphoma Collapse <<	Phase 1 Phase 2	Completed	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01133886	Acute Myeloid Leukemia ... more >> Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Collapse <<	Phase 2	Unknown	September 2013	United Kingdom ... more >> King's College Hospital NHS Foundation Trust Recruiting London, United Kingdom, SE5 9RS Contact: Ghulam J Mufti, MB, DM, FRCP, FRCPath +44 (0) 20 3299 9000 ext 3238 ghulam.mufti@kcl.ac.uk Collapse <<
NCT01835587	Leukemia, Myeloid, Acute ... more >> Myelodysplastic Syndromes Collapse <<	Phase 1 Phase 2	Completed	-	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center. New York, New York, United States, 10065 United States, Ohio University Hospitals Cleveland Medical Center Cleveland, Ohio, United States, 44106 United States, Texas MD Anderson Cancer Center The University of Texas Houston, Texas, United States, 77030 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-4417 United Kingdom Queen Elizabeth Hospital UHB NHS Foundation Trust Birmingham, United Kingdom, B15 2TH Collapse <<
NCT00700011	Myelodysplastic Syndromes	Phase 2	Terminated(poor accrual)	-	United States, Texas ... more >> Texas Oncology Cancer Center Amarillo, Texas, United States, 79106 Collapse <<
NCT00700011	-	-	Terminated(poor accrual)	-	-
NCT01845805	Pancreatic Cancer	Phase 2	Recruiting	December 2018	United States, Maryland ... more >> Johns Hopkins Recruiting Baltimore, Maryland, United States, 21205 Principal Investigator: Nilofer Azad, MD Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Susan Sartorius-Mergenthaler, RN 410-614-3644 sartosu@jhmi.edu Contact: Amber-Lynn Mitcheltree, BA 410-502-5327 amiche13@jhmi.edu Principal Investigator: Nilo Azad, MD United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Colin Weekes, MD, PhD 617-724-4000 cdweekes@mgh.harvard.edu Contact: Patricia Lynch, RN 617-643-0816 Lynch.Patricia2@mgh.harvard.edu Principal Investigator: Colin Weekes, MD, PhD United States, Pennsylvania The Hospital of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Colleen Redlinger 215-220-9693 Colleen.Redlinger@uphs.upenn.edu Principal Investigator: Peter J O'Dwyer, MD Collapse <<
NCT01168219	Acute Myeloid Leukemia ... more >> Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Erythroleukemia Adult Pure Erythroid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Secondary Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 2	Active, not recruiting	November 15, 2018	United States, Delaware ... more >> Beebe Medical Center Lewes, Delaware, United States, 19958 Christiana Care Health System-Christiana Hospital Newark, Delaware, United States, 19718 United States, Florida Florida Hospital Orlando Orlando, Florida, United States, 32803 United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Union Hospital of Cecil County Elkton, Maryland, United States, 21921 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Hampshire Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New Jersey Cooper Hospital University Medical Center Camden, New Jersey, United States, 08103 United States, New York Northwell Health NCORP Lake Success, New York, United States, 11042 Mount Sinai Hospital New York, New York, United States, 10029 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Collapse <<
NCT01835587	-	-	Completed	-	-
NCT02494258	Hematologic Neoplasm ... more >> Neoplasms Collapse <<	Phase 2	Recruiting	December 31, 2020	United States, Florida ... more >> University of Florida College of Med Recruiting Gainesville, Florida, United States, 32610-0277 United States, Maryland Johns Hopkins Oncology Center Recruiting Baltimore, Maryland, United States, 21231 United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 United States, Virginia Virginia Oncology Associates Not yet recruiting Norfolk, Virginia, United States, 23502 Collapse <<
NCT01168219	-	-	Active, not recruiting	-	-

5-氮胞苷 Catalog No. CSN19354

靶点选择性

请登录您的专属账户

确认信息